BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nagtegaal ID, Odze RD, Klimstra D, Paradis V, Rugge M, Schirmacher P, Washington MK, Carneiro F, Cree IA. The 2019 WHO classification of tumours of the digestive system. Histopathology.  2019. [PMID: 31433515 DOI: 10.1111/his.13975] [Cited by in Crossref: 388] [Cited by in F6Publishing: 403] [Article Influence: 129.3] [Reference Citation Analysis]
Number Citing Articles
1 Maekawa A, Kudo A, Kishino M, Murase Y, Watanabe S, Ishikawa Y, Ueda H, Akahoshi K, Ogawa K, Ono H, Tanaka S, Kinowaki Y, Tanabe M. Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy. J Cancer Res Clin Oncol 2021. [PMID: 33904982 DOI: 10.1007/s00432-021-03650-2] [Reference Citation Analysis]
2 Shi H, Chen L, Meng L, Zhang Q, Lin Y, Lin R, Chen J. The Role of Ki-67 Index Cut-off of 55% and Differentiation in Redefining NET and NEC for Grade 3 Gastrointestinal Neuroendocrine Neoplasms. J Gastrointest Surg 2020;24:2302-5. [PMID: 32578023 DOI: 10.1007/s11605-020-04651-1] [Reference Citation Analysis]
3 Tobaly D, Santinha J, Sartoris R, Dioguardi Burgio M, Matos C, Cros J, Couvelard A, Rebours V, Sauvanet A, Ronot M, Papanikolaou N, Vilgrain V. CT-Based Radiomics Analysis to Predict Malignancy in Patients with Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. Cancers (Basel) 2020;12:E3089. [PMID: 33114028 DOI: 10.3390/cancers12113089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
4 Jiang J, Teng L. Comment on: "Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric cancer, 2021 Aug 5" by Kim et al. Gastric Cancer 2021;24:1370-1. [PMID: 34426941 DOI: 10.1007/s10120-021-01232-2] [Reference Citation Analysis]
5 Zhao T, Li Y, Zhang J, Zhang B. PD-L1 expression increased by IFN-γ via JAK2-STAT1 signaling and predicts a poor survival in colorectal cancer. Oncol Lett 2020;20:1127-34. [PMID: 32724352 DOI: 10.3892/ol.2020.11647] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Shi H, Chen L, Zhang Q, Lin Y, Jiang C, Yao H, Hou X, Chen M, Lin R, Chen J. Concordance Between the Ki-67 Index Cutoff Value of 55% and Differentiation in Neuroendocrine Tumor and Neuroendocrine Carcinoma in Grade 3 Pancreatic Neuroendocrine Neoplasms. Pancreas 2020;49:1378-82. [PMID: 33122528 DOI: 10.1097/MPA.0000000000001693] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
7 Yan C, Yang H, Chen L, Liu R, Shang W, Yuan W, Yang F, Sun Q, Xia L. Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study. BMC Cancer 2021;21:1286. [PMID: 34852768 DOI: 10.1186/s12885-021-09031-9] [Reference Citation Analysis]
8 Kolb JM, Molmenti CL, Patel SG, Lieberman DA, Ahnen DJ. Increased Risk of Colorectal Cancer Tied to Advanced Colorectal Polyps: An Untapped Opportunity to Screen First-Degree Relatives and Decrease Cancer Burden. Am J Gastroenterol 2020;115:980-8. [PMID: 32618646 DOI: 10.14309/ajg.0000000000000639] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Lee SW, Lee T, Sul HJ, Park KC, Park J. Differences in Somatic Mutation Profiles between Korean Gastric Cancer and Gastric Adenoma Patients. J Clin Med 2021;10:2038. [PMID: 34068652 DOI: 10.3390/jcm10092038] [Reference Citation Analysis]
10 Fragkou N, Sideras L, Panas P, Emmanouilides C, Sinakos E. Update on the association of hepatitis B with intrahepatic cholangiocarcinoma: Is there new evidence? World J Gastroenterol 2021; 27(27): 4252-4275 [PMID: 34366604 DOI: 10.3748/wjg.v27.i27.4252] [Reference Citation Analysis]
11 Cao GJ, Wang D, Zeng ZP, Wang GX, Hu CJ, Xing ZF. Direct interaction between Rab5a and Rab4a enhanced epidermal growth factor-stimulated proliferation of gastric cancer cells. World J Gastrointest Oncol 2021; 13(10): 1492-1505 [PMID: 34721780 DOI: 10.4251/wjgo.v13.i10.1492] [Reference Citation Analysis]
12 Lin H, Huang H, Yu Y, Chen W, Zhang S, Zhang Y. Nerve growth factor regulates liver cancer cell polarity and motility. Mol Med Rep 2021;23:288. [PMID: 33649819 DOI: 10.3892/mmr.2021.11927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Woo LT, Ding YF, Mao CY, Qian J, Zhang XM, Xu N. Long-term survival of gastric mixed neuroendocrine-non-neuroendocrine neoplasm: Two case reports. World J Clin Cases 2022; 10(22): 7936-7943 [DOI: 10.12998/wjcc.v10.i22.7936] [Reference Citation Analysis]
14 Son J, Park IJ, Yang DH, Kim J, Kim KJ, Byeon JS, Hong SM, Kim YI, Kim JB, Lim SB, Yu CS, Kim JC. Oncological outcomes according to the treatment modality based on the size of rectal neuroendocrine tumors: a single-center retrospective study. Surg Endosc 2021. [PMID: 34009477 DOI: 10.1007/s00464-021-08527-6] [Reference Citation Analysis]
15 Zhu H, Wang G, Zheng J, Zhu H, Huang J, Luo E, Hu X, Wei Y, Wang C, Xu A, He X. Preoperative prediction for lymph node metastasis in early gastric cancer by interpretable machine learning models: A multicenter study. Surgery 2022. [DOI: 10.1016/j.surg.2021.12.015] [Reference Citation Analysis]
16 Basukala S, Bhusal U, Sharma S, Tamang A, Gurung S. An incidental finding of ANET in a patient with perforated appendix: A case report. Int J Surg Case Rep 2021;89:106625. [PMID: 34839114 DOI: 10.1016/j.ijscr.2021.106625] [Reference Citation Analysis]
17 Inoue K, Yoshida N, Kobayashi R, Tomita Y, Hashimoto H, Sugino S, Hirose R, Dohi O, Yasuda H, Yasuda R, Murakami T, Inada Y, Itoh Y, Ryozawa S. The Efficacy of Tumor Characterization for Colorectal Lesions with Blue Light Imaging of a Compact Light-Emitting Diode Endoscopic System Compared to a Laser Endoscopic System: A Pilot Study. Gastroenterology Research and Practice 2022;2022:1-7. [DOI: 10.1155/2022/9998280] [Reference Citation Analysis]
18 Neumann O, Burn TC, Allgäuer M, Ball M, Kirchner M, Albrecht T, Volckmar A, Beck S, Endris V, Goldschmid H, Lehmann U, Seker-cin H, Uhrig S, Roessler S, Budczies J, Fröhling S, Longerich T, Wagner AH, Vogel A, Schirmacher P, Stenzinger A, Kazdal D. Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing. Br J Cancer. [DOI: 10.1038/s41416-022-01908-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Kwak MS, Eun YG, Lee YC. Benefit of postoperative radiotherapy in patients with oropharyngeal squamous cell carcinoma in human papillomavirus (HPV) era: A Surveillance, Epidemiology, and End Results (SEER) database analysis. Surgery 2021;170:541-9. [PMID: 33663877 DOI: 10.1016/j.surg.2021.01.034] [Reference Citation Analysis]
20 Lopes A, de Mello ES, Mendoza Lopez RV, Leonardi PC, Ribeiro U Jr. Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei. J Surg Res 2022;274:68-76. [PMID: 35123285 DOI: 10.1016/j.jss.2022.01.001] [Reference Citation Analysis]
21 Zhang F, Lu S, Tian M, Hu K, Chen R, Zhang B, Ren Z, Shi Y, Yin X. Albumin-to-Alkaline Phosphatase Ratio is an Independent Prognostic Indicator in Combined Hepatocellular and Cholangiocarcinoma. J Cancer 2020;11:5177-86. [PMID: 32742464 DOI: 10.7150/jca.45633] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Han D, Li YL, Zhou ZW, Yin F, Chen J, Liu F, Shi YF, Wang W, Zhang Y, Yu XJ, Xu JM, Yang RX, Tian C, Luo J, Tan HY. Clinicopathological characteristics and prognosis of 232 patients with poorly differentiated gastric neuroendocrine neoplasms. World J Gastroenterol 2021; 27(21): 2895-2909 [PMID: 34135560 DOI: 10.3748/wjg.v27.i21.2895] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Watanabe H, Yamazaki Y, Fujishima F, Izumi K, Imamura M, Hijioka S, Toriyama K, Yatabe Y, Kudo A, Motoi F, Unno M, Sasano H. O6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms. BMC Cancer 2020;20:1195. [PMID: 33287738 DOI: 10.1186/s12885-020-07579-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Iwasaki K, Barroga E, Enomoto M, Tsurui K, Shimoda Y, Matsumoto M, Miyoshi K, Ota Y, Matsubayashi J, Nagakawa Y. Long-term surgical outcomes of gastric neuroendocrine carcinoma and mixed neuroendocrine-non-neuroendocrine neoplasms. World J Surg Oncol 2022;20:165. [PMID: 35610656 DOI: 10.1186/s12957-022-02625-y] [Reference Citation Analysis]
25 Zakaria A, Al-Share B, Klapman JB, Dam A. The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Pancreatic Cancer. Cancers (Basel) 2022;14:1373. [PMID: 35326524 DOI: 10.3390/cancers14061373] [Reference Citation Analysis]
26 Dhruv S, Anwar S, Polavarapu A, Liliane D. Gastric Carcinoid: The Invisible Tumor! Cureus 2021;13:e13556. [PMID: 33791175 DOI: 10.7759/cureus.13556] [Reference Citation Analysis]
27 Li X, Li J, Liu K, Tan L, Liu Y. Sarcomatoid intrahepatic cholangiocarcinoma in a patient with poor prognosis: a case report and literature review. J Int Med Res 2020;48:300060520969473. [PMID: 33161814 DOI: 10.1177/0300060520969473] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Kaiser J, Hinz U, Mayer P, Hank T, Niesen W, Hackert T, Gaida MM, Büchler MW, Strobel O. Clinical presentation and prognosis of adenosquamous carcinoma of the pancreas - Matched-pair analysis with pancreatic ductal adenocarcinoma. Eur J Surg Oncol 2021;47:1734-41. [PMID: 33622577 DOI: 10.1016/j.ejso.2021.02.011] [Reference Citation Analysis]
29 Van Herck Y, Feyaerts A, Alibhai S, Papamichael D, Decoster L, Lambrechts Y, Pinchuk M, Bechter O, Herrera-caceres J, Bibeau F, Desmedt C, Hatse S, Wildiers H. Is cancer biology different in older patients? The Lancet Healthy Longevity 2021;2:e663-77. [DOI: 10.1016/s2666-7568(21)00179-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
30 Wang HH, Liu ZC, Zhang G, Li LH, Li L, Meng QB, Wang PJ, Shen DQ, Dang XW. Clinical characteristics and outcome of primary hepatic neuroendocrine tumors after comprehensive therapy. World J Gastrointest Oncol 2020; 12(9): 1031-1043 [PMID: 33005296 DOI: 10.4251/wjgo.v12.i9.1031] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
31 Ning YZ, Liu GY, Rao XL, Ma YC, Rong L. Synchronized early gastric cancer occurred in a patient with serrated polyposis syndrome: A case report. World J Clin Cases 2022; 10(8): 2644-2649 [DOI: 10.12998/wjcc.v10.i8.2644] [Reference Citation Analysis]
32 Lamarca A, Frizziero M, Barriuso J, Kapacee Z, Mansoor W, Mcnamara MG, Hubner RA, Valle JW. Molecular Profiling of Well-Differentiated Neuroendocrine Tumours: The Role of ctDNA in Real-World Practice. Cancers 2022;14:1017. [DOI: 10.3390/cancers14041017] [Reference Citation Analysis]
33 Abdou AG, Holah NS, Elazab DS, El-Gendy WG, Badr MT, Al-Sharaky DR. Hepatocellular Carcinoma Score and Subclassification Into Aggressive Subtypes Using Immunohistochemical Expression of p53, β-Catenin, CD133, and Ki-67. Appl Immunohistochem Mol Morphol 2021;29:20-33. [PMID: 32287076 DOI: 10.1097/PAI.0000000000000840] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Washington MK, Goldberg RM, Chang GJ, Limburg P, Lam AK, Salto-Tellez M, Arends MJ, Nagtegaal ID, Klimstra DS, Rugge M, Schirmacher P, Lazar AJ, Odze RD, Carneiro F, Fukayama M, Cree IA; WHO Classification of Tumours Editorial Board. Diagnosis of digestive system tumours. Int J Cancer 2021;148:1040-50. [PMID: 32674220 DOI: 10.1002/ijc.33210] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
35 Liu Q, Polydorides AD. Diagnosis and prognostic significance of extramural venous invasion in neuroendocrine tumors of the small intestine. Mod Pathol 2020;33:2318-29. [PMID: 32514164 DOI: 10.1038/s41379-020-0585-1] [Reference Citation Analysis]
36 Cholangiocarcinoma Working Group. Italian Clinical Practice Guidelines on Cholangiocarcinoma - Part I: Classification, diagnosis and staging. Dig Liver Dis 2020;52:1282-93. [PMID: 32893173 DOI: 10.1016/j.dld.2020.06.045] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
37 Bösch F, Altendorf-Hofmann A, Jacob S, Auernhammer CJ, Spitzweg C, Boeck S, Schubert-Fritschle G, Werner J, Kirchner T, Angele MK, Knösel T. Distinct Expression Patterns of VEGFR 1-3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Supporting Clinical Relevance, but not a Prognostic Factor. J Clin Med 2020;9:E3368. [PMID: 33096620 DOI: 10.3390/jcm9103368] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Qian YR, Jiang N, Liu P, Zhang XF, Liu XM, Lv Y, Xiang JX. Hepatocellular-cholangiocarcinoma with sarcomatous change: Clinicopathological features and outcomes. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00070-9. [PMID: 33934975 DOI: 10.1016/j.hbpd.2021.03.011] [Reference Citation Analysis]
39 Li S, Niu M, Deng W, Li N, Wei C, Zhang C, Luo S. Efficacy of Chemotherapy versus Transcatheter Arterial Chemoembolization in Patients with Advanced Primary Hepatic Neuroendocrine Carcinoma and an Analysis of the Prognostic Factors: A Retrospective Study. Cancer Manag Res 2021;13:9085-93. [PMID: 34916851 DOI: 10.2147/CMAR.S343572] [Reference Citation Analysis]
40 Mori N, Hongo M, Takemura S, Sugitani Y, Nakamura F, Tani M, Nishida A, Inatomi O, Andoh A, Ban H. Mixed neuroendocrine–non‐neuroendocrine neoplasm associated with autoimmune gastritis. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5640] [Reference Citation Analysis]
41 Raevskaya O, Appelman H, Razumilava N. A Contemporary Approach to Diagnosis and Treatment of Combined Hepatocellular-Cholangiocarcinoma. Curr Hepatol Rep 2020;19:478-85. [PMID: 33415066 DOI: 10.1007/s11901-020-00556-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Schirren R, Novotny A, Slotta-Huspenina J, Friess H, Reim D. Novel Histologic Categorization Based on Lauren Histotypes Conveys Prognostic Information for Gastroesophageal Junction Cancers-Analysis from a Large Single Center Cohort in Germany. Cancers (Basel) 2021;13:1303. [PMID: 33804009 DOI: 10.3390/cancers13061303] [Reference Citation Analysis]
43 Triki M, Kallel R, Feki J, Mellouli M, Charfi S, Ayadi L, Boudawara T. Prognostic significance of E-cadherin and Cox 2 expression in Tunisian patients with colorectal mucinous adenocarcinoma. Ann Diagn Pathol 2020;49:151624. [PMID: 32919337 DOI: 10.1016/j.anndiagpath.2020.151624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Qu D, Wang Y, Xia Q, Chang J, Jiang X, Zhang H. Intratumoral Microbiome of Human Primary Liver Cancer. Hepatol Commun 2022. [PMID: 35191218 DOI: 10.1002/hep4.1908] [Reference Citation Analysis]
45 Hashimoto M, Uesugi N, Osakabe M, Yanagawa N, Otsuka K, Kajiwara Y, Ueno H, Sasaki A, Sugai T. Expression Patterns of Microenvironmental Factors and Tenascin-C at the Invasive Front of Stage II and III Colorectal Cancer: Novel Tumor Prognostic Markers. Front Oncol 2021;11:690816. [PMID: 34490089 DOI: 10.3389/fonc.2021.690816] [Reference Citation Analysis]
46 Fu Q, Liu P, Jin S, Zhang X, Liu C, Hu M, Wang Y, Zhang H, Qin T. A Metastatic Intrahepatic Cholangiocarcinoma With HPCs Features: Report of a Case. Front Oncol 2022;12:829235. [PMID: 35299731 DOI: 10.3389/fonc.2022.829235] [Reference Citation Analysis]
47 King DA, Rahalkar S, Bingham DB, Fisher GA. Pancreatic INI1-deficient undifferentiated rhabdoid carcinoma achieves complete clinical response on gemcitabine and nab-paclitaxel following immediate progression on FOLFIRINOX: a case report. J Gastrointest Oncol 2021;12:874-9. [PMID: 34012674 DOI: 10.21037/jgo-20-478] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Vaes RDW, van Dijk DPJ, Welbers TTJ, Blok MJ, Aberle MR, Heij L, Boj SF, Olde Damink SWM, Rensen SS. Generation and initial characterization of novel tumour organoid models to study human pancreatic cancer-induced cachexia. J Cachexia Sarcopenia Muscle 2020;11:1509-24. [PMID: 33047901 DOI: 10.1002/jcsm.12627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
49 Chakraborty S, Ecker BL, Seier K, Aveson VG, Balachandran VP, Drebin JA, D'Angelica MI, Kingham TP, Sigel CS, Soares KC, Vakiani E, Wei AC, Chandwani R, Gonen M, Shen R, Jarnagin WR. Genome-Derived Classification Signature for Ampullary Adenocarcinoma to Improve Clinical Cancer Care. Clin Cancer Res 2021;27:5891-9. [PMID: 34433650 DOI: 10.1158/1078-0432.CCR-21-1906] [Reference Citation Analysis]
50 Quero G, Laterza V, Fiorillo C, Menghi R, De Sio D, Schena CA, Rosa F, Tortorelli AP, Di Cesare L, Cina C, Bensi M, Salvatore L, Alfieri S. The impact of the histological classification of ampullary carcinomas on long-term outcomes after pancreaticoduodenectomy: a single tertiary referral center evaluation. Langenbecks Arch Surg 2022. [PMID: 35670860 DOI: 10.1007/s00423-022-02563-z] [Reference Citation Analysis]
51 Tanaka H, Yoshii M, Imai T, Tamura T, Toyokawa T, Muguruma K, Hirakawa K, Ohira M. Clinical significance of coexisting histological diffuse type in stage II/III gastric cancer. Mol Clin Oncol 2021;15:234. [PMID: 34650801 DOI: 10.3892/mco.2021.2397] [Reference Citation Analysis]
52 Ramachandran A, Madhusudhan KS. Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(26): 3008-3026 [DOI: 10.3748/wjg.v28.i26.3008] [Reference Citation Analysis]
53 Nardo AD, Grün NG, Zeyda M, Dumanic M, Oberhuber G, Rivelles E, Helbich TH, Markgraf DF, Roden M, Claudel T, Trauner M, Stulnig TM. Impact of osteopontin on the development of non-alcoholic liver disease and related hepatocellular carcinoma. Liver Int 2020;40:1620-33. [PMID: 32281248 DOI: 10.1111/liv.14464] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
54 Karnaukhov NS, Khomeriki SG, Derizhanova IS, Mantsov AA, Izrailov RE, Tsvirkun VV, Khatkov IE. [Poorly cohesive gastric carcinoma. Validity of using the term; translation variants]. Arkh Patol 2021;83:69-72. [PMID: 34278764 DOI: 10.17116/patol20218304169] [Reference Citation Analysis]
55 Li X, Chu Y, Song Q, Hu Q, Xu Y. The Incidence-Based Mortality and Survival Trends in Patients with Gastric Signet Ring Cell Carcinoma. Journal of Oncology 2022;2022:1-7. [DOI: 10.1155/2022/3308801] [Reference Citation Analysis]
56 Kameyama A, Ye J, Shimomura A, Yokohira M, Nakano-Narusawa Y, Yamakawa K, Mukai Y, Sanomura T, Okuyama H, Miyatake N, Furihata M, Tanaka C, Kitazawa R, Bando Y, Suemitsu Y, Kojima M, Mino-Kenudson M, Suzuki Y, Okano K, Matsuda Y. Reproducibility and prognostic significance of area of residual tumor (ART) in post-neoadjuvant resections of pancreatic ductal adenocarcinoma. Pancreatology 2021:S1424-3903(21)00570-6. [PMID: 34563448 DOI: 10.1016/j.pan.2021.09.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Thompson ED, Zhang ML, Vandenbussche CJ. The Diagnostic Challenge of Evaluating Small Biopsies from the Pancreatobiliary System. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.05.001] [Reference Citation Analysis]
58 Yu Z, Wang A, Hu C, Yu T, Chen J. Type-1 Grade 2 Multi-Focal Gastric Neuroendocrine Tumors Secondary to Chronic Autoimmune Gastritis. Front Med 2022;9:856125. [DOI: 10.3389/fmed.2022.856125] [Reference Citation Analysis]
59 Mowrey K, Northrup H, Rougeau P, Hashmi SS, Krueger DA, Ebrahimi-Fakhari D, Towbin AJ, Trout AT, Capal JK, Franz DN, Rodriguez-Buritica D. Frequency, Progression, and Current Management: Report of 16 New Cases of Nonfunctional Pancreatic Neuroendocrine Tumors in Tuberous Sclerosis Complex and Comparison With Previous Reports. Front Neurol 2021;12:627672. [PMID: 33897589 DOI: 10.3389/fneur.2021.627672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Griffin N, Rowe CW, Gao F, Jobling P, Wills V, Walker MM, Faulkner S, Hondermarck H. Clinicopathological Significance of Nerves in Esophageal Cancer. Am J Pathol 2020;190:1921-30. [PMID: 32479822 DOI: 10.1016/j.ajpath.2020.05.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
61 Wei YY, Li Y, Shi YJ, Li XT, Sun YS. Primary extra-pancreatic pancreatic-type acinar cell carcinoma in the right perinephric space: A case report and review of literature. World J Clin Cases 2021; 9(20): 5637-5646 [PMID: 34307619 DOI: 10.12998/wjcc.v9.i20.5637] [Reference Citation Analysis]
62 Liu H, Zhang Z, Xu Y, Wang N, Huang Y, Yang Z, Jiang R, Chen H. Use of BERT (Bidirectional Encoder Representations from Transformers)-Based Deep Learning Method for Extracting Evidences in Chinese Radiology Reports: Development of a Computer-Aided Liver Cancer Diagnosis Framework. J Med Internet Res 2021;23:e19689. [PMID: 33433395 DOI: 10.2196/19689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
63 Tran CG, Sherman SK, Howe JR. Small Bowel Neuroendocrine Tumors. Curr Probl Surg 2020;57:100823. [PMID: 33234227 DOI: 10.1016/j.cpsurg.2020.100823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Li HL, Wang Y, Ren YB, Yang XS, Wang L, Zhang L, Lin XC. Pyloric gland adenoma with low-grade intraepithelial neoplasia: A case report and literature review. Medicine (Baltimore) 2021;100:e26378. [PMID: 34160413 DOI: 10.1097/MD.0000000000026378] [Reference Citation Analysis]
65 Jawlakh H, Velikyan I, Welin S, Sundin A. 68 Ga-DOTATOC-PET/MRI and 11 C-5-HTP-PET/MRI are superior to 68 Ga-DOTATOC-PET/CT for neuroendocrine tumour imaging. J Neuroendocrinol 2021;33:e12981. [PMID: 34046974 DOI: 10.1111/jne.12981] [Reference Citation Analysis]
66 Koh J, Nam SK, Kwak Y, Kim G, Kim KK, Lee BC, Ahn SH, Park DJ, Kim HH, Park KU, Kim WH, Lee HS. Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas. J Pathol 2021;253:94-105. [PMID: 32985687 DOI: 10.1002/path.5556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
67 Wang H, Lu Y, Liu R, Wang L, Liu Q, Han S. A Non-Invasive Nomogram for Preoperative Prediction of Microvascular Invasion Risk in Hepatocellular Carcinoma. Front Oncol 2021;11:745085. [PMID: 35004273 DOI: 10.3389/fonc.2021.745085] [Reference Citation Analysis]
68 Kahraman S, Yalcin S. Recent Advances in Systemic Treatments for HER-2 Positive Advanced Gastric Cancer. Onco Targets Ther 2021;14:4149-62. [PMID: 34285507 DOI: 10.2147/OTT.S315252] [Reference Citation Analysis]
69 Das S, Al-Toubah T, Strosberg J. Chemotherapy in Neuroendocrine Tumors. Cancers (Basel) 2021;13:4872. [PMID: 34638356 DOI: 10.3390/cancers13194872] [Reference Citation Analysis]
70 Harvitkar RU, Peri H, Zallipalli SN, Joseph SJ, Gattupalli GB, Ansari K. Non-Cancer Causes of Death in Patients With Pancreatic Adenocarcinoma: A Surveillance, Epidemiology, and End Results (SEER)-Based Study. Cureus 2021;13:e20289. [PMID: 34926091 DOI: 10.7759/cureus.20289] [Reference Citation Analysis]
71 Magris R, De Re V, Maiero S, Fornasarig M, Guarnieri G, Caggiari L, Mazzon C, Zanette G, Steffan A, Canzonieri V, Cannizzaro R. Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors. Clin Transl Gastroenterol 2020;11:e00238. [PMID: 33094954 DOI: 10.14309/ctg.0000000000000238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
72 Huang J, Yao H, Li Y, Dong M, Han C, He L, Huang X, Xia T, Yi Z, Wang H, Zhang Y, He J, Liang C, Liu Z. Development and validation of a CT-based radiomics nomogram for preoperative prediction of tumor histologic grade in gastric adenocarcinoma. Chin J Cancer Res 2021;33:69-78. [PMID: 33707930 DOI: 10.21147/j.issn.1000-9604.2021.01.08] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Palmeri M, Funel N, Franco GD, Furbetta N, Gianardi D, Guadagni S, Bianchini M, Pollina LE, Ricci C, Chiaro MD, Candio GD, Morelli L. Tissue microarray-chip featuring computerized immunophenotypical characterization more accurately subtypes ampullary adenocarcinoma than routine histology. World J Gastroenterol 2020;26:6822-36. [PMID: 33268964 DOI: 10.3748/wjg.v26.i43.6822] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Zhou J, Zhao R, Pan Y, Ju H, Huang X, Jiang Y, Jin J, Zhang Y. The Diagnostic and Grading Accuracy of 68Ga-DOTATATE and 18F-FDG PET/MR for Pancreatic Neuroendocrine Neoplasms. Front Oncol 2022;12:796391. [PMID: 35273910 DOI: 10.3389/fonc.2022.796391] [Reference Citation Analysis]
75 Kang DW, Kim BH, Kim JM, Kim J, Chang HJ, Chang MS, Sohn JH, Cho MY, Jin SY, Chang HK, Han HS, Kim JY, Kim HS, Park DY, Park HY, Lee SJ, Lee W, Lee HS, Kang YN, Choi Y; Gastrointestinal Pathology Study Group of the Korean Society of Pathologists. Standardization of the pathologic diagnosis of appendiceal mucinous neoplasms. J Pathol Transl Med 2021;55:247-64. [PMID: 34233112 DOI: 10.4132/jptm.2021.05.28] [Reference Citation Analysis]
76 Zavrtanik H, Luzar B, Tomažič A. Intra-ampullary papillary-tubular neoplasm combined with ampullary neuroendocrine carcinoma: A case report. World J Clin Cases 2022; 10(22): 8045-8053 [DOI: 10.12998/wjcc.v10.i22.8045] [Reference Citation Analysis]
77 Chen K, Collins G, Wang H, Toh JWT. Pathological Features and Prognostication in Colorectal Cancer. Curr Oncol 2021;28:5356-83. [PMID: 34940086 DOI: 10.3390/curroncol28060447] [Reference Citation Analysis]
78 Zhang W, Gao H, Liu W, Qin Y, Ye Z, Lou X, Wang F, Zhang Y, Chen X, Chen J, Yu X, Zhuo Q, Xu X, Ji S. A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival. Front Endocrinol 2022;13:941210. [DOI: 10.3389/fendo.2022.941210] [Reference Citation Analysis]
79 Wei Y, Ke X, Yu J, Jing Q, Bu H, Zeng X, Wei B. Clinical and genomic analyses of neuroendocrine neoplasms of the breast. Mod Pathol 2021. [PMID: 34728787 DOI: 10.1038/s41379-021-00965-w] [Reference Citation Analysis]
80 Yang Z, Shi G, Zhang P. Development and Validation of Nomograms to Predict Overall Survival and Cancer-Specific Survival in Patients With Pancreatic Adenosquamous Carcinoma. Front Oncol 2022;12:831649. [PMID: 35330710 DOI: 10.3389/fonc.2022.831649] [Reference Citation Analysis]
81 Rajamohan N, Khasawneh H, Singh A, Suman G, Johnson GB, Majumder S, Halfdanarson TR, Goenka AH. PET/CT and PET/MRI in neuroendocrine neoplasms. Abdom Radiol (NY) 2022. [PMID: 35426497 DOI: 10.1007/s00261-022-03516-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
82 Li Y, Zhong YX, Xu Q, Tian YT. Protective effects of female reproductive factors on gastric signet-ring cell carcinoma. World J Clin Cases 2022; 10(16): 5217-5229 [DOI: 10.12998/wjcc.v10.i16.5217] [Reference Citation Analysis]
83 Alzahrani SM, Al Doghaither HA, Al-Ghafari AB. General insight into cancer: An overview of colorectal cancer (Review). Mol Clin Oncol 2021;15:271. [PMID: 34790355 DOI: 10.3892/mco.2021.2433] [Reference Citation Analysis]
84 Oleynikova NA, Malkov PG, Danilova NV. [A new one in the classification of benign colon epithelial tumors (WHO, 2019, 5th edition)]. Arkh Patol 2020;82:35-42. [PMID: 32307437 DOI: 10.17116/patol20208202135] [Reference Citation Analysis]
85 Park RHS, Lim GRS, Wu JJY, Koh YX, Teo JY, Cheow PC, Chan CY, Ooi LLPJ, Chung AYF, Goh BKP. Validation of the clinical utility of 4 guidelines in the initial triage of mucinous cystic lesions of the pancreas based on cross-sectional imaging: Experience with 188 surgically-treated patients. Eur J Surg Oncol 2020;46:2114-21. [PMID: 32828582 DOI: 10.1016/j.ejso.2020.07.027] [Reference Citation Analysis]
86 Hiltunen N, Rintala J, Väyrynen JP, Böhm J, Karttunen TJ, Huhta H, Helminen O. Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors. Cancers 2022;14:2552. [DOI: 10.3390/cancers14102552] [Reference Citation Analysis]
87 Mounajjed T. Hepatocellular Adenoma and Focal Nodular Hyperplasia. Clin Liver Dis (Hoboken) 2021;17:244-8. [PMID: 33968383 DOI: 10.1002/cld.1069] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Li S, Tang J, Wang J, Liu X, Zhou Y, Gu P. Metastasis of Mixed Adenoneuroendocrine Carcinoma of the Uterine Cervix to Thyroid Gland. Ear Nose Throat J 2022;:1455613221113817. [PMID: 35861212 DOI: 10.1177/01455613221113817] [Reference Citation Analysis]
89 Noh MG, Yoon Y, Kim G, Kim H, Lee E, Kim Y, Park C, Lee KH, Park H. Practical prediction model of the clinical response to programmed death-ligand 1 inhibitors in advanced gastric cancer. Exp Mol Med 2021;53:223-34. [PMID: 33547412 DOI: 10.1038/s12276-021-00559-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
90 Antelo G, Hierro C, Fernández JP, Baena E, Bugés C, Layos L, Manzano JL, Caro M, Mesia R. Rectal neuroendocrine carcinoma: case report of a rare entity and perspective review of promising agents. Drugs Context 2020;9:2020-2-4. [PMID: 32477420 DOI: 10.7573/dic.2020-2-4] [Reference Citation Analysis]
91 Zhou H, Wang Y, Guo C, Li X, Cui W, Wang Z, Chen X. Microscopic Invasion of Nerve Is Associated With Aggressive Behaviors in Pancreatic Neuroendocrine Tumors. Front Oncol 2021;11:630316. [PMID: 33718210 DOI: 10.3389/fonc.2021.630316] [Reference Citation Analysis]
92 Meunier C, Lisotti A, Gupta V, Lemaistre AI, Fumex F, Gincul R, Lefort C, Lepillez V, Bourdariat R, Napoléon B. Oral anticoagulants but not antiplatelet agents increase the risk of delayed bleeding after endoscopic papillectomy: a large study in a tertiary referral center. Surg Endosc 2022. [PMID: 35233659 DOI: 10.1007/s00464-022-09138-5] [Reference Citation Analysis]
93 Shi M, Fan Z, Xu J, Yang J, Li Y, Gao C, Su P, Wang X, Zhan H. Gastroenteropancreatic neuroendocrine neoplasms G3: Novel insights and unmet needs. Biochim Biophys Acta Rev Cancer 2021;1876:188637. [PMID: 34678439 DOI: 10.1016/j.bbcan.2021.188637] [Reference Citation Analysis]
94 Zhang Y, Yu C. Development and validation of a Surveillance, Epidemiology, and End Results (SEER)-based prognostic nomogram for predicting survival in elderly patients with gastric cancer after surgery. J Gastrointest Oncol 2021;12:278-96. [PMID: 34012626 DOI: 10.21037/jgo-20-536] [Reference Citation Analysis]
95 Qasemi Rad M, Pouresmaeil V, Hosseini Mojahed F, Amirabadi A, Aalami AH. Clinicopathological utility of miR-203a-3p in diagnosing colorectal cancer. Mol Biol Rep 2022. [PMID: 35511316 DOI: 10.1007/s11033-022-07465-3] [Reference Citation Analysis]
96 Gallo C, Rossi RE, Cavalcoli F, Barbaro F, Boškoski I, Invernizzi P, Massironi S. Rectal neuroendocrine tumors: Current advances in management, treatment, and surveillance. World J Gastroenterol 2022; 28(11): 1123-1138 [DOI: 10.3748/wjg.v28.i11.1123] [Reference Citation Analysis]
97 Xiong X, Feng J, Yang X, Li H, Shi Q, Tao J, Chang J. Circular RNA CDR1as promotes tumor progression by regulating miR-432-5p/E2F3 axis in pancreatic cancer. Cancer Cell Int 2021;21:112. [PMID: 33593338 DOI: 10.1186/s12935-021-01812-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
98 Dou D, Li XK, Xia QS, Chen YY, Li YL, Wang C, Qi ZR, Tan HY. Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms. BMC Gastroenterol 2021;21:188. [PMID: 33892648 DOI: 10.1186/s12876-021-01769-7] [Reference Citation Analysis]
99 Chi Z, Lin Y, Huang J, Lv M, Chen J, Chen X, Zhang B, Chen Y, Hu J, He X, Lan P. Risk factors for recurrence of colorectal conventional adenoma and serrated polyp. Gastroenterology Report 2021. [DOI: 10.1093/gastro/goab038] [Reference Citation Analysis]
100 Jiang S, Zhao L, Xie C, Su H, Yan Y. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors. Front Endocrinol (Lausanne) 2020;11:402. [PMID: 32733379 DOI: 10.3389/fendo.2020.00402] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
101 Uprak TK, Akmercan A, Coşkun M, Attaallah W. Gastric medullary carcinoma: clinicopathological features and prognosis-a single-center study. ANZ J Surg 2021;91:2425-9. [PMID: 34405504 DOI: 10.1111/ans.17129] [Reference Citation Analysis]
102 Fang WL, Chen MH, Huang KH, Lin CH, Chao Y, Lo SS, Li AF, Wu CW, Shyr YM. The Clinicopathological Features and Genetic Alterations in Epstein-Barr Virus-Associated Gastric Cancer Patients after Curative Surgery. Cancers (Basel). 2020;12. [PMID: 32531970 DOI: 10.3390/cancers12061517] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
103 Kanani T, Isherwood J, Chung WY, Dennison A. Diagnostic approaches for pancreatic cystic lesions. ANZ J Surg 2020;90:2211-8. [PMID: 32815222 DOI: 10.1111/ans.16251] [Reference Citation Analysis]
104 Gerbaudo VH, Latif MA. A Step Forward in PET-Based Quantitation of G3 Neuroendocrine Tumor Aggressiveness - The FDZ Score…. Acad Radiol 2022:S1076-6332(22)00140-4. [PMID: 35365399 DOI: 10.1016/j.acra.2022.03.001] [Reference Citation Analysis]
105 Shi Z, Zhu C, Zhang Y, Wang Y, Hou W, Li X, Lu J, Guo X, Xu F, Jiang X, Wang Y, Liu J, Jin M. Deep learning for automatic diagnosis of gastric dysplasia using whole-slide histopathology images in endoscopic specimens. Gastric Cancer 2022. [PMID: 35394573 DOI: 10.1007/s10120-022-01294-w] [Reference Citation Analysis]
106 Arantes VN, Ramos JA, White JR, Parra-Blanco A. Clinical effectiveness of short course oral prednisone for stricture prevention after semi-circumferential esophageal endoscopic submucosal dissection. Endosc Int Open 2022;10:E753-61. [PMID: 35692934 DOI: 10.1055/a-1789-0266] [Reference Citation Analysis]
107 Vullierme MP, Gregory J, Rebours V, Cros J, Abelhady-Attia Y, Vilgrain V, Aguilera-Munoz L, Laurent L, Levy P, Sauvanet A, Ronot M. MRI is useful to suggest and exclude malignancy in mucinous cystic neoplasms of the pancreas. Eur Radiol 2021. [PMID: 34374801 DOI: 10.1007/s00330-021-08091-6] [Reference Citation Analysis]
108 Li X, Yao Q, Liu C, Wang J, Zhang H, Li S, Cai P. Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know? JHC 2022;Volume 9:379-87. [DOI: 10.2147/jhc.s364742] [Reference Citation Analysis]
109 Chou A, Sioson L, Sheen A, Ahadi MS, Gill AJ. Up-regulation of ALK is associated with altered Wnt/beta-catenin pathway in adult pancreatoblastoma. Pathology 2022. [DOI: 10.1016/j.pathol.2022.04.005] [Reference Citation Analysis]
110 Del Piccolo L, Marinelli V, Mazzi MA, Danzi OP, Bonamini D, Secchettin E, Tuveri M, Bassi C, Rimondini M, Salvia R. Prevalence of depression in a cohort of 400 patients with pancreatic neoplasm attending day hospital for major surgery: Role on depression of psychosocial functioning and clinical factors. Psychooncology 2021;30:455-62. [PMID: 33247996 DOI: 10.1002/pon.5607] [Reference Citation Analysis]
111 Kamiya M, Yamamoto N, Kamioka Y, Inoue H, Yotsumoto H, Murakawa M, Aoyama T, Washimi K, Kawachi K, Oshima T, Ueno M, Yukawa N, Rino Y, Masuda M, Morinaga S. Rapidly progressed neuroendocrine carcinoma in the extrahepatic bile duct: a case report and review of the literature. Surg Case Rep 2020;6:191. [PMID: 32748005 DOI: 10.1186/s40792-020-00945-3] [Reference Citation Analysis]
112 Qi X, Liu Z, Zhang Q, Yang M, Wan Y, Huang J, Xu L. Systematic analysis of the function and prognostic value of RNA binding proteins in Colon Adenocarcinoma. J Cancer 2021;12:2537-49. [PMID: 33854615 DOI: 10.7150/jca.50407] [Reference Citation Analysis]
113 Lee S. Helicobacter pylori-negative Gastric Cancer. Korean J Helicobacter Up Gastrointest Res 2021;21:10-21. [DOI: 10.7704/kjhugr.2020.0036] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
114 Sobhrakhshankhah E, Sohrabi M, Norouzi HR, Zamani F, Ajdarkosh H, Nikkhah M, Khoonsari MR, Faraji AH. Tissue Sampling through Endoscopic Ultrasound-Guided Fine Needle Aspiration versus Endoscopic Retrograde Cholangiopancreatographic Brushing Cytology Technique in Suspicious Malignant Biliary Stricture. Middle East J Dig Dis 2021;13:294-301. [DOI: 10.34172/mejdd.2021.238] [Reference Citation Analysis]
115 Jin M, Zhou B, Jiang XL, Zhang QY, Zheng X, Jiang YC, Yan S. Flushing as atypical initial presentation of functional gallbladder neuroendocrine carcinoma: A case report. World J Gastroenterol 2020; 26(6): 686-695 [PMID: 32103876 DOI: 10.3748/wjg.v26.i6.686] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
116 Pellat A, Cottereau AS, Palmieri LJ, Soyer P, Marchese U, Brezault C, Coriat R. Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions. Cancers (Basel) 2021;13:2448. [PMID: 34070035 DOI: 10.3390/cancers13102448] [Reference Citation Analysis]
117 Bräutigam K, Rodriguez-Calero A, Kim-Fuchs C, Kollár A, Trepp R, Marinoni I, Perren A. Update on Histological Reporting Changes in Neuroendocrine Neoplasms. Curr Oncol Rep 2021;23:65. [PMID: 33855635 DOI: 10.1007/s11912-021-01062-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
118 Alromaih S, Alqaryan S, Alabood S, Alabaishi S, Ajlan A, Alsuhaibani A, Sumaily I, Alsolami A. Alveolar Soft-Part Sarcoma in Olfactory Cleft: A Case Report and Clinicopathological Review. Ear Nose Throat J 2020;:145561320955134. [PMID: 32931333 DOI: 10.1177/0145561320955134] [Reference Citation Analysis]
119 Lee JWJ, Zhu F, Srivastava S, Tsao SK, Khor C, Ho KY, Fock KM, Lim WC, Ang TL, Chow WC, So JBY, Koh CJ, Chua SJ, Wong ASY, Rao J, Lim LG, Ling KL, Chia CK, Ooi CJ, Rajnakova A, Yap WM, Salto-Tellez M, Ho B, Soong R, Chia KS, Teo YY, Teh M, Yeoh KG. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP). Gut 2022;71:854-63. [PMID: 33975867 DOI: 10.1136/gutjnl-2021-324057] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
120 Liu LL, Sun JD, Xiang ZL. A nomogram to predict the prognosis of patients with unresected rectal adenocarcinoma undergoing chemoradiotherapy: a population-based study. J Cancer 2021;12:4745-61. [PMID: 34234846 DOI: 10.7150/jca.61642] [Reference Citation Analysis]
121 Hiltunen N, Väyrynen JP, Böhm J, Helminen O. CD3+, CD8+, CD4+ and FOXP3+ T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors. Diseases 2021;9:42. [PMID: 34208144 DOI: 10.3390/diseases9020042] [Reference Citation Analysis]
122 Chen J, Wang P, Lv K, Zhou W. Case report: composite pancreatic intraductal papillary mucinous neoplasm and neuroendocrine tumor: a new mixed neuroendocrine-non-neuroendocrine neoplasm? Diagn Pathol 2021;16:108. [PMID: 34801052 DOI: 10.1186/s13000-021-01165-5] [Reference Citation Analysis]
123 Massa I, Ghignone F, Ugolini G, Ercolani G, Montroni I, Capelli P, Garulli G, Catena F, Lucchi A, Ansaloni L, Gentili N, Danesi V, Montella MT, Altini M; ESCA Collaborative Group. Emilia-Romagna Surgical Colorectal Cancer Audit (ESCA): a value-based healthcare retro-prospective study to measure and improve the quality of surgical care in colorectal cancer. Int J Colorectal Dis 2022. [PMID: 35779080 DOI: 10.1007/s00384-022-04203-w] [Reference Citation Analysis]
124 Qiu Y, Mao YT, Zhu JH, Zhao K, Wang JF, Huang JM, Chang GQ, Guan YT, Huang FY, Hu YJ, Chen JQ, Liu JL. CLIC1 knockout inhibits invasion and migration of gastric cancer by upregulating AMOT-p130 expression. Clin Transl Oncol 2021;23:514-25. [PMID: 32656583 DOI: 10.1007/s12094-020-02445-0] [Reference Citation Analysis]
125 Chen Q, Ning Z, Liu Z, Zhou Y, He Q, Tian Y, Hao H, Lin W, Jiang L, Zhao G, Li P, Zheng C, Huang C; Study Group for Gastric Neuroendocrine Tumors. Textbook Outcome as a measure of surgical quality assessment and prognosis in gastric neuroendocrine carcinoma: A large multicenter sample analysis. Chin J Cancer Res 2021;33:433-46. [PMID: 34584369 DOI: 10.21147/j.issn.1000-9604.2021.04.01] [Reference Citation Analysis]
126 Lv L, Liang X, Wu D, Wang F, Zhang Y, Cang H, Deng X, Li M. Is cardia cancer a special type of gastric cancer? A differential analysis of early cardia cancer and non-cardia cancer. J Cancer 2021;12:2385-94. [PMID: 33758614 DOI: 10.7150/jca.51433] [Reference Citation Analysis]
127 Li DH, Liu XY, Huang C, Deng CN, Zhang JL, Xu XW, Xu LB. Pathological Analysis and Endoscopic Characteristics of Colorectal Laterally Spreading Tumors. Cancer Manag Res 2021;13:1137-44. [PMID: 33603459 DOI: 10.2147/CMAR.S286039] [Reference Citation Analysis]
128 Do MY, Jang SI, Kang HP, Kim EJ, Lee KJ, Park GE, Lee SJ, Lee DK, Woo SM, Cho JH. Comparison of the Clinical Features and Outcomes of Gallbladder Neuroendocrine Carcinoma with Those of Adenocarcinoma: A Propensity Score-Matched Analysis. Cancers (Basel) 2021;13:4713. [PMID: 34572940 DOI: 10.3390/cancers13184713] [Reference Citation Analysis]
129 Jackson T, Darwish M, Cho E, Nagatomo K, Osman H, Jeyarajah DR. 68Ga-DOTATATE PET/CT compared to standard imaging in metastatic neuroendocrine tumors: a more sensitive test to detect liver metastasis? Abdom Radiol (NY) 2021;46:3179-83. [PMID: 33665733 DOI: 10.1007/s00261-021-02990-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
130 Andhalgaonkar T, Sinha R. Mesenchymal Tumors and Lymphoproliferative Diseases of the Stomach and Duodenum. Journal of Gastrointestinal and Abdominal Radiology 2022;4:170-6. [DOI: 10.1055/s-0040-1722794] [Reference Citation Analysis]
131 Jacob A, Raj R, Allison DB, Soares HP, Chauhan A. An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN). Curr Treat Options in Oncol . [DOI: 10.1007/s11864-022-00968-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Agarwal P, Mohamed A. Systemic Therapy of Advanced Well-differentiated Small Bowel Neuroendocrine Tumors Progressive on Somatostatin Analogues. Curr Treat Options Oncol 2022. [PMID: 35939200 DOI: 10.1007/s11864-022-00998-6] [Reference Citation Analysis]
133 Shi H, Jiang C, Zhang Q, Qi C, Yao H, Lin R. Clinicopathological heterogeneity between primary and metastatic sites of gastroenteropancreatic neuroendocrine neoplasm. Diagn Pathol 2020;15:108. [PMID: 32917216 DOI: 10.1186/s13000-020-01030-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
134 Hackeng WM, Assi HA, Westerbeke FH, Brosens LA, Heaphy CM. Prognostic and Predictive Biomarkers for Pancreatic Neuroendocrine Tumors. Surgical Pathology Clinics 2022. [DOI: 10.1016/j.path.2022.05.007] [Reference Citation Analysis]
135 Diaconescu S, Gîlcă-Blanariu GE, Poamaneagra S, Marginean O, Paduraru G, Stefanescu G. Could the burden of pancreatic cancer originate in childhood? World J Gastroenterol 2021; 27(32): 5322-5340 [PMID: 34539135 DOI: 10.3748/wjg.v27.i32.5322] [Reference Citation Analysis]
136 Glückstein MI, Dintner S, Arndt TT, Vlasenko D, Schenkirsch G, Agaimy A, Müller G, Märkl B, Grosser B. Comprehensive Immunohistochemical Study of the SWI/SNF Complex Expression Status in Gastric Cancer Reveals an Adverse Prognosis of SWI/SNF Deficiency in Genomically Stable Gastric Carcinomas. Cancers (Basel) 2021;13:3894. [PMID: 34359794 DOI: 10.3390/cancers13153894] [Reference Citation Analysis]
137 Fuchs TL, Chou A, Ahadi M, Sheen A, Sioson L, Mittal A, Samra J, Gill AJ. Necrosis is an independent predictor of disease-free and overall survival in pancreatic well-differentiated neuroendocrine tumours (NETs): a proposal to include it in grading systems. Pathology 2022. [DOI: 10.1016/j.pathol.2022.05.008] [Reference Citation Analysis]
138 Lee W, Chandan VS, Johnson C, Li X. Atypical Cells in Peritoneal Cleft: A Pitfall in Diagnosis of Colorectal Adenocarcinoma. Int J Surg Pathol 2021;29:506-9. [PMID: 33455512 DOI: 10.1177/1066896920988346] [Reference Citation Analysis]
139 Sweed D, Sultan MM, Mosbeh A, Fayed YA, Abdelsameea E, Ehsan NA, Abdel-Rahman MH, Waked I. Lymphoepithelioma-like Hepatocellular Carcinoma: a Case Report and Review of Literature. J Gastrointest Cancer 2021. [PMID: 34813031 DOI: 10.1007/s12029-021-00757-0] [Reference Citation Analysis]
140 Ichikawa S, Isoda H, Shimizu T, Tamada D, Taura K, Togashi K, Onishi H, Motosugi U. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study. Eur Radiol 2020;30:5992-6002. [PMID: 32500195 DOI: 10.1007/s00330-020-06972-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
141 Natalicchio A, Faggiano A, Zatelli MC, Argentiero A, D'Oronzo S, Marrano N, Beretta GD, Acquati S, Adinolfi V, Di Bartolo P, Danesi R, Ferrari P, Gori S, Morviducci L, Russo A, Tuveri E, Montagnani M, Gallo M, Silvestris N, Giorgino F. Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper. Crit Rev Oncol Hematol 2021;:103572. [PMID: 34954047 DOI: 10.1016/j.critrevonc.2021.103572] [Reference Citation Analysis]
142 Bremer SCB, Bittner G, Elakad O, Dinter H, Gaedcke J, König AO, Amanzada A, Ellenrieder V, Freiherr von Hammerstein-Equord A, Ströbel P, Bohnenberger H. Enhancer of Zeste Homolog 2 (EZH2) Is a Marker of High-Grade Neuroendocrine Neoplasia in Gastroenteropancreatic and Pulmonary Tract and Predicts Poor Prognosis. Cancers (Basel) 2022;14:2828. [PMID: 35740494 DOI: 10.3390/cancers14122828] [Reference Citation Analysis]
143 Eng C, Ciombor KK, Cho M, Dorth JA, Rajdev LN, Horowitz DP, Gollub MJ, Jácome AA, Lockney NA, Muldoon RL, Washington MK, O'Brian BA, Benny A, Lebeck Lee CM, Benson AB 3rd, Goodman KA, Morris VK. Anal Cancer: Emerging Standards in a Rare Rare Disease. J Clin Oncol 2022;:JCO2102566. [PMID: 35649196 DOI: 10.1200/JCO.21.02566] [Reference Citation Analysis]
144 Egal ESA, Jacenik D, Soares HP, Beswick EJ. Translational challenges in pancreatic neuroendocrine tumor immunotherapy. Biochim Biophys Acta Rev Cancer 2021;1876:188640. [PMID: 34695532 DOI: 10.1016/j.bbcan.2021.188640] [Reference Citation Analysis]
145 Rivero-Sánchez L, Gavric A, Herrero J, Remedios D, Alvarez V, Albéniz E, Gordillo J, Puig I, López-Vicente J, Huerta A, López-Cerón M, Salces I, Peñas B, Parejo S, Rodriguez E, Herraiz M, Carretero C, Gimeno-Garcia AZ, Saperas E, Alvarez C, Arnau-Collell C, Ortiz O, Sánchez A, Jung G, Balaguer F, Pellisé M. The "diagnose and leave in" strategy for diminutive rectosigmoid polyps in Lynch syndrome: a post hoc analysis from a randomized controlled trial. Endoscopy 2020. [PMID: 33271604 DOI: 10.1055/a-1328-5405] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Levy S, Verbeek WH, Eskens FA, van den Berg JG, de Groot DJA, van Leerdam ME, Tesselaar ME. First-line everolimus and cisplatin in patients with advanced extrapulmonary neuroendocrine carcinoma: a nationwide phase 2 single-arm clinical trial. Ther Adv Med Oncol 2022;14:175883592210770. [DOI: 10.1177/17588359221077088] [Reference Citation Analysis]
147 Prado-Wohlwend S, Bernal-Vergara JC, Utrera-Costero A, Cañón-Sánchez JR, Agudelo-Cifuentes M, Bello-Arques P; Endocrinology Working Group of the SEMNIM. Peptide receptor radionuclide therapy with [177Lu]Lu-DOTA-TATE. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021:S2253-8089(21)00164-6. [PMID: 34920969 DOI: 10.1016/j.remnie.2021.11.001] [Reference Citation Analysis]
148 Marini F, Giusti F, Tonelli F, Brandi ML. Pancreatic Neuroendocrine Neoplasms in Multiple Endocrine Neoplasia Type 1. Int J Mol Sci 2021;22:4041. [PMID: 33919851 DOI: 10.3390/ijms22084041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Li YL, Cheng ZX, Yu FH, Tian C, Tan HY. Advances in medical treatment for pancreatic neuroendocrine neoplasms. World J Gastroenterol 2022; 28(20): 2163-2175 [DOI: 10.3748/wjg.v28.i20.2163] [Reference Citation Analysis]
150 Touloupas C, Faron M, Hadoux J, Deschamps F, Roux C, Ronot M, Yevich S, Joskin J, Gelli M, Barbé R, Lamartina L, Tissot H, Scoazec JY, Malka D, Ducreux M, Baudin E, de Baère T, Tselikas L. Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience. Cancers (Basel) 2021;13:5366. [PMID: 34771531 DOI: 10.3390/cancers13215366] [Reference Citation Analysis]
151 Lin J, Peng X, Dong K, Long J, Guo X, Li H, Bai Y, Yang X, Wang D, Lu X, Mao Y, Sang X, Ji X, Zhao H, Liang H. Genomic characterization of co-existing neoplasia and carcinoma lesions reveals distinct evolutionary paths of gallbladder cancer. Nat Commun 2021;12:4753. [PMID: 34362903 DOI: 10.1038/s41467-021-25012-9] [Reference Citation Analysis]
152 Sugiyama K, Shiraishi K, Sato M, Nishibori R, Nozawa K, Kitagawa C. Salvage Chemotherapy by FOLFIRI Regimen for Poorly Differentiated Gastrointestinal Neuroendocrine Carcinoma. J Gastrointest Cancer 2021;52:947-51. [PMID: 32918273 DOI: 10.1007/s12029-020-00516-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
153 Papaefthymiou A, Laskaratos FM, Koffas A, Manolakis A, Gkolfakis P, Coda S, Sodergren M, Suzuki N, Toumpanakis C. State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors. Curr Treat Options Oncol 2022. [PMID: 35511346 DOI: 10.1007/s11864-022-00986-w] [Reference Citation Analysis]
154 Holmberg M, Ghorbani P, Gilg S, Del Chiaro M, Arnelo U, Löhr JM, Sparrelid E. Outcome after resection for invasive intraductal papillary mucinous neoplasia is similar to conventional pancreatic ductal adenocarcinoma. Pancreatology 2021;21:1371-7. [PMID: 34426077 DOI: 10.1016/j.pan.2021.07.009] [Reference Citation Analysis]
155 Al-toubah T, Morse B, Strosberg J. Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors. Current Oncology 2022;29:510-5. [DOI: 10.3390/curroncol29020046] [Reference Citation Analysis]
156 Ishida N, Miyazu T, Tamura S, Suzuki S, Tani S, Yamade M, Iwaizumi M, Osawa S, Hamaya Y, Shinmura K, Sugimura H, Miura K, Furuta T, Sugimoto K. Tuberous sclerosis patient with neuroendocrine carcinoma of the esophagogastric junction: A case report. World J Gastroenterol 2020; 26(45): 7263-7271 [PMID: 33362382 DOI: 10.3748/wjg.v26.i45.7263] [Cited by in CrossRef: 2] [Article Influence: 1.0] [Reference Citation Analysis]
157 Kunprom W, Aphivatanasiri C, Sa-Ngiamwibool P, Sangkhamanon S, Intarawichian P, Bamrungkit W, Thanee M, Prajumwongs P, Loilome W, Khuntikeo N, Titapun A, Jareanrat A, Thanasukarn V, Srisuk T, Luvira V, Eurboonyanun K, Promsorn J, Koonmee S. Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand. Front Public Health 2022;10:816028. [PMID: 35651852 DOI: 10.3389/fpubh.2022.816028] [Reference Citation Analysis]
158 Obermannová R, Alsina M, Cervantes A, Leong T, Lordick F, Nilsson M, van Grieken N, Vogel A, Smyth E. Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology 2022. [DOI: 10.1016/j.annonc.2022.07.003] [Reference Citation Analysis]
159 Tustumi F, Marques SSB, Barros EF, Henriques AC, Waisberg J, Dias AR. THE PROGNOSIS OF THE DIFFERENT ESOPHAGEAL NEUROENDOCRINE CARCINOMA SUBTYPES: A POPULATION-BASED STUDY. Arq Gastroenterol 2022;59:53-7. [DOI: 10.1590/s0004-2803.202200001-10] [Reference Citation Analysis]
160 Kaewput C, Vinjamuri S. Role of Combined 68Ga DOTA-Peptides and 18F FDG PET/CT in the Evaluation of Gastroenteropancreatic Neuroendocrine Neoplasms. Diagnostics 2022;12:280. [DOI: 10.3390/diagnostics12020280] [Reference Citation Analysis]
161 Zheng BH, Zhang C, Wan WZ, Sun WT, Cheng X, Ni XJ, Ni XL, Suo T, Liu H, Shen S, Liu HB. The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database. BMC Surg 2022;22:253. [PMID: 35768809 DOI: 10.1186/s12893-022-01689-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
162 Katabathina VS, Marji H, Khanna L, Ramani N, Yedururi S, Dasyam A, Menias CO, Prasad SR. Decoding Genes: Current Update on Radiogenomics of Select Abdominal Malignancies. Radiographics 2020;40:1600-26. [PMID: 33001791 DOI: 10.1148/rg.2020200042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
163 Resende C, Gomes CP, Machado JC. Review: Gastric cancer: Basic aspects. Helicobacter 2020;25 Suppl 1:e12739. [PMID: 32918356 DOI: 10.1111/hel.12739] [Reference Citation Analysis]
164 Goksu SY, Ozer M, Beg MS, Sanford NN, Ahn C, Fangman BD, Goksu BB, Verma U, Sanjeevaiah A, Hsiehchen D, Jones AL, Kainthla R, Kazmi SM. Racial/Ethnic Disparities and Survival Characteristics in Non-Pancreatic Gastrointestinal Tract Neuroendocrine Tumors. Cancers (Basel) 2020;12:E2990. [PMID: 33076486 DOI: 10.3390/cancers12102990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
165 Ainechi D, Misawa M, Barua I, Larsen SLV, Paulsen V, Garborg KK, Aabakken L, Tønnesen CJ, Løberg M, Kalager M, Kudo SE, Hotta K, Ohtsuka K, Saito S, Ikematsu H, Saito Y, Matsuda T, Itoh H, Mori K, Bretthauer M, Mori Y. Impact of artificial intelligence on colorectal polyp detection for early-career endoscopists: an international comparative study. Scand J Gastroenterol 2022;:1-6. [PMID: 35605150 DOI: 10.1080/00365521.2022.2070436] [Reference Citation Analysis]
166 Shiratori Y, Suzuki K, Ikeya T. Colonic clear cell adenocarcinoma with enteroblastic differentiation. Clin J Gastroenterol 2020;13:1196-9. [PMID: 32803644 DOI: 10.1007/s12328-020-01209-1] [Reference Citation Analysis]
167 Shimoyama R, Hijioka S, Mizuno N, Ogawa G, Kataoka T, Katayama H, Machida N, Honma Y, Boku N, Hamaguchi T, Fukuda H, Terashima M, Kanemitsu Y, Furuse J; Stomach Cancer Study Group/Colorectal Cancer Study Group/Hepatobiliary and Pancreatic Oncology Group in Japan Clinical Oncology Group. Study protocol for a multi-institutional randomized phase III study comparing combined everolimus plus lanreotide therapy and everolimus monotherapy in patients with unresectable or recurrent gastroenteropancreatic neuroendocrine tumors; Japan Clinical Oncology Group Study JCOG1901 (STARTER-NET study). Pancreatology 2020;20:1183-8. [PMID: 32798144 DOI: 10.1016/j.pan.2020.07.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Kohno S, Aoki H, Kato M, Ogawa M, Yoshida K. Gastric mixed adenoma-neuroendocrine tumor: A case report. World J Clin Cases 2020; 8(22): 5744-5750 [PMID: 33344569 DOI: 10.12998/wjcc.v8.i22.5744] [Reference Citation Analysis]
169 Zeng P, Ma L, Liu J, Song Z, Liu J, Yuan H. The diagnostic value of intravoxel incoherent motion diffusion-weighted imaging for distinguishing nonhypervascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas. European Journal of Radiology 2022;150:110261. [DOI: 10.1016/j.ejrad.2022.110261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Peng D, Feng L, Li H, Picardi E. Identification of Novel circRNA-Based ceRNA Network Involved in the Pathogenesis of Gastric Cancer. International Journal of Genomics 2022;2022:1-10. [DOI: 10.1155/2022/5281846] [Reference Citation Analysis]
171 Moradi N, Ohadian Moghadam S, Heidarzadeh S. Application of next-generation sequencing in the diagnosis of gastric cancer. Scand J Gastroenterol 2022;:1-14. [PMID: 35293278 DOI: 10.1080/00365521.2022.2041717] [Reference Citation Analysis]
172 Yang Y, Li Y, Du X. Prognostic Analysis of Gastric Signet Ring Cell Carcinoma and Hepatoid Adenocarcinoma of the Stomach: A Propensity Score-Matched Study. Front Oncol 2021;11:716962. [PMID: 34458152 DOI: 10.3389/fonc.2021.716962] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Melone V, Salvati A, Palumbo D, Giurato G, Nassa G, Rizzo F, Palo L, Giordano A, Incoronato M, Vitale M, Mian C, Di Biase I, Cristiano S, Narciso V, Cantile M, Di Mauro A, Tatangelo F, Tafuto S, Modica R, Pivonello C, Salvatore M, Colao A, Weisz A, Tarallo R. Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03511-7] [Reference Citation Analysis]
174 Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep (Oxf) 2021;9:91-104. [PMID: 34026216 DOI: 10.1093/gastro/goab010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
175 Gebauer L, Moltz JH, Mühlberg A, Holch JW, Huber T, Enke J, Jäger N, Haas M, Kruger S, Boeck S, Sühling M, Katzmann A, Hahn H, Kunz WG, Heinemann V, Nörenberg D, Maurus S. Quantitative Imaging Biomarkers of the Whole Liver Tumor Burden Improve Survival Prediction in Metastatic Pancreatic Cancer. Cancers (Basel) 2021;13:5732. [PMID: 34830885 DOI: 10.3390/cancers13225732] [Reference Citation Analysis]
176 Baczewska M, Knapp P, Dobroch J, Bernaczyk P, Guzik P, Sitnik P, Bortnik W. Two Concurrent Cancers in a 19-Year-Old Patient: Yolk Sac Ovarian Tumor and Metastatic Gastrointestinal Tract Malignancy-Case Report. J Pediatr Adolesc Gynecol 2021;34:561-5. [PMID: 33689915 DOI: 10.1016/j.jpag.2021.02.104] [Reference Citation Analysis]
177 Rossi RE, Milanetto AC, Andreasi V, Campana D, Coppa J, Nappo G, Rinzivillo M, Invernizzi P, Modica R, David A, Partelli S, Lamberti G, Mazzaferro V, Zerbi A, Panzuto F, Pasquali C, Falconi M, Massironi S; ItaNet (Italian Association for Neuroendocrine Tumours) study group. Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy. J Endocrinol Invest 2021;44:2227-34. [PMID: 33651317 DOI: 10.1007/s40618-021-01528-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
178 Yang Z, Shi G. Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population-based cohort study. Cancer Med 2021. [PMID: 34862762 DOI: 10.1002/cam4.4474] [Reference Citation Analysis]
179 Wang FH, Zhang XT, Li YF, Tang L, Qu XJ, Ying JE, Zhang J, Sun LY, Lin RB, Qiu H, Wang C, Qiu MZ, Cai MY, Wu Q, Liu H, Guan WL, Zhou AP, Zhang YJ, Liu TS, Bi F, Yuan XL, Rao SX, Xin Y, Sheng WQ, Xu HM, Li GX, Ji JF, Zhou ZW, Liang H, Zhang YQ, Jin J, Shen L, Li J, Xu RH. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021. Cancer Commun (Lond) 2021;41:747-95. [PMID: 34197702 DOI: 10.1002/cac2.12193] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
180 Palmer K, Weerasuriya S, Chandrakumaran K, Rous B, White BE, Paisey S, Srirajaskanthan R, Ramage JK. Goblet Cell Adenocarcinoma of the Appendix: A Systematic Review and Incidence and Survival of 1,225 Cases From an English Cancer Registry. Front Oncol 2022;12:915028. [DOI: 10.3389/fonc.2022.915028] [Reference Citation Analysis]
181 Holmager P, Langer SW, Federspiel B, Willemoe GL, Garbyal RS, Melchior L, Klose M, Kjaer A, Hansen CP, Andreassen M, Knigge U. Increase of Ki-67 index and influence on mortality in patients with neuroendocrine neoplasms. J Neuroendocrinol 2021;33:e13018. [PMID: 34414612 DOI: 10.1111/jne.13018] [Reference Citation Analysis]
182 Mun J, Hur W, Ku N. Roles of Keratins in Intestine. IJMS 2022;23:8051. [DOI: 10.3390/ijms23148051] [Reference Citation Analysis]
183 Sessa A, Mulé S, Brustia R, Regnault H, Galletto Pregliasco A, Rhaiem R, Leroy V, Sommacale D, Luciani A, Calderaro J, Amaddeo G. Macrotrabecular-Massive Hepatocellular Carcinoma: Light and Shadow in Current Knowledge. JHC 2022;Volume 9:661-70. [DOI: 10.2147/jhc.s364703] [Reference Citation Analysis]
184 Huang C, Luo H, Huang Y, Fang C, Zhao L, Li P, Zhong C, Liu F. AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis. Int J Gen Med 2021;14:3295-312. [PMID: 34285555 DOI: 10.2147/IJGM.S318077] [Reference Citation Analysis]
185 Tang CT, Chen Y, Zeng C. Prognostic analysis of gastric signet ring cell carcinoma and mucinous carcinoma: a propensity score-matched study and competing risk analysis. Aging (Albany NY) 2020;12:22059-77. [PMID: 33130635 DOI: 10.18632/aging.104048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
186 Sakamoto A, Nozawa H, Sonoda H, Hinata M, Ishii H, Emoto S, Anzai H, Yokoyama Y, Murono K, Sasaki K, Kawai K, Ushiku T, Ishihara S. Rectal neuroendocrine tumor with extracapsular lymph node metastasis: a case report. Clin J Gastroenterol 2021. [PMID: 34028785 DOI: 10.1007/s12328-021-01447-x] [Reference Citation Analysis]
187 Pereira D, Kővári B, Brown I, Chaves P, Choi WT, Clauditz T, Ghayouri M, Jiang K, Miller GC, Nakanishi Y, Kim KM, Kim BH, Kumarasinghe MP, Kushima R, Ushiku T, Yozu M, Srivastava A, Goldblum JR, Pai RK, Lauwers GY. Non-conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum. Histopathology 2021;78:658-75. [PMID: 33124049 DOI: 10.1111/his.14294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
188 Bezzi C, Mapelli P, Presotto L, Neri I, Scifo P, Savi A, Bettinardi V, Partelli S, Gianolli L, Falconi M, Picchio M. Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance. Eur J Nucl Med Mol Imaging 2021. [PMID: 33835220 DOI: 10.1007/s00259-021-05338-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
189 Tang YY, Zhao YN, Zhang T, Chen ZY, Ma XL. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma. World J Gastroenterol 2021; 27(41): 7173-7189 [PMID: 34887636 DOI: 10.3748/wjg.v27.i41.7173] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
190 Gherghe M, Lazăr AM, Stanciu AE, Mutuleanu MD, Sterea MC, Petroiu C, Galeș LN. The New Radiolabeled Peptide 99mTcEDDA/HYNIC-TOC: Is It a Feasible Choice for Diagnosing Gastroenteropancreatic NETs? Cancers (Basel) 2022;14:2725. [PMID: 35681704 DOI: 10.3390/cancers14112725] [Reference Citation Analysis]
191 Jacob A, Gabriel G, Ramirez RA, Wang Y, Anthony L, Chauhan A. How I Treat Neuroendocrine Tumors. Indian J Med Paediatr Oncol 2021;42:470-8. [DOI: 10.1055/s-0041-1732833] [Reference Citation Analysis]
192 Zhang F, Hu KS, Lu SX, Li M, Chen RX, Ren ZG, Shi YH, Yin X. Prognostic significance of preoperative systemic immune-inflammation index in combined hepatocellular-cholangiocarcinoma. Cancer Biomark 2021;31:211-25. [PMID: 33896819 DOI: 10.3233/CBM-200643] [Reference Citation Analysis]
193 Jeong H, Shin J, Jeong JH, Kim KP, Hong SM, Kim YI, Ryu JS, Ryoo BY, Yoo C. Capecitabine plus temozolomide in patients with grade 3 unresectable or metastatic gastroenteropancreatic neuroendocrine neoplasms with Ki-67 index <55%: single-arm phase II study. ESMO Open 2021;6:100119. [PMID: 33901869 DOI: 10.1016/j.esmoop.2021.100119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Souza D, Queiroga E, de T, Cunha K, Dias E. Stromal scoring in advanced colon and rectal cancer: Stroma-rich tumors and their association with aggressive phenotypes. Arch Oncol 2022;28:1-6. [DOI: 10.2298/aoo210403003s] [Reference Citation Analysis]
195 Gao F, Griffin N, Faulkner S, Li X, King SJ, Jobling P, Denham JW, Jiang CC, Hondermarck H. The Membrane Protein Sortilin Can Be Targeted to Inhibit Pancreatic Cancer Cell Invasion. Am J Pathol 2020;190:1931-42. [PMID: 32526166 DOI: 10.1016/j.ajpath.2020.05.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
196 Elzein S, Bao F, Lin R, Schnickel G, Lowy AM, Botta GP. Tri-modal management of primary small cell carcinoma of the pancreas (SCCP): a rare neuroendocrine carcinoma (NEC). BMC Gastroenterol 2021;21:340. [PMID: 34479480 DOI: 10.1186/s12876-021-01901-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
197 Petrelli F, Spagnoli L, Giusti A, Perotti B, Cavazzana A, Arganini M, Ambrosio MR. Jejunal gastrointestinal stromal tumor with rectal lymph nodes metastases synchronous to intestinal adenocarcinoma: a possible common origin. Dig Liver Dis 2021;53:796-8. [PMID: 33896750 DOI: 10.1016/j.dld.2021.03.032] [Reference Citation Analysis]
198 Laudicella R, Comelli A, Liberini V, Vento A, Stefano A, Spataro A, Crocè L, Baldari S, Bambaci M, Deandreis D, Arico’ D, Ippolito M, Gaeta M, Alongi P, Minutoli F, Burger IA, Baldari S. [68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept. Cancers 2022;14:984. [DOI: 10.3390/cancers14040984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Cheng J, Liu Y, Huang W, Hong W, Wang L, Zhan X, Han Z, Ni D, Huang K, Zhang J. Computational Image Analysis Identifies Histopathological Image Features Associated With Somatic Mutations and Patient Survival in Gastric Adenocarcinoma. Front Oncol 2021;11:623382. [PMID: 33869007 DOI: 10.3389/fonc.2021.623382] [Reference Citation Analysis]
200 Wang Z, Liu Z, Wen Z, Li R, An K, Mei S, Chen J, Shen H, Li J, Zhao F, Wei F, Xiao T, Liu Q. Evaluation of radical surgical treatment in the management of 58 locally advanced rectal neuroendocrine neoplasms, one multicenter retrospective study. Eur J Surg Oncol 2021:S0748-7983(21)00631-4. [PMID: 34294465 DOI: 10.1016/j.ejso.2021.07.010] [Reference Citation Analysis]
201 Feng Z, Qiao R, Ren Z, Hou X, Feng J, He X, Chen D. Could CTSK and COL4A2 be specific biomarkers of poor prognosis for patients with gastric cancer in Asia?-a microarray analysis based on regional population. J Gastrointest Oncol 2020;11:386-401. [PMID: 32399279 DOI: 10.21037/jgo.2020.03.01] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
202 Hemachandran N, Goyal A, Bhattacharjee HK, Sharma R. Radiology of anal and lower rectal cancers. Clin Radiol 2021:S0009-9260(21)00312-3. [PMID: 34246493 DOI: 10.1016/j.crad.2021.06.007] [Reference Citation Analysis]
203 Zhang Z, Guo T, Huang X, Xie P, Wang L, Yu Y. Age-specific clinicopathological characteristics and prognostic analysis of neuroendocrine carcinomas of the gallbladder. Cancer Med 2021. [PMID: 34841738 DOI: 10.1002/cam4.4463] [Reference Citation Analysis]
204 Kaliszewski K, Ludwig M, Greniuk M, Mikuła A, Zagórski K, Rudnicki J. Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs). Cancers (Basel) 2022;14:2028. [PMID: 35454934 DOI: 10.3390/cancers14082028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
205 Yu WM, Li R, Sun BL, Du JK, Tuo HF. Primary hepatic neuroendocrine tumour with multiple liver metastases: A case report with literature review. Int J Surg Case Rep 2021;89:106590. [PMID: 34784532 DOI: 10.1016/j.ijscr.2021.106590] [Reference Citation Analysis]
206 van der Wel MJ, Klaver E, Pouw RE, Brosens LAA, Biermann K, Doukas M, Huysentruyt C, Karrenbeld A, Ten Kate FJW, Kats-Ugurlu G, van der Laan J, van Lijnschoten I, Moll FCP, Offerhaus GJA, Ooms AHAG, Seldenrijk CA, Visser M, Tijssen JG, Meijer SL, Bergman JJGHM. Significant variation in histopathological assessment of endoscopic resections for Barrett's neoplasia suggests need for consensus reporting: propositions for improvement. Dis Esophagus 2021:doab034. [PMID: 34100554 DOI: 10.1093/dote/doab034] [Reference Citation Analysis]
207 Li D, Xie J, Hong D, Liu G, Wang R, Jiang C, Ye Z, Xu B, Wang W. Efficacy and safety of ligation-assisted endoscopic submucosal resection combined with endoscopic ultrasonography for treatment of rectal neuroendocrine tumors. Scand J Gastroenterol 2022;:1-6. [PMID: 35108155 DOI: 10.1080/00365521.2022.2033828] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Kitada T, Masui T, Kasai Y, Uchida Y, Ogiso S, Ito T, Ishii T, Seo S, Katsuragawa H, Uemoto S. A subcentimeter duodenal neuroendocrine neoplasm with a liver metastasis upgraded to G3: a case report. Surg Case Rep 2021;7:72. [PMID: 33742297 DOI: 10.1186/s40792-021-01155-1] [Reference Citation Analysis]
209 Gao Y, Cai B, Yin L, Song G, Lu Z, Guo F, Chen J, Xi C, Wei J, Wu J, Gao W, Jiang K, Miao Y. Undifferentiated Carcinoma of Pancreas with Osteoclast-Like Giant Cells: One Center’s Experience of 13 Cases and Characteristic Pre-Operative Images. CMAR 2022;Volume 14:1409-19. [DOI: 10.2147/cmar.s349625] [Reference Citation Analysis]
210 Folkestad O, Wasmuth HH, Mjønes P, Fougner R, Hauso Ø, Fossmark R. Survival and Disease Recurrence in Patients with Duodenal Neuroendocrine Tumours-A Single Centre Cohort. Cancers (Basel) 2021;13:3985. [PMID: 34439140 DOI: 10.3390/cancers13163985] [Reference Citation Analysis]
211 Exarchou K, Howes N, Pritchard DM. Systematic review: management of localised low-grade upper gastrointestinal neuroendocrine tumours. Aliment Pharmacol Ther 2020;51:1247-67. [PMID: 32390152 DOI: 10.1111/apt.15765] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
212 Khader A, Braschi-Amirfarzan M, McIntosh LJ, Gosangi B, Wortman JR, Wald C, Thomas R. Importance of tumor subtypes in cancer imaging. Eur J Radiol Open 2022;9:100433. [PMID: 35909389 DOI: 10.1016/j.ejro.2022.100433] [Reference Citation Analysis]
213 Li Y, Pan F, Sun G, Wang ZK, Meng K, Peng LH, Lu ZS, Dou Y, Yan B, Liu QS. Risk Factors and Clinical Outcomes of 54 Cases of Rectal Neuroendocrine Tumors with Incomplete Resection: A Retrospective Single-Center Study. Ther Clin Risk Manag 2021;17:1153-61. [PMID: 34764651 DOI: 10.2147/TCRM.S332838] [Reference Citation Analysis]
214 Ramachandran A, Srivastava DN, Madhusudhan KS. Gallbladder cancer revisited: the evolving role of a radiologist. Br J Radiol 2021;94:20200726. [PMID: 33090880 DOI: 10.1259/bjr.20200726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
215 Luo R, Huang W, Chen L, Liu Y, Xu L, Zhang X, Xu C, Hou Y. SP70 is a potential biomarker to identify gastric fundic gland neoplasms. World J Surg Oncol 2022;20:132. [PMID: 35468832 DOI: 10.1186/s12957-022-02564-8] [Reference Citation Analysis]
216 LA Barba G, Pacilio CA, Binda C, Fappiano F, Fabbri C, Ercolani G. INTRAHEPATIC BILIARY STRICTURES WITH UNDERLYING PRE-MALIGNANT BILIARY LESIONS: IS IT TIME TO BUILD GUIDELINES ON DIAGNOSIS AND MANAGEMENT? Arq Bras Cir Dig 2022;34:e1613. [PMID: 35019125 DOI: 10.1590/0102-672020210002e1613] [Reference Citation Analysis]
217 Sato C, Hirasawa K, Tateishi Y, Ozeki Y, Sawada A, Ikeda R, Fukuchi T, Nishio M, Kobayashi R, Makazu M, Kaneko H, Inayama Y, Maeda S. Clinicopathological features of early gastric cancers arising in Helicobacter pylori uninfected patients. World J Gastroenterol 2020; 26(20): 2618-2631 [PMID: 32523315 DOI: 10.3748/wjg.v26.i20.2618] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
218 Rajlawot K, Jiang T, Zhou J, Lin C, Kuang S, Chen J, Zhang Y, Yang H, Deng Y, He B, Hernando D, Reeder SB, Wang J. Accuracies of Chemical Shift In/Opposed Phase and Chemical Shift Encoded Magnetic Resonance Imaging to Detect Intratumoral Fat in Hepatocellular Carcinoma. J Magn Reson Imaging 2021;53:1791-802. [PMID: 33580551 DOI: 10.1002/jmri.27539] [Reference Citation Analysis]
219 Saragoni L, Pacilio CA, Cavaliere D, Limarzi F, Isopi C, Ercolani G. Solid serous cystadenoma of the pancreas: A rare tumor with challenging differential diagnosis. Hepatobiliary Pancreat Dis Int 2021:S1499-3872(21)00116-8. [PMID: 34256995 DOI: 10.1016/j.hbpd.2021.06.005] [Reference Citation Analysis]
220 Quach DT, Tran LT, Tran TL, Tran VL, Le NQ, Hiyama T. Age Cutoff and Yield of Prompt Esophagogastroduodenoscopy to Detect Malignancy in Vietnamese with Upper Gastrointestinal Symptoms: An Endoscopic Database Review of 472,744 Patients from 2014 to 2019. Can J Gastroenterol Hepatol 2021;2021:1184848. [PMID: 34931167 DOI: 10.1155/2021/1184848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Yoshihara A, Nishihama K, Inoue C, Okano Y, Eguchi K, Tanaka S, Maki K, Fridman D'Alessandro V, Takeshita A, Yasuma T, Uemura M, Suzuki T, Gabazza EC, Yano Y. Adrenocorticotropic hormone-secreting pancreatic neuroendocrine carcinoma with multiple organ infections and widespread thrombosis: A case report. World J Clin Cases 2022; 10(17): 5723-5731 [DOI: 10.12998/wjcc.v10.i17.5723] [Reference Citation Analysis]
222 El Dein Mohameda AS, El-Rebey HS, AboElnasr LSA, Abdou AG. The role and relationship between programmed death ligand 1 and cytotoxic T lymphocyte-associated antigen-4 immunohistochemical expression in colorectal carcinoma patients: an impact on outcome. Ecancermedicalscience 2021;15:1323. [PMID: 35047074 DOI: 10.3332/ecancer.2021.1323] [Reference Citation Analysis]
223 Casolino R, Braconi C, Malleo G, Paiella S, Bassi C, Milella M, Dreyer SB, Froeling FEM, Chang DK, Biankin AV, Golan T. Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine. Ann Oncol 2021;32:183-96. [PMID: 33248227 DOI: 10.1016/j.annonc.2020.11.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
224 Lombardi PM, Mazzola M, Achilli P, Aquilano MC, De Martini P, Curaba A, Gualtierotti M, Bertoglio CL, Magistro C, Ferrari G. Prognostic value of pathological tumor regression grade in locally advanced gastric cancer: New perspectives from a single-center experience. J Surg Oncol 2021;123:923-31. [PMID: 33497471 DOI: 10.1002/jso.26391] [Reference Citation Analysis]
225 Maldonado-García EL, Álvarez-Barragán AF, Acevedo-Aguirre CE, Galicia-Alemán B, Arellano-Gutiérrez G. Neuroendocrine tumor of the ileocecal valve: A case report and review of the literature. Rev Gastroenterol Mex (Engl Ed) 2021:S2255-534X(21)00123-7. [PMID: 34794925 DOI: 10.1016/j.rgmxen.2021.11.008] [Reference Citation Analysis]
226 Chen K, Dong Y, Zhang W, Han H, Mao F, Zhang Q, Zheng Z, He W, Wang WP. Analysis of contrast-enhanced ultrasound features of hepatocellular adenoma according to different pathological molecular classifications. Clin Hemorheol Microcirc 2020;76:391-403. [PMID: 32675402 DOI: 10.3233/CH-200899] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
227 Kato J, Maruta A, Shirakami Y, Mizutani T, Ozawa N, Ideta T, Takada J, Kubota M, Sakai H, Ibuka T, Araki H, Shimizu M. Advanced appendiceal goblet cell carcinoids with intestinal obstruction: two case reports. Clin J Gastroenterol 2020;13:1205-12. [PMID: 32989687 DOI: 10.1007/s12328-020-01232-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
228 Feng M, Pan Y, Kong R, Shu S. Therapy of Primary Liver Cancer. Innovation (N Y) 2020;1:100032. [PMID: 32914142 DOI: 10.1016/j.xinn.2020.100032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
229 Wang XZ, Zeng ZY, Ye X, Sun J, Zhang ZM, Kang WM. Interpretation of the development of neoadjuvant therapy for gastric cancer based on the vicissitudes of the NCCN guidelines. World J Gastrointest Oncol 2020; 12(1): 37-53 [PMID: 31966912 DOI: 10.4251/wjgo.v12.i1.37] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
230 Regmi P, Paudyal A, Paudyal P, Hu HJ, Liu F, Ma WJ, Jin YW, Li FY. Prognostic significance of tumor budding in biliary tract cancer. Eur J Surg Oncol 2021:S0748-7983(21)00678-8. [PMID: 34412954 DOI: 10.1016/j.ejso.2021.08.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
231 Krenzien F, Nevermann N, Krombholz A, Benzing C, Haber P, Fehrenbach U, Lurje G, Pelzer U, Pratschke J, Schmelzle M, Schöning W. Treatment of Intrahepatic Cholangiocarcinoma-A Multidisciplinary Approach. Cancers (Basel) 2022;14:362. [PMID: 35053523 DOI: 10.3390/cancers14020362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
232 Folkestad O, Wasmuth HH, Mjønes P, Fougner R, Hauso Ø, Fossmark R. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital. Surg Oncol 2020;35:336-43. [PMID: 32979699 DOI: 10.1016/j.suronc.2020.09.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
233 Zhou Y, Yin S, Zhao L, Zhang X, Li M, Ding J, Yan K, Jing X. CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma. Front Oncol 2022;12:897090. [PMID: 35651804 DOI: 10.3389/fonc.2022.897090] [Reference Citation Analysis]
234 Li J, Huang WF, Zhang JY. A rare case of duodenal neuroendocrine tumor with hepatic metastasis. Clin Res Hepatol Gastroenterol 2021;:101850. [PMID: 34923182 DOI: 10.1016/j.clinre.2021.101850] [Reference Citation Analysis]
235 Muñoz de Nova JL, Hernando J, Sampedro Núñez M, Vázquez Benítez GT, Triviño Ibáñez EM, del Olmo García MI, Barriuso J, Capdevila J, Martín-Pérez E. Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy. World J Gastroenterol 2022; 28(13): 1304-1314 [DOI: 10.3748/wjg.v28.i13.1304] [Reference Citation Analysis]
236 Lim JH, Song JH, Chung SJ, Chung GE, Kim JS. Characteristics of interval gastric neoplasms detected within two years after negative screening endoscopy among Koreans. BMC Cancer 2021;21:218. [PMID: 33653298 DOI: 10.1186/s12885-021-07929-y] [Reference Citation Analysis]
237 Zhang K, Tao C, Tao Z, Wu F, An S, Wu J, Rong W. Lymphoepithelioma-like carcinoma in liver not associated with Epstein-Barr virus: a report of 3 cases and literature review. Diagn Pathol. 2020;15:115. [PMID: 32967689 DOI: 10.1186/s13000-020-01035-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
238 Gile JJ, Liu AJ, McGarrah PW, Eiring RA, Hobday TJ, Starr JS, Sonbol MB, Halfdanarson TR. Efficacy of Checkpoint Inhibitors in Neuroendocrine Neoplasms: Mayo Clinic Experience. Pancreas 2021;50:500-5. [PMID: 33939660 DOI: 10.1097/MPA.0000000000001794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
239 Gerber TS, Goeppert B, Hausen A, Witzel HR, Bartsch F, Schindeldecker M, Gröger L, Ridder DA, Cahyadi O, Esposito I, Gaida MM, Schirmacher P, Galle PR, Lang H, Roth W, Straub BK. N-Cadherin Distinguishes Intrahepatic Cholangiocarcinoma from Liver Metastases of Ductal Adenocarcinoma of the Pancreas. Cancers 2022;14:3091. [DOI: 10.3390/cancers14133091] [Reference Citation Analysis]
240 Li H, Qu L, Zhang H, Liu J, Zhang X. A comprehensive transcriptomic landscape of cholangiocarcinoma based on bioinformatics analysis from large cohort of patients. Sci Rep 2021;11:13713. [PMID: 34211100 DOI: 10.1038/s41598-021-93250-4] [Reference Citation Analysis]
241 Cuny T, van Koetsveld PM, Mondielli G, Dogan F, de Herder WW, Barlier A, Hofland LJ. Reciprocal Interactions between Fibroblast and Pancreatic Neuroendocrine Tumor Cells: Putative Impact of the Tumor Microenvironment. Cancers 2022;14:3481. [DOI: 10.3390/cancers14143481] [Reference Citation Analysis]
242 Serei VD, Poplin E, Ganesan S, Riedlinger G. Molecular Profiling for Proper Diagnosis of Gastroenteropancreatic Neuroendocrine Tumor. JCO Precis Oncol 2020;4:PO. [PMID: 32923901 DOI: 10.1200/PO.20.00111] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
243 Deliwala SS, Ponnapalli A, Gakhal I, Modi V, Haykal T, Bachuwa G, Chawla S. When Variants Collide: An Unusual Presentation of Metastatic Gastric Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm. ACG Case Rep J 2021;8:e00569. [PMID: 34476269 DOI: 10.14309/crj.0000000000000569] [Reference Citation Analysis]
244 Costa AC, Santa-Cruz F, Guimarães H, Paz AR, Costa EAC, Figueiredo JL, Ferraz ÁAB. Primary hepatic neuroendocrine tumor: A case report and literature review. Int J Surg Case Rep 2020;72:1-4. [PMID: 32506020 DOI: 10.1016/j.ijscr.2020.05.057] [Reference Citation Analysis]
245 Ooki A, Yamaguchi K. The dawn of precision medicine in diffuse-type gastric cancer. Ther Adv Med Oncol 2022;14:175883592210830. [DOI: 10.1177/17588359221083049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
246 Calomino N, Fusario D, Cencini E, Lazzi S. Two secondary localisation of non-Hodgkin's lymphomas in the upper gastrointestinal tract. BMJ Case Rep 2022;15:e247607. [PMID: 35584861 DOI: 10.1136/bcr-2021-247607] [Reference Citation Analysis]
247 Krieger AG, Karmazanovskiy GG, Panteleev VI, Gorin DS, Vetsheva NN, Berelavichus SV, Kaldarov AR, Glotov AV. [Diagnostic and treatment of the intraductal papillary mucinous tumor of pancreas]. Khirurgiia (Mosk) 2020;:14-24. [PMID: 31994495 DOI: 10.17116/hirurgia202001114] [Reference Citation Analysis]
248 Liu H, Xu Y, Zhang Z, Wang N, Huang Y, Hu Y, Yang Z, Jiang R, Chen H. A Natural Language Processing Pipeline of Chinese Free-Text Radiology Reports for Liver Cancer Diagnosis. IEEE Access 2020;8:159110-9. [DOI: 10.1109/access.2020.3020138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
249 Xia C, Yin H, Zhang K, Wang Z, Yang X, Huang H. The global research status and trends of the application of endoscopic ultrasonography in pancreatic tumors over the last decades: A bibliometric study. Front Oncol 2022;12:980415. [DOI: 10.3389/fonc.2022.980415] [Reference Citation Analysis]
250 Laenkholm IT, Langer SW, Andreassen M, Holmager P, Kjaer A, Klose M, Federspiel BH, Hansen CP, Knigge U. A short report of 50 patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN). Acta Oncol 2021;60:808-12. [PMID: 33779475 DOI: 10.1080/0284186X.2021.1903077] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
251 Xu P, Xu X, Zhang L, Li Z, Qiang J, Yao J, Xu A. hsa_circ_0060975 is highly expressed and predicts a poor prognosis in gastric cancer. Oncol Lett 2021;22:619. [PMID: 34257727 DOI: 10.3892/ol.2021.12880] [Reference Citation Analysis]
252 Vanbiervliet G, Strijker M, Arvanitakis M, Aelvoet A, Arnelo U, Beyna T, Busch O, Deprez PH, Kunovsky L, Larghi A, Manes G, Moss A, Napoleon B, Nayar M, Pérez-Cuadrado-Robles E, Seewald S, Barthet M, van Hooft JE. Endoscopic management of ampullary tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2021;53:429-48. [PMID: 33728632 DOI: 10.1055/a-1397-3198] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 21.0] [Reference Citation Analysis]
253 Zengin M, Karahan İ. The role of cancer-related inflammation for prediction of poor survival in postmenopausal female patients with stage II/III colon cancer. Int Immunopharmacol 2020;85:106624. [PMID: 32492626 DOI: 10.1016/j.intimp.2020.106624] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
254 Tang M, Zhao Y, Zhao J, Wei S, Liu M, Zheng N, Geng D, Han S, Zhang Y, Zhong G, Li S, Zhang X, Wang C, Yan H, Cao X, Li L, Bai X, Ji J, Feng XH, Qin J, Liang T, Zhao B. Liver cancer heterogeneity modeled by in situ genome editing of hepatocytes. Sci Adv 2022;8:eabn5683. [PMID: 35731873 DOI: 10.1126/sciadv.abn5683] [Reference Citation Analysis]
255 Mcguinness MJ, Woodhouse B, Harmston C, Parker K, Kramer N, Findlay M, Print C, Merrie A, Lawrence B. Survival of patients with small bowel neuroendocrine neoplasms in Auckland, Aotearoa New Zealand. ANZ Journal of Surgery. [DOI: 10.1111/ans.17851] [Reference Citation Analysis]
256 Bal MM, Hubale B, Janu A, Patil A. Salivary duct carcinoma and small cell carcinoma ex-pleomorphic adenoma: A heretofore undescribed entity and the naming conundrum: MiNEN, combined, collision, or composite tumor? Oral Surg Oral Med Oral Pathol Oral Radiol 2021;132:e92-6. [PMID: 33741286 DOI: 10.1016/j.oooo.2021.01.022] [Reference Citation Analysis]
257 Peruhova M, Peshevska-Sekulovska M, Krastev B, Panayotova G, Georgieva V, Konakchieva R, Nikolaev G, Velikova TV. What could microRNA expression tell us more about colorectal serrated pathway carcinogenesis? World J Gastroenterol 2020; 26(42): 6556-6571 [PMID: 33268946 DOI: 10.3748/wjg.v26.i42.6556] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
258 Li YL, Qiu XD, Chen J, Zhang Y, Li J, Xu JM, Wang C, Qi ZR, Luo J, Tan HY. Clinicopathological characteristics and prognosis of 77 cases with type 3 gastric neuroendocrine tumours. World J Gastrointest Oncol 2020; 12(12): 1416-1427 [PMID: 33362912 DOI: 10.4251/wjgo.v12.i12.1416] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
259 Xu X, Peng C, Tong R, Dong M, Deng J. An extremely rare phenomenon of mucinous cystic neoplasm of the liver: spontaneous rupture. Hepatobiliary Surg Nutr 2021;10:424-7. [PMID: 34159183 DOI: 10.21037/hbsn-21-102] [Reference Citation Analysis]
260 Traub B, Link KH, Kornmann M. Curing pancreatic cancer. Semin Cancer Biol 2021:S1044-579X(21)00160-7. [PMID: 34062264 DOI: 10.1016/j.semcancer.2021.05.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Kong ZZ, Zhang L. Esophagogastric junctional neuroendocrine tumor with adenocarcinoma: A case report. World J Clin Cases 2022; 10(18): 6241-6246 [DOI: 10.12998/wjcc.v10.i18.6241] [Reference Citation Analysis]
262 Lea D, Gudlaugsson EG, Skaland I, Lillesand M, Søreide K, Søreide JA. Digital Image Analysis of the Proliferation Markers Ki67 and Phosphohistone H3 in Gastroenteropancreatic Neuroendocrine Neoplasms: Accuracy of Grading Compared With Routine Manual Hot Spot Evaluation of the Ki67 Index. Appl Immunohistochem Mol Morphol 2021;29:499-505. [PMID: 33758143 DOI: 10.1097/PAI.0000000000000934] [Reference Citation Analysis]
263 Lira-treviño A, Carranza Mendoza I, Borbolla Arizti J, Soriano-ríos A, Uscanga-domínguez L, Peláez-luna M. Pancreatic cystic lesions. Differential diagnosis and treatment strategy. Revista de Gastroenterología de México (English Edition) 2022. [DOI: 10.1016/j.rgmxen.2022.05.002] [Reference Citation Analysis]
264 Chen HY, Lee WH, Hsu HL, Chou YT, Su FL, Wu IH, Chao TH. Arterial stiffness is associated with high-risk colorectal adenomas and serrated lesions: A cross-sectional study in a Taiwanese population. J Cardiol 2022:S0914-5087(22)00073-9. [PMID: 35469715 DOI: 10.1016/j.jjcc.2022.03.013] [Reference Citation Analysis]
265 Li G, Ma S, Wu Q, Kong D, Yang Z, Gu Z, Feng L, Zhang K, Cheng S, Tian Y, Zhang W. Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing. Cell Death Discov 2022;8:6. [PMID: 35013129 DOI: 10.1038/s41420-021-00803-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
266 Lenkiewicz E, Malasi S, Hogenson TL, Flores LF, Barham W, Phillips WJ, Roesler AS, Chambers KR, Rajbhandari N, Hayashi A, Antal CE, Downes M, Grandgenett PM, Hollingsworth MA, Cridebring D, Xiong Y, Lee JH, Ye Z, Yan H, Hernandez MC, Leiting JL, Evans RM, Ordog T, Truty MJ, Borad MJ, Reya T, Von Hoff DD, Fernandez-Zapico ME, Barrett MT. Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas. Cancer Res 2020;80:4324-34. [PMID: 32928922 DOI: 10.1158/0008-5472.CAN-20-0078] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
267 Massironi S, Rossi RE, Milanetto AC, Andreasi V, Campana D, Nappo G, Partelli S, Gallo C, Scaravaglio M, Zerbi A, Panzuto F, Pasquali C, Falconi M, Invernizzi P, On Behalf Of ItaNet Italian Association For Neuroendocrine Tumours Study Group. Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence? J Clin Med 2022;11:2658. [PMID: 35566783 DOI: 10.3390/jcm11092658] [Reference Citation Analysis]
268 Li Y, Zhong Y, Xu Q, Zhu Z, Tian Y. Prognostic Significance of Signet Ring Cells in Gastric Cancer: The Higher Proportion, The Better Survival. Front Oncol 2021;11:713587. [PMID: 34858807 DOI: 10.3389/fonc.2021.713587] [Reference Citation Analysis]
269 Katabathina VS, Khanna L, Surabhi VR, Minervini M, Shanbhogue K, Dasyam AK, Prasad SR. Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma. Radiographics 2022;:210106. [PMID: 35776676 DOI: 10.1148/rg.210206] [Reference Citation Analysis]
270 Noreen F, Chaber-Ciopinska A, Regula J, Schär P, Truninger K. Longitudinal analysis of healthy colon establishes aspirin as a suppressor of cancer-related epigenetic aging. Clin Epigenetics 2020;12:164. [PMID: 33143725 DOI: 10.1186/s13148-020-00956-9] [Reference Citation Analysis]
271 Lin YH, Yao W, Fei Q, Wang Y. Gastric cancer with calcifications: A case report. World J Clin Cases 2021; 9(27): 8135-8141 [PMID: 34621872 DOI: 10.12998/wjcc.v9.i27.8135] [Reference Citation Analysis]
272 Lima de Souza Gonçalves V, Cordeiro Santos ML, Silva Luz M, Santos Marques H, de Brito BB, França da Silva FA, Souza CL, Oliveira MV, de Melo FF. From Helicobacter pylori infection to gastric cancer: Current evidence on the immune response. World J Clin Oncol 2022; 13(3): 186-199 [DOI: 10.5306/wjco.v13.i3.186] [Reference Citation Analysis]
273 Nguyen H, Nguyen NC, Thieu TTM, Luong TH, Tran NM, Nguyen DH, Nguyen AK. Complete resection for a giant recurrent biliary cystadenoma: A surgical case report and review of literature. Annals of Medicine and Surgery 2022;78:103785. [DOI: 10.1016/j.amsu.2022.103785] [Reference Citation Analysis]
274 Liang Y, Xu F, Wang Z, Tan C, Zhang N, Wei X, Jiang X, Wu H. A gadoxetic acid-enhanced MRI-based multivariable model using LI-RADS v2018 and other imaging features for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Eur J Radiol 2022;153:110356. [PMID: 35623312 DOI: 10.1016/j.ejrad.2022.110356] [Reference Citation Analysis]
275 Xia Y, Zhang L, Wu H, Qiao L, Xia L. Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with literature review. J Int Med Res 2020;48:300060520932114. [PMID: 32589085 DOI: 10.1177/0300060520932114] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Sakamoto T, Furukawa T, Lami K, Pham HHN, Uegami W, Kuroda K, Kawai M, Sakanashi H, Cooper LAD, Bychkov A, Fukuoka J. A narrative review of digital pathology and artificial intelligence: focusing on lung cancer. Transl Lung Cancer Res 2020;9:2255-76. [PMID: 33209648 DOI: 10.21037/tlcr-20-591] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
277 Silva RMSD, Collaço PMC, Cunha KS, Dias EP. Diagnosis of Advanced Disease in Cases of Colorectal Cancer in a Developing Country. Journal of Coloproctology. [DOI: 10.1055/s-0041-1736517] [Reference Citation Analysis]
278 Becker A, Schalin-Jäntti C, Itkonen O. Comparison of Serum and Urinary 5-Hydroxyindoleacetic Acid as Biomarker for Neuroendocrine Neoplasms. J Endocr Soc 2021;5:bvab106. [PMID: 34195530 DOI: 10.1210/jendso/bvab106] [Reference Citation Analysis]
279 Zhang X, Xiao R, Lu B, Wu H, Jiang C, Li P, Huang J. Kinase DYRK2 acts as a regulator of autophagy and an indicator of favorable prognosis in gastric carcinoma. Colloids Surf B Biointerfaces 2021;209:112182. [PMID: 34749023 DOI: 10.1016/j.colsurfb.2021.112182] [Reference Citation Analysis]
280 Qi J, Liu X, Yan P, He S, Lin Y, Huang Z, Zhang S, Xie S, Li Y, Lu X, Wu Y, Zhou Y, Yuan J, Cai T, Zheng X, Ding Y, Yang W. Analysis of Immune Landscape Reveals Prognostic Significance of Cytotoxic CD4+ T Cells in the Central Region of pMMR CRC. Front Oncol 2021;11:724232. [PMID: 34631551 DOI: 10.3389/fonc.2021.724232] [Reference Citation Analysis]
281 Yang KC, Kalloger SE, Aird JJ, Lee MKC, Rushton C, Mungall KL, Mungall AJ, Gao D, Chow C, Xu J, Karasinska JM, Colborne S, Jones SJM, Schrader J, Morin RD, Loree JM, Marra MA, Renouf DJ, Morin GB, Schaeffer DF, Gorski SM. Proteotranscriptomic classification and characterization of pancreatic neuroendocrine neoplasms. Cell Rep 2021;37:109817. [PMID: 34644566 DOI: 10.1016/j.celrep.2021.109817] [Reference Citation Analysis]
282 Li Z, Dou L, Zhang Y, He S, Zhao D, Hao C, Song G, Zhang W, Liu Y, Wang G. Characterization of the Oral and Esophageal Microbiota in Esophageal Precancerous Lesions and Squamous Cell Carcinoma. Front Cell Infect Microbiol 2021;11:714162. [PMID: 34604107 DOI: 10.3389/fcimb.2021.714162] [Reference Citation Analysis]
283 Shen B, Sun K. Exosomal circular RNAs: A new frontier in the metastasis of digestive system tumors. Oncol Lett 2021;22:826. [PMID: 34691253 DOI: 10.3892/ol.2021.13087] [Reference Citation Analysis]
284 Liu DH, Šefčovičová N, Emmerson J, Spaans LN, Saito Y, Hutchins G, Nankivell MG, Langley RE, Allum W, Cunningham D, Langer R, Grabsch HI. Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 trials. European Journal of Cancer 2022;170:140-8. [DOI: 10.1016/j.ejca.2022.04.026] [Reference Citation Analysis]
285 Kanavati F, Ichihara S, Rambeau M, Iizuka O, Arihiro K, Tsuneki M. Deep Learning Models for Gastric Signet Ring Cell Carcinoma Classification in Whole Slide Images. Technol Cancer Res Treat 2021;20:15330338211027901. [PMID: 34191660 DOI: 10.1177/15330338211027901] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
286 Wu H, Xin L, Lin JH, Wang QH, Li B, Jin ZD, Hu LH, Zou WB, Qi K, Yang T, Li ZS, Liao Z. Association between sedation and small neoplasm detection during diagnostic esophagogastroduodenoscopy: a propensity score-matched retrospective study. Scand J Gastroenterol 2022;:1-7. [PMID: 34983263 DOI: 10.1080/00365521.2021.2023212] [Reference Citation Analysis]
287 Prall OWJ. Malignant Pleural Mesothelioma-Does Ki67 Make the Grade? JTO Clin Res Rep 2021;2:100170. [PMID: 34590021 DOI: 10.1016/j.jtocrr.2021.100170] [Reference Citation Analysis]
288 O'Connell E, Reynolds IS, McNamara DA, Burke JP, Prehn JHM. Resistance to Cell Death in Mucinous Colorectal Cancer-A Review. Cancers (Basel) 2021;13:1389. [PMID: 33808549 DOI: 10.3390/cancers13061389] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
289 Fu M, Yu L, Yang L, Chen Y, Chen X, Hu Q, Sun H. Gender differences in pancreatic neuroendocrine neoplasms: A retrospective study based on the population of Hubei Province, China. Front Endocrinol 2022;13:885895. [DOI: 10.3389/fendo.2022.885895] [Reference Citation Analysis]
290 Mathews AA, Draganov PV, Yang D. Endoscopic management of colorectal polyps: From benign to malignant polyps. World J Gastrointest Endosc 2021; 13(9): 356-370 [PMID: 34630886 DOI: 10.4253/wjge.v13.i9.356] [Reference Citation Analysis]
291 Sun J, Shen D, Gao Y, Zheng Y, Zhao L, Maa M, Liu H, Chen X. Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation. Onco Targets Ther 2020;13:7973-84. [PMID: 32848421 DOI: 10.2147/OTT.S264108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
292 Galgano SJ, Wei B, Rose JB. PET Imaging of Neuroendocrine Tumors. Radiol Clin North Am 2021;59:789-99. [PMID: 34392919 DOI: 10.1016/j.rcl.2021.05.006] [Reference Citation Analysis]
293 Shi H, Wang C, Wu J, Qin B, Jiang J, Liu N, Song Y, Qin Y, Ma S. Underwater endoscopic mucosal resection for rectal neuroendocrine tumors (with videos): a single center retrospective study. BMC Gastroenterol 2022;22:276. [PMID: 35655173 DOI: 10.1186/s12876-022-02350-6] [Reference Citation Analysis]
294 Yang F, Dong Z, Shen Y, Shi J, Wu Y, Zhao Z, Jiang G, Song X. Cribriform growth pattern in lung adenocarcinoma: More aggressive and poorer prognosis than acinar growth pattern. Lung Cancer 2020;147:187-92. [PMID: 32721653 DOI: 10.1016/j.lungcan.2020.07.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
295 Liu H, Zhang C. Paeonol induces antitumor effects in hepatocellular carcinoma cells through survivin via the cyclooxygenase-2/prostaglandin E2 signaling pathway. Transl Cancer Res 2020;9:7183-95. [PMID: 35117322 DOI: 10.21037/tcr-20-322A] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
296 Yao B, Feng Y, Zhao K, Liang Y, Huang P, Zang J, Song J, Li M, Wang X, Shu H, Shi R. Artificial intelligence assisted cytological detection for early esophageal squamous epithelial lesions by using low-grade squamous intraepithelial lesion as diagnostic threshold. Cancer Med 2022. [PMID: 35766144 DOI: 10.1002/cam4.4984] [Reference Citation Analysis]
297 Carballal S, Balaguer F, Ijspeert J. Serrated polyposis syndrome; epidemiology and management. Best Practice & Research Clinical Gastroenterology 2022. [DOI: 10.1016/j.bpg.2022.101791] [Reference Citation Analysis]
298 Cannella R, Cunha GM, Catania R, Chupetlovska K, Borhani AA, Fowler KJ, Furlan A. Magnetic Resonance Imaging of Nonhepatocellular Malignancies in Chronic Liver Disease. Magn Reson Imaging Clin N Am 2021;29:404-18. [PMID: 34243926 DOI: 10.1016/j.mric.2021.05.009] [Reference Citation Analysis]
299 Innocenti T, Danti G, Lynch EN, Dragoni G, Gottin M, Fedeli F, Palatresi D, Biagini MR, Milani S, Miele V, Galli A. Higher volume growth rate is associated with development of worrisome features in patients with branch duct-intraductal papillary mucinous neoplasms. World J Clin Cases 2022; 10(17): 5667-5679 [DOI: 10.12998/wjcc.v10.i17.5667] [Reference Citation Analysis]
300 Li Z, Wang J, Ji Y, Song F. Expression Characteristics and Clinical Correlations of BRD1 in Colorectal Cancer Samples. Technol Cancer Res Treat 2021;20:15330338211039678. [PMID: 34482774 DOI: 10.1177/15330338211039678] [Reference Citation Analysis]
301 Armwood AR, Mayer J, Walth GB, Rissi DR. Pathology in Practice. J Am Vet Med Assoc 2022;:1-3. [PMID: 35460547 DOI: 10.2460/javma.20.03.0165] [Reference Citation Analysis]
302 Canakis A, Lee LS. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Endosc 2022; 14(5): 267-290 [DOI: 10.4253/wjge.v14.i5.267] [Reference Citation Analysis]
303 Ohmoto A, Fujiwara Y, Horita N, Nakano K, Takahashi S. Platinum-doublet chemotherapy for advanced gastroenteropancreatic neuroendocrine carcinoma: a systematic review and meta-analysis. Discov Onc 2022;13. [DOI: 10.1007/s12672-022-00499-w] [Reference Citation Analysis]
304 Propst R, Chen Wongworawat Y, Choo E, Cobb C, Raza A. Metastatic prostate adenocarcinoma and high-grade appendiceal mucinous neoplasm mimicking acute appendicitis in a post-radiation therapy patient. SAGE Open Med Case Rep 2021;9:2050313X20988421. [PMID: 33796305 DOI: 10.1177/2050313X20988421] [Reference Citation Analysis]
305 Massa A, Varamo C, Vita F, Tavolari S, Peraldo-Neia C, Brandi G, Rizzo A, Cavalloni G, Aglietta M. Evolution of the Experimental Models of Cholangiocarcinoma. Cancers (Basel) 2020;12:E2308. [PMID: 32824407 DOI: 10.3390/cancers12082308] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 20.0] [Reference Citation Analysis]
306 Singhal S, Patel G, Singh RB, Potdar R. Grade 3 Neuroendocrine Tumor (G3NET): An Unusual Tumor With A Histochemical Surprise. Cureus 2021;13:e19103. [PMID: 34868755 DOI: 10.7759/cureus.19103] [Reference Citation Analysis]
307 van Riet J, van de Werken HJG, Cuppen E, Eskens FALM, Tesselaar M, van Veenendaal LM, Klümpen HJ, Dercksen MW, Valk GD, Lolkema MP, Sleijfer S, Mostert B. The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets. Nat Commun 2021;12:4612. [PMID: 34326338 DOI: 10.1038/s41467-021-24812-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Toledo PF, Berger Z, Carreño L, Cardenas G, Castillo J, Orellana O. Sarcomatoid carcinoma of the pancreas — a rare tumor with an uncommon presentation and course: A case report and review of literature. World J Clin Cases 2021; 9(15): 3716-3725 [PMID: 34046475 DOI: 10.12998/wjcc.v9.i15.3716] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
309 Ciarrocchi A, Rindi G, Pietroletti R. Diagnosis and Treatment of Primary Tumors of the Appendix: a Critical Review. J Gastrointest Cancer 2021;52:471-5. [PMID: 33740229 DOI: 10.1007/s12029-021-00628-8] [Reference Citation Analysis]
310 Desjonqueres E, Campani C, Marra F, Zucman-Rossi J, Nault JC. Preneoplastic lesions in the liver: Molecular insights and relevance for clinical practice. Liver Int 2022. [PMID: 34982503 DOI: 10.1111/liv.15152] [Reference Citation Analysis]
311 Rao YY, Zhang HJ, Wang XJ, Li MF. Primary hepatic neuroendocrine tumor — 18F-fluorodeoxyglucose positron emission tomography/computed tomography findings: A case report. World J Clin Cases 2021; 9(22): 6450-6456 [PMID: 34435011 DOI: 10.12998/wjcc.v9.i22.6450] [Reference Citation Analysis]
312 Allam M, Hidalgo Salinas C, Machairas N, Kostakis ID, Watkins J, Fusai GK. Solid Pseudopapillary Neoplasms of the Pancreas: a Single-Center Experience and Review of the Literature. J Gastrointest Cancer 2021. [PMID: 33877570 DOI: 10.1007/s12029-021-00638-6] [Reference Citation Analysis]
313 Huang YC, Yang NN, Chen HC, Huang YL, Yan WT, Yang RX, Li N, Zhang S, Yang PP, Feng ZZ. Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients. World J Gastroenterol 2021; 27(7): 624-640 [PMID: 33642833 DOI: 10.3748/wjg.v27.i7.624] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
314 Liao T, Su T, Huang L, Li B, Feng LH. Development and validation of a novel nomogram for predicting survival rate in pancreatic neuroendocrine neoplasms. Scand J Gastroenterol 2021;:1-6. [PMID: 34592854 DOI: 10.1080/00365521.2021.1984571] [Reference Citation Analysis]
315 Zhang Z, Zhao G, Jiang B, Li B, Wang Y. Clinicopathological features and differential diagnosis of gastrofibromatosis-like undifferentiated carcinoma. J Int Med Res 2020;48:300060520974463. [PMID: 33373269 DOI: 10.1177/0300060520974463] [Reference Citation Analysis]
316 Kim YM, Kim JH, Park JS, Baik SJ, Chun J, Youn YH, Park H. Correction to: Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study. Gastric Cancer 2021. [PMID: 34463823 DOI: 10.1007/s10120-021-01240-2] [Reference Citation Analysis]
317 Tullio V, Gasperi V, Catani MV, Savini I. The Impact of Whole Grain Intake on Gastrointestinal Tumors: A Focus on Colorectal, Gastric, and Esophageal Cancers. Nutrients 2020;13:E81. [PMID: 33383776 DOI: 10.3390/nu13010081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
318 Ke X, He H, Zhang Q, Yuan J, Ao Q. Epstein-Barr virus-positive inflammatory follicular dendritic cell sarcoma presenting as a solitary colonic mass: two rare cases and a literature review. Histopathology. 2020;77:832-840. [PMID: 32506505 DOI: 10.1111/his.14169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
319 Krug S, Schrader J, Rinke A. Updates on Diagnostic and Therapeutic Management of Gastrointestinal and Pancreatic NET. Cancers (Basel) 2022;14:2628. [PMID: 35681608 DOI: 10.3390/cancers14112628] [Reference Citation Analysis]
320 Li ZF, Lu HZ, Chen YT, Bai XF, Wang TB, Fei H, Zhao DB. Mixed large and small cell neuroendocrine carcinoma of the stomach: A case report and review of literature. World J Clin Cases 2022; 10(16): 5502-5509 [DOI: 10.12998/wjcc.v10.i16.5502] [Reference Citation Analysis]
321 Gopalakrishnan G, Srinivas BH, Pottakkat B, Gnanasekaran S, Kalayarasan R. Perforated High-Grade Mixed Neuroendocrine Nonneuroendocrine Neoplasm of Cecum: Unusual Presentation of Rare Disease. Gastrointest Tumors 2021;8:128-33. [PMID: 34307311 DOI: 10.1159/000512237] [Reference Citation Analysis]
322 Rimassa L, Personeni N, Czauderna C, Foerster F, Galle P. Systemic treatment of HCC in special populations. J Hepatol 2021;74:931-43. [PMID: 33248171 DOI: 10.1016/j.jhep.2020.11.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
323 Molasy B, Zemła P, Mrowiec S, Grudzińska E, Kuśnierz K. Evaluation of Risk Factors for Distant and Lymph Node Metastasis of Pancreatic Neuroendocrine Tumors. TCRM 2022;Volume 18:745-52. [DOI: 10.2147/tcrm.s361332] [Reference Citation Analysis]
324 Chu H, Zhang C, Shi Y, Wu W, Hu Z, Zhang J, Huang D. Gallbladder neuroendocrine carcinoma: A single center experience. Medicine (Baltimore) 2020;99:e21912. [PMID: 32899024 DOI: 10.1097/MD.0000000000021912] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
325 Gong H, Chu Y, Hu Q, Song Q. Preoperative Radiotherapy Is Associated With Significant Survival Benefits for Patients With Gastric Signet Ring Cell Carcinoma: A SEER-Based Approach. Technol Cancer Res Treat 2020;19:1533033820960746. [PMID: 32945232 DOI: 10.1177/1533033820960746] [Reference Citation Analysis]
326 Qian Y, Gong Y, Liu Y, Chen Y, Wang R, Dai Z, Zou X, Tasiheng Y, Luo G, Lin X, Wang X, Cheng H, Yu X, Liu C, Song J. Atypical Mucin Expression Predicts Worse Overall Survival in Resectable Pancreatic Ductal Adenocarcinoma. Journal of Immunology Research 2022;2022:1-10. [DOI: 10.1155/2022/7353572] [Reference Citation Analysis]
327 Toyoshima O, Nishizawa T, Yoshida S, Watanabe H, Odawara N, Sakitani K, Arano T, Takiyama H, Kobayashi H, Kogure H, Fujishiro M. Brown slits for colorectal adenoma crypts on conventional magnifying endoscopy with narrow band imaging using the X1 system. World J Gastroenterol 2022; 28(24): 2748-2757 [DOI: 10.3748/wjg.v28.i24.2748] [Reference Citation Analysis]
328 Akce M, Zakka K, Penley M, Jiang R, Khalil L, Alese OB, Shaib WL, Wu C, Behera M, El-Rayes BF. Impact of high-risk features for stage II adenocarcinoma of the appendix. Cancer Treat Res Commun 2021;27:100329. [PMID: 33609973 DOI: 10.1016/j.ctarc.2021.100329] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
329 Warsinggih, Liliyanto, Prihantono, Ariani GDW, Faruk M. Colorectal neuroendocrine tumors: A case series. Int J Surg Case Rep 2020;72:411-7. [PMID: 32563832 DOI: 10.1016/j.ijscr.2020.06.030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
330 Gao R, Zhao S, Aishanjiang K, Cai H, Wei T, Zhang Y, Liu Z, Zhou J, Han B, Wang J, Ding H, Liu Y, Xu X, Yu Z, Gu J. Deep learning for differential diagnosis of malignant hepatic tumors based on multi-phase contrast-enhanced CT and clinical data. J Hematol Oncol 2021;14:154. [PMID: 34565412 DOI: 10.1186/s13045-021-01167-2] [Reference Citation Analysis]
331 Sun Z, Chen H, Han Z, Huang W, Hu Y, Zhao M, Lin T, Yu J, Liu H, Jiang Y, Li G. Genomics Score Based on Genome-Wide Network Analysis for Prediction of Survival in Gastric Cancer: A Novel Prognostic Signature. Front Genet 2020;11:835. [PMID: 32849822 DOI: 10.3389/fgene.2020.00835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
332 Loeffler MA, Hu J, Kirchner M, Wei X, Xiao Y, Albrecht T, De La Torre C, Sticht C, Banales JM, Vogel MN, Pathil-Warth A, Mehrabi A, Hoffmann K, Rupp C, Köhler B, Springfeld C, Schirmacher P, Ji J, Roessler S, Goeppert B. miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis. J Pathol 2020;252:239-51. [PMID: 32710569 DOI: 10.1002/path.5514] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
333 Zhang P, Xiao Z, Xu H, Zhu X, Wang L, Huang D, Liang Y, Ni Q, Chen J, Yu X, Luo G. Hyperglycemia is associated with adverse prognosis in patients with pancreatic neuroendocrine neoplasms. Endocrine 2022. [PMID: 35790660 DOI: 10.1007/s12020-022-03100-0] [Reference Citation Analysis]
334 Shuwen H, Xi Y, Qing Z, Jing Z, Wei W. Predicting biomarkers from classifier for liver metastasis of colorectal adenocarcinomas using machine learning models. Cancer Med 2020;9:6667-78. [DOI: 10.1002/cam4.3289] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
335 Ranallo N, Bocchini M, Menis J, Pilotto S, Severi S, Liverani C, Bongiovanni A. Delta-like ligand 3 (DLL3): an attractive actionable target in tumors with neuroendocrine origin. Expert Rev Anticancer Ther 2022. [PMID: 35477310 DOI: 10.1080/14737140.2022.2071703] [Reference Citation Analysis]
336 Jiang W, Wu T, Shi X, Xu J. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma. Bioengineered 2021;12:7941-9. [PMID: 34612781 DOI: 10.1080/21655979.2021.1982844] [Reference Citation Analysis]
337 Talakić E, Igrec J, Kaufmann-Bühler AK, Janek E, Stephan S, Schemmer P, Fuchsjäger M. Undifferentiated carcinoma with osteoclast-like giant cells of the pancreas mimicking pancreatic pseudocyst. Hepatobiliary Pancreat Dis Int 2022:S1499-3872(22)00143-6. [PMID: 35792012 DOI: 10.1016/j.hbpd.2022.06.011] [Reference Citation Analysis]
338 Rait JS, McGillicuddy J, Ajzajian J. Appendiceal neoplasms and histological involvement of the mesoappendix: A case series. Ann Med Surg (Lond) 2020;56:64-7. [PMID: 32577233 DOI: 10.1016/j.amsu.2020.05.037] [Reference Citation Analysis]
339 Tang Y, Wang L, Teng F, Zhang T, Zhao Y, Chen Z. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis. Int J Med Sci 2021;18:187-98. [PMID: 33390787 DOI: 10.7150/ijms.50883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
340 Zhu M, Bassam Sonbol M, Halfdanarson T, Hobday T, Ahn D, Ma WW, Bekaii-Saab T. Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors. Oncologist 2020;25:e1246-8. [PMID: 32510802 DOI: 10.1634/theoncologist.2020-0029] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
341 Ishii T, Ito T, Sumiyoshi S, Ogiso S, Fukumitsu K, Seo S, Taura K, Uemoto S. Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma. World J Surg Oncol 2020;18:319. [PMID: 33276780 DOI: 10.1186/s12957-020-02099-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
342 Ogasawara N, Kikuchi D, Inoshita N, Nakayama A, Kohno K, Ochiai Y, Hayasaka J, Suzuki Y, Dan N, Okamura T, Mitsunaga Y, Tanaka M, Nomura K, Odagiri H, Yamashita S, Matsui A, Hoteya S, Iizuka T. Metachronous carcinogenesis of superficial esophagus squamous cell carcinoma after endoscopic submucosal dissection: incidence and risk stratification during long-term observation. Esophagus 2021;18:806-16. [PMID: 33974189 DOI: 10.1007/s10388-021-00848-8] [Reference Citation Analysis]
343 Virarkar M, Wong VK, Morani AC, Tamm EP, Bhosale P. Update on quantitative radiomics of pancreatic tumors. Abdom Radiol (NY) 2021. [PMID: 34292365 DOI: 10.1007/s00261-021-03216-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Borbon LC, Tran CG, Sherman SK, Ear PH, Chandrasekharan C, Bellizzi AM, Dillon JS, O'Dorisio TM, Howe JR. Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms? Ann Surg Oncol 2022. [PMID: 35802214 DOI: 10.1245/s10434-022-12100-3] [Reference Citation Analysis]
345 Cavalcanti E, Galleggiante V, Coletta S, Stasi E, Chieppa M, Armentano R, Serino G. Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades. Front Oncol 2020;10:1187. [PMID: 32766159 DOI: 10.3389/fonc.2020.01187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
346 Hasegawa S, Kobayashi N, Wild D, Kaul F, Okubo N, Suzuki A, Kurita Y, Takano S, Nakajima A, Ichikawa Y. Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors. Cancers 2022;14:3317. [DOI: 10.3390/cancers14143317] [Reference Citation Analysis]
347 Venugopal A, Gillick-Walker J, Michalczyk A, Khasraw M, Ackland ML. mRNA profiling of a well-differentiated G1 pancreatic NET correlates with immunohistochemistry profile: a case report. BMC Gastroenterol 2021;21:194. [PMID: 33906633 DOI: 10.1186/s12876-021-01705-9] [Reference Citation Analysis]
348 Min CC, Wu J, Hou F, Mao T, Li XY, Ding XL, Liu H. Gastric pyloric gland adenoma resembling a submucosal tumor: A case report. World J Clin Cases 2020; 8(11): 2380-2386 [PMID: 32548171 DOI: 10.12998/wjcc.v8.i11.2380] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
349 Zhao ZT, Li Y, Yuan HY, Ma FH, Song YM, Tian YT. Identification of key genes and pathways in gastric signet ring cell carcinoma based on transcriptome analysis. World J Clin Cases 2020; 8(4): 658-669 [PMID: 32149050 DOI: 10.12998/wjcc.v8.i4.658] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
350 Pietropaolo G, Scarno G, Stabile H, Grimaldi A, Gismondi A, Santoni A, Sciumè G. NK cell and ILC heterogeneity in colorectal cancer. New perspectives from high dimensional data. Mol Aspects Med 2021;:100967. [PMID: 33941383 DOI: 10.1016/j.mam.2021.100967] [Reference Citation Analysis]
351 Zhou Z, Wang Z, Zhang B, Wu Y, Li G, Wang Z. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors. Front Endocrinol (Lausanne) 2021;12:727327. [PMID: 34539577 DOI: 10.3389/fendo.2021.727327] [Reference Citation Analysis]
352 Yue YM, Ling ZM, Bangwei ZM, Zhikui CP. Comparison of Diagnostic Efficacy of US, CT, and MRI for Pancreatic Intraductal Papillary Mucinous Neoplasms. Advanced Ultrasound in Diagnosis and Therapy 2021;5:291. [DOI: 10.37015/audt.2021.210008] [Reference Citation Analysis]
353 Ravegnini G, Fosso B, Saverio VD, Sammarini G, Zanotti F, Rossi G, Ricci M, D'Amico F, Valori G, Ioli A, Turroni S, Brigidi P, Hrelia P, Angelini S. Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis-Deepening Heterogeneity for a Personalized Therapy. Int J Mol Sci 2020;21:E9735. [PMID: 33419357 DOI: 10.3390/ijms21249735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
354 Doornebal EJ, Harris N, Riva A, Jagatia R, Pizanias M, Prachalias A, Menon K, Preziosi M, Zamalloa A, Miquel R, Zen Y, Orford MR, Eaton S, Heaton N, Ramage J, Palma E, Srirajaskanthan R, Chokshi S. Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment. Front Endocrinol 2022;13:909180. [DOI: 10.3389/fendo.2022.909180] [Reference Citation Analysis]
355 Ma F, Wang B, Xue L, Kang W, Li Y, Li W, Liu H, Ma S, Tian Y. Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach. J Cancer Res Clin Oncol. 2020;146:2135-2142. [PMID: 32306127 DOI: 10.1007/s00432-020-03214-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
356 Espinosa-Olarte P, La Salvia A, Riesco-Martinez MC, Anton-Pascual B, Garcia-Carbonero R. Chemotherapy in NEN: still has a role? Rev Endocr Metab Disord 2021;22:595-614. [PMID: 33843007 DOI: 10.1007/s11154-021-09638-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
357 Kriger AG. [Actual issues of pancreatic tumor surgery]. Khirurgiia (Mosk) 2021;:5-12. [PMID: 34608775 DOI: 10.17116/hirurgia20211015] [Reference Citation Analysis]
358 Kang HJ, Kim H, Lee DH, Hur BY, Hwang YJ, Suh KS, Han JK. Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery. Radiology 2021;:204352. [PMID: 34227881 DOI: 10.1148/radiol.2021204352] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
359 Gupta A, Lubner MG, Liu JB, Richards ES, Pickhardt PJ. Small bowel neuroendocrine neoplasm: what surgeons want to know. Abdom Radiol (NY) 2022. [PMID: 35312820 DOI: 10.1007/s00261-022-03485-6] [Reference Citation Analysis]
360 Kaiser J, Scheifele C, Hinz U, Leonhardt C, Hank T, Koenig A, Tjaden C, Hackert T, Bergmann F, Büchler MW, Strobel O. IPMN-associated pancreatic cancer: Survival, prognostic staging and impact of adjuvant chemotherapy. European Journal of Surgical Oncology 2021. [DOI: 10.1016/j.ejso.2021.12.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
361 Gambella A, Scabini S, Zoppoli G, De Silvestri A, Pigozzi S, Paudice M, Campora M, Fiocca R, Grillo F, Mastracci L. HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet. Histochem Cell Biol 2022. [PMID: 35902421 DOI: 10.1007/s00418-022-02141-w] [Reference Citation Analysis]
362 Liberini V, Huellner MW, Grimaldi S, Finessi M, Thuillier P, Muni A, Pellerito RE, Papotti MG, Piovesan A, Arvat E, Deandreis D. The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future. Diagnostics (Basel) 2020;10:E1083. [PMID: 33322819 DOI: 10.3390/diagnostics10121083] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
363 You Z, Peng D, Cao Y, Zhu Y, Yin J, Zhang G, Peng X. P53 suppresses the progression of hepatocellular carcinoma via miR-15a by decreasing OGT expression and EZH2 stabilization. J Cell Mol Med 2021;25:9168-82. [PMID: 34510715 DOI: 10.1111/jcmm.16792] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
364 Cervelli R, Cencini M, Buonincontri G, Campana F, Cacciato Insilla A, Aringhieri G, De Simone P, Boggi U, Campani D, Tosetti M, Crocetti L. 7-T MRI of explanted liver and ex-vivo pancreatic specimens: prospective study protocol of radiological-pathological correlation feasibility (the EXLIPSE project). Eur Radiol Exp 2020;4:58. [PMID: 33057851 DOI: 10.1186/s41747-020-00185-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
365 Shin D, Lee S, Lee JH, Hong SM, Park SY, Yoo C, Lee W, Song KB, Hwang DW, Kim SC. Prognostic implication of high grade biliary intraepithelial neoplasia in bile duct resection margins in patients with resected perihilar cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2020;27:604-13. [PMID: 32639085 DOI: 10.1002/jhbp.800] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
366 Kole C, Charalampakis N, Vailas M, Tolia M, Sotiropoulou M, Tsakatikas S, Kouris NI, Tsoli M, Koumarianou A, Karamouzis MV, Schizas D. Immunotherapy for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a 2021 update. Cancer Immunol Immunother 2021. [PMID: 34471940 DOI: 10.1007/s00262-021-03046-8] [Reference Citation Analysis]
367 Sorrentino L, De Ruvo N, Serra F, Salati M, Ricciardolo AA, Bonetti LR, Gelmini R. Role of poorly differentiated cluster in gastric cancer: is it a new prognosis factor? Scand J Gastroenterol 2021;:1-6. [PMID: 34524049 DOI: 10.1080/00365521.2021.1974932] [Reference Citation Analysis]
368 Amorim LC, Ferreira AR, Perez RO, Peixoto RD. Localized Well-Differentiated Rectal Neuroendocrine Tumors - Where Are We in 2021? Clin Colorectal Cancer 2021:S1533-0028(21)00101-8. [PMID: 34838461 DOI: 10.1016/j.clcc.2021.10.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
369 Long J, Huang S, Bai Y, Mao J, Wang A, Lin Y, Yang X, Wang D, Lin J, Bian J, Yang X, Sang X, Wang X, Zhao H. Transcriptional landscape of cholangiocarcinoma revealed by weighted gene coexpression network analysis. Brief Bioinform 2021;22:bbaa224. [PMID: 33051665 DOI: 10.1093/bib/bbaa224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
370 Nishizawa T, Yoshida S, Toyoshima A, Yamada T, Sakaguchi Y, Irako T, Ebinuma H, Kanai T, Koike K, Toyoshima O. Endoscopic diagnosis for colorectal sessile serrated lesions. World J Gastroenterol 2021; 27(13): 1321-1329 [PMID: 33833485 DOI: 10.3748/wjg.v27.i13.1321] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
371 Lu X, Yan S, Koral KA, Chen Z. Surufatinib for the treatment of advanced extrapancreatic neuroendocrine tumors. Expert Rev Anticancer Ther 2021;21:917-26. [PMID: 34142932 DOI: 10.1080/14737140.2021.1944110] [Reference Citation Analysis]
372 Lan W, Fang N, Tiantian D, Ci Y, Ming L, Yuanyuan L. Nonhypovascular pancreatic ductal adenocarcinomas: CEUS imaging findings and differentiation from other types of solid pancreatic lesions. CH 2022. [DOI: 10.3233/ch-221397] [Reference Citation Analysis]
373 Khanam R, Pachika PS, Arya P, Bierenbaum J, Kane K, Saha P. "A Tale of 2 Demons"-Concomitant Presence of Hepatocellular Carcinoma and Primary Neuroendocrine Tumor of Liver: A Case Report and Review of Literatures. J Investig Med High Impact Case Rep 2021;9:23247096211043397. [PMID: 34472368 DOI: 10.1177/23247096211043397] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
374 Matsuo S, Amano T, Miyamatsu Y, Hayashi D, Yamashita S, Momosaki S, Kawabe K, Nakamizo A. Discrepancy in the Ki67 labeling index of brain and orbital metastatic lesions from gastrointestinal neuroendocrine tumors: A case report. Neurocirugia (Astur) 2021:S1130-1473(21)00052-X. [PMID: 34154907 DOI: 10.1016/j.neucir.2021.04.003] [Reference Citation Analysis]
375 Marano L, Ambrosio MR, Resca L, Carbone L, Carpineto Samorani O, Petrioli R, Savelli V, Costantini M, Malaspina L, Polom K, Biviano I, Marrelli D, Roviello F. The Percentage of Signet Ring Cells Is Inversely Related to Aggressive Behavior and Poor Prognosis in Mixed-Type Gastric Cancer. Front Oncol 2022;12:897218. [PMID: 35719955 DOI: 10.3389/fonc.2022.897218] [Reference Citation Analysis]
376 Feng LH, Su T, Lu Y, Ren S, Huang L, Qin X, Liao T. A model for predicting the overall survival of gastroenteropancreatic neuroendocrine neoplasms after surgery. Scand J Gastroenterol 2022;:1-8. [PMID: 35001789 DOI: 10.1080/00365521.2021.2024247] [Reference Citation Analysis]
377 Mansuri N, Birkman EM, Heuser VD, Lintunen M, Ålgars A, Sundström J, Ristamäki R, Lehtinen L, Carpén O. Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome. Virchows Arch 2021;478:707-17. [PMID: 32954467 DOI: 10.1007/s00428-020-02932-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
378 Zengin M, Çifci A. Tumour budding in preoperative biopsy specimens is a useful prognostic index for identifying high-risk patients in early-stage (pN0) colon cancer. Turk J Med Sci 2020;50:375-85. [PMID: 32011836 DOI: 10.3906/sag-1903-142] [Reference Citation Analysis]
379 Li Y, Li XY, Li LX, Zhou RC, Sikong Y, Gu X, Jin BY, Li B, Li YQ, Zuo XL. S100A10 Accelerates Aerobic Glycolysis and Malignant Growth by Activating mTOR-Signaling Pathway in Gastric Cancer. Front Cell Dev Biol 2020;8:559486. [PMID: 33324631 DOI: 10.3389/fcell.2020.559486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
380 Xiang Z, He Q, Huang L, Xiong B, Xiang Q. Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation. Front Oncol 2021;11:818869. [PMID: 35083162 DOI: 10.3389/fonc.2021.818869] [Reference Citation Analysis]
381 Zhang MY, He D, Zhang S. Pancreatic neuroendocrine tumors G3 and pancreatic neuroendocrine carcinomas: Differences in basic biology and treatment. World J Gastrointest Oncol 2020; 12(7): 705-718 [PMID: 32864039 DOI: 10.4251/wjgo.v12.i7.705] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
382 Jungels C, Deleporte A. State of the art and future directions in the systemic treatment of neuroendocrine neoplasms. Curr Opin Oncol 2021;33:378-85. [PMID: 33973550 DOI: 10.1097/CCO.0000000000000740] [Reference Citation Analysis]
383 Wang Y, Zhu GQ, Zhou CW, Li N, Yang C, Zeng MS. Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors. Eur Radiol 2022. [PMID: 35316365 DOI: 10.1007/s00330-022-08691-w] [Reference Citation Analysis]
384 Djordjevic V, Grubor N, Kovac JD, Micev M, Milic N, Knezevic D, Gregoric P, Lausevic Z, Kerkez M, Knezevic S, Radenkovic D. Comparison of Preoperative Evaluation with the Pathological Report in Intraductal Papillary Mucinous Neoplasms: A Single-Center Experience. J Clin Med 2021;10:678. [PMID: 33578680 DOI: 10.3390/jcm10040678] [Reference Citation Analysis]
385 Tessier-Cloutier B, Schaeffer DF, Bacani J, Marginean CE, Kalloger S, Köbel M, Lee CH. Loss of switch/sucrose non-fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas. Histopathology 2020;77:46-54. [PMID: 32413172 DOI: 10.1111/his.14096] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
386 Stensbøl AB, Krogh J, Holmager P, Klose M, Oturai P, Kjaer A, Hansen CP, Federspiel B, Langer SW, Knigge U, Andreassen M. Incidence, Clinical Presentation and Trends in Indication for Diagnostic Work-Up of Small Intestinal and Pancreatic Neuroendocrine Tumors. Diagnostics (Basel) 2021;11:2030. [PMID: 34829377 DOI: 10.3390/diagnostics11112030] [Reference Citation Analysis]
387 Schiroli D, Marraccini C, Zanetti E, Ragazzi M, Gianoncelli A, Quartieri E, Gasparini E, Iotti S, Baricchi R, Merolle L. Imbalance of Mg Homeostasis as a Potential Biomarker in Colon Cancer. Diagnostics (Basel) 2021;11:727. [PMID: 33923883 DOI: 10.3390/diagnostics11040727] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
388 Reizine E, Mulé S, Luciani A. Focal Benign Liver Lesions and Their Diagnostic Pitfalls. Radiologic Clinics of North America 2022. [DOI: 10.1016/j.rcl.2022.05.005] [Reference Citation Analysis]
389 Wang Q, Wang X, Zhang Q, Chen J, Zhou Y, Tang Z, Wang R, Chen H, Chen H, Li X. ERBB2 Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing. Front Oncol 2022;12:769709. [DOI: 10.3389/fonc.2022.769709] [Reference Citation Analysis]
390 Li Y, Zhu Z, Ma F, Xue L, Tian Y. Gastric Signet Ring Cell Carcinoma: Current Management and Future Challenges. Cancer Manag Res 2020;12:7973-81. [PMID: 32943931 DOI: 10.2147/CMAR.S268032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
391 Ehrlichman PD, Vijayvergia N. Unlocking the Code to Management of Neuroendocrine Neoplasms: A Clinician's Perspective. JCO Oncol Pract 2021;:OP2100628. [PMID: 34731030 DOI: 10.1200/OP.21.00628] [Reference Citation Analysis]
392 Caramaschi S, Mangogna A, Salviato T, Ammendola S, Barresi V, Manco G, Canu PG, Zanelli G, Bonetti LR. Cytoproliferative activity in colorectal poorly differentiated clusters: Biological significance in tumor setting. Ann Diagn Pathol 2021;53:151772. [PMID: 34153686 DOI: 10.1016/j.anndiagpath.2021.151772] [Reference Citation Analysis]
393 Hanif A, Lee S, Gupta M, Chander A, Kannisto ED, Punnanitinont A, Fenstermaker R, Ciesielski M, Attwood K, Qiu J, Yendamuri S, Iyer R. Exploring the role of survivin in neuroendocrine neoplasms. Oncotarget 2020;11:2246-58. [PMID: 32577168 DOI: 10.18632/oncotarget.27631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
394 Wang Y, Zhang Y, Lin H, Xu M, Zhou X, Zhuang J, Yang Y, Chen B, Liu X, Guan G. Risk factors for lymph node metastasis in rectal neuroendocrine tumors: A recursive partitioning analysis based on multicenter data. J Surg Oncol 2021. [PMID: 34291822 DOI: 10.1002/jso.26615] [Reference Citation Analysis]
395 Chen X, Lu Y, Shi X, Chen X, Rong D, Han G, Zhang L, Ni C, Zhao J, Gao Y, Wang X. Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma. J Oncol 2021;2021:3002480. [PMID: 34925507 DOI: 10.1155/2021/3002480] [Reference Citation Analysis]
396 Li YQ, Pan SB, Yan SS, Jin ZD, Huang HJ, Sun LQ. Impact of parenchyma-preserving surgical methods on treating patients with solid pseudopapillary neoplasms: A retrospective study with a large sample size. World J Gastrointest Surg 2022; 14(2): 174-184 [DOI: 10.4240/wjgs.v14.i2.174] [Reference Citation Analysis]
397 Tomihara H, Hashimoto K, Wakasa T, Ishikawa H, Tsujimoto T, Gakuhara A, Fukuda S, Ohta K, Kitani K, Hida JI, Ohta Y, Yukawa M. Successful resection of a neuroendocrine tumor in the gallbladder: a case report. Surg Case Rep 2020;6:274. [PMID: 33108599 DOI: 10.1186/s40792-020-01055-w] [Reference Citation Analysis]
398 Wang R, Mohapatra S, Jovani M, Akshintala VS, Kamal A, Brewer OG, Kumbhari V, Shin EJ, Canto MI, Khashab MA, Singh VK, Lennon AM, Kalloo AN, Ngamruengphong S. Risk factors for lymph node metastasis and survival of patients with nonampullary duodenal carcinoid tumors treated with endoscopic therapy versus surgical resection: analysis of the Surveillance, Epidemiology, and End Results program. Gastrointest Endosc 2021;93:1384-92. [PMID: 33347833 DOI: 10.1016/j.gie.2020.12.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
399 Lithgow K, Venkataraman H, Hughes S, Shah H, Kemp-Blake J, Vickrage S, Smith S, Humphries S, Elshafie M, Taniere P, Diaz-Cano S, Dasari BVM, Almond M, Ford S, Ayuk J, Shetty S, Shah T, Geh I. Well-differentiated gastroenteropancreatic G3 NET: findings from a large single centre cohort. Sci Rep 2021;11:17947. [PMID: 34504148 DOI: 10.1038/s41598-021-97247-x] [Reference Citation Analysis]
400 Duan H, Baratto L, Laudicella R, Stracuzzi F, Baldari S, Iagaru A. Molecular imaging of pancreatic neoplasms. Clin Transl Imaging 2021;9:141-51. [DOI: 10.1007/s40336-020-00408-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
401 Feng JY, Li XP, Wu ZY, Ying LP, Xin C, Dai ZZ, Shen Y, Wu YF. Sarcomatoid intrahepatic cholangiocarcinoma with good patient prognosis after treatment with Huaier granules following hepatectomy: A case report. World J Clin Cases 2022;10:2829-35. [PMID: 35434085 DOI: 10.12998/wjcc.v10.i9.2829] [Reference Citation Analysis]
402 Aslam A, Wasnik AP, Shi J, Sahai V, Mendiratta-Lala M. Intraductal papillary neoplasm of the bile duct (IPNB): CT and MRI appearance with radiology-pathology correlation. Clin Imaging. 2020;66:10-17. [PMID: 32438236 DOI: 10.1016/j.clinimag.2020.04.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
403 Okasha HH, Awad A, El-meligui A, Ezzat R, Aboubakr A, AbouElenin S, El-Husseiny R, Alzamzamy A. Cystic pancreatic lesions, the endless dilemma. World J Gastroenterol 2021; 27(21): 2664-2680 [PMID: 34135548 DOI: 10.3748/wjg.v27.i21.2664] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
404 Jeon SK, Kim JH, Yoo J, Kim JE, Park SJ, Han JK. Assessment of malignant potential in intraductal papillary mucinous neoplasms of the pancreas using MR findings and texture analysis. Eur Radiol 2021;31:3394-404. [PMID: 33140171 DOI: 10.1007/s00330-020-07425-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
405 Fionda C, Scarno G, Stabile H, Molfetta R, Di Censo C, Gismondi A, Paolini R, Sozzani S, Santoni A, Sciumè G. NK Cells and Other Cytotoxic Innate Lymphocytes in Colorectal Cancer Progression and Metastasis. Int J Mol Sci 2022;23:7859. [PMID: 35887206 DOI: 10.3390/ijms23147859] [Reference Citation Analysis]
406 Su R, Cai L, Xiong P, Liu Z, Chen S, Liu X, Lin R, Lei Z, Tian D, Su M. TLR3 Expression is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma. JIR 2022;Volume 15:1437-56. [DOI: 10.2147/jir.s348786] [Reference Citation Analysis]
407 Alburquerque-González B, López-Calderón FF, López-Abellán MD, Esteban-Gil Á, García-Solano J, Conesa-Zamora P. Biology and Therapeutic Targets of Colorectal Serrated Adenocarcinoma; Clues for a Histologically Based Treatment against an Aggressive Tumor. Int J Mol Sci 2020;21:E1991. [PMID: 32183342 DOI: 10.3390/ijms21061991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
408 Yang H, Messina-pacheco J, Corredor ALG, Gregorieff A, Liu J, Nehme A, Najafabadi HS, Riazalhosseini Y, Gao B, Gao Z. An integrated model of acinar to ductal metaplasia-related N7-methyladenosine regulators predicts prognosis and immunotherapy in pancreatic carcinoma based on digital spatial profiling. Front Immunol 2022;13:961457. [DOI: 10.3389/fimmu.2022.961457] [Reference Citation Analysis]
409 Exarchou K, Stephens NA, Moore AR, Howes NR, Pritchard DM. New Developments in Gastric Neuroendocrine Neoplasms. Curr Oncol Rep. [DOI: 10.1007/s11912-021-01175-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
410 Tramontano L, Cavaliere C, Salvatore M, Brancato V. The Role of Non-Gaussian Models of Diffusion Weighted MRI in Hepatocellular Carcinoma: A Systematic Review. J Clin Med 2021;10:2641. [PMID: 34203995 DOI: 10.3390/jcm10122641] [Reference Citation Analysis]
411 Mollazadegan K, Welin S, Crona J. Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma. Curr Treat Options Oncol 2021;22:68. [PMID: 34110508 DOI: 10.1007/s11864-021-00866-9] [Reference Citation Analysis]
412 Saiki Y, Jiang C, Ohmuraya M, Furukawa T. Genetic Mutations of Pancreatic Cancer and Genetically Engineered Mouse Models. Cancers (Basel) 2021;14:71. [PMID: 35008235 DOI: 10.3390/cancers14010071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
413 Ye H, Yuan Y, Chen P, Zheng Q. Risk factors for metastasis and survival of patients with T1 gastric neuroendocrine carcinoma treated with endoscopic therapy versus surgical resection. Surg Endosc 2022. [PMID: 35507062 DOI: 10.1007/s00464-022-09190-1] [Reference Citation Analysis]
414 Wege H, Schulze K, von Felden J, Calderaro J, Reig M; rare liver tumors working group of the European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas. Eur J Med Genet 2021;64:104313. [PMID: 34418585 DOI: 10.1016/j.ejmg.2021.104313] [Reference Citation Analysis]
415 Skorupan N, Ahmad MI, Steinberg SM, Trepel JB, Cridebring D, Han H, Von Hoff DD, Alewine C. A phase II trial of the super-enhancer inhibitor Minnelide™ in advanced refractory adenosquamous carcinoma of the pancreas. Future Oncol 2022. [PMID: 35535581 DOI: 10.2217/fon-2021-1609] [Reference Citation Analysis]
416 Wu IC, Chu YY, Wang YK, Tsai CL, Lin JC, Kuo CH, Shih HY, Chung CS, Hu ML, Sun WC, Wang JP, Wang HP. Clinicopathological features and outcome of esophageal neuroendocrine tumor: A retrospective multicenter survey by the digestive endoscopy society of Taiwan. J Formos Med Assoc 2021;120:508-14. [PMID: 32600867 DOI: 10.1016/j.jfma.2020.06.024] [Reference Citation Analysis]
417 Holmberg M, Linder S, Kordes M, Liljefors M, Ghorbani P, Löhr J, Sparrelid E. Impact of spatio-temporal recurrence pattern on overall survival for invasive intraductal papillary mucinous neoplasia – A comparison with pancreatic ductal adenocarcinoma. Pancreatology 2022. [DOI: 10.1016/j.pan.2022.04.007] [Reference Citation Analysis]
418 Lemos Garcia J, Rosa I, Saraiva S, Marques I, Fonseca R, Lage P, Francisco I, Silva P, Filipe B, Albuquerque C, Claro I. Routine Immunohistochemical Analysis of Mismatch Repair Proteins in Colorectal Cancer—A Prospective Analysis. Cancers 2022;14:3730. [DOI: 10.3390/cancers14153730] [Reference Citation Analysis]
419 Chen X, Sun S, Lu Y, Shi X, Wang Z, Chen X, Han G, Zhao J, Gao Y, Wang X. Promising role of liver transplantation in patients with combined hepatocellular-cholangiocarcinoma: a propensity score matching analysis. Ann Transl Med 2022;10:434. [PMID: 35571416 DOI: 10.21037/atm-21-5391] [Reference Citation Analysis]
420 Ahn JH, Kwak MS, Lee HH, Cha JM, Shin HP, Jeon JW, Yoon JY. Development of a Novel Prognostic Model for Predicting Lymph Node Metastasis in Early Colorectal Cancer: Analysis Based on the Surveillance, Epidemiology, and End Results Database. Front Oncol 2021;11:614398. [PMID: 33842317 DOI: 10.3389/fonc.2021.614398] [Reference Citation Analysis]
421 Yuan ZB, Fang HB, Feng QK, Li T, Li J. Prognostic factors of recurrent intrahepatic cholangiocarcinoma after hepatectomy: A retrospective study. World J Gastroenterol 2022; 28(15): 1574-1587 [DOI: 10.3748/wjg.v28.i15.1574] [Reference Citation Analysis]
422 Kostiainen I, Karppinen N, Simonen P, Rosengård-Bärlund M, Lindén R, Tarkkanen M, Gordin D, Rapola J, Schalin-Jäntti C, Matikainen N. Arterial function, biomarkers, carcinoid syndrome and carcinoid heart disease in patients with small intestinal neuroendocrine tumours. Endocrine 2022. [PMID: 35536452 DOI: 10.1007/s12020-022-03065-0] [Reference Citation Analysis]
423 Weng Y, Ran J, Peng Y, Xiang Y, Xu L. Comparison of characteristics between true rectal neuroendocrine tumors and rectal hyperplastic polyps among patients with endoscope-diagnosed rectal neuroendocrine tumors. J Gastrointest Oncol 2022;13:1121-31. [PMID: 35837162 DOI: 10.21037/jgo-22-369] [Reference Citation Analysis]
424 Prisciandaro M, Antista M, Raimondi A, Corti F, Morano F, Centonze G, Sabella G, Mangogna A, Randon G, Pagani F, Prinzi N, Niger M, Corallo S, Castiglioni di Caronno E, Massafra M, Bartolomeo MD, Braud FD, Milione M, Pusceddu S. Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective. Front Oncol 2022;12:780716. [DOI: 10.3389/fonc.2022.780716] [Reference Citation Analysis]
425 Nam JY, Chung HJ, Choi KS, Lee H, Kim TJ, Soh H, Kang EA, Cho SJ, Ye JC, Im JP, Kim SG, Kim JS, Chung H, Lee JH. Deep learning model for diagnosing gastric mucosal lesions using endoscopic images: development, validation, and method comparison. Gastrointest Endosc 2021:S0016-5107(21)01613-8. [PMID: 34492271 DOI: 10.1016/j.gie.2021.08.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
426 Minczeles NS, Hofland J, de Herder WW, Brabander T. Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy. Curr Oncol Rep 2021;23:46. [PMID: 33721105 DOI: 10.1007/s11912-021-01037-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
427 Kasprzak A. Somatostatin and Its Receptor System in Colorectal Cancer. Biomedicines 2021;9:1743. [PMID: 34829972 DOI: 10.3390/biomedicines9111743] [Reference Citation Analysis]
428 Liang L, Fang J, Han X, Zhai X, Song Y, Lu Y, Zhang Q, Ma R. Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei. Front Oncol 2021;11:594763. [PMID: 34733775 DOI: 10.3389/fonc.2021.594763] [Reference Citation Analysis]
429 Rebelo R, Polónia B, Santos LL, Vasconcelos MH, Xavier CPR. Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma. Pharmaceuticals (Basel) 2021;14:280. [PMID: 33804613 DOI: 10.3390/ph14030280] [Reference Citation Analysis]
430 Mansour MM, Smith ZD, Ghouri Y, Tahan V. Ulcerative Colitis With Concomitant Serrated Polyposis Syndrome: A Case Report and Literature Review. Cureus 2021;13:e14591. [PMID: 34036009 DOI: 10.7759/cureus.14591] [Reference Citation Analysis]
431 Liu AJ, Ueberroth BE, McGarrah PW, Buckner Petty SA, Kendi AT, Starr J, Hobday TJ, Halfdanarson TR, Sonbol MB. Treatment Outcomes of Well-Differentiated High-Grade Neuroendocrine Tumors. Oncologist 2021;26:383-8. [PMID: 33496040 DOI: 10.1002/onco.13686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
432 Shuyao W, Mingyang B, Feifei M, Xiaoqin H. CK19 Predicts Recurrence and Prognosis of HBV Positive HCC. J Gastrointest Surg 2021. [PMID: 34506016 DOI: 10.1007/s11605-021-05107-w] [Reference Citation Analysis]
433 Ciobanu OA, Martin S, Fica S. Perspectives on the diagnostic, predictive and prognostic markers of neuroendocrine neoplasms (Review). Exp Ther Med 2021;22:1479. [PMID: 34765020 DOI: 10.3892/etm.2021.10914] [Reference Citation Analysis]
434 Kang G, Pyo JS, Kim NY, Kang DW. Clinicopathological Significances of Tumor-Stroma Ratio (TSR) in Colorectal Cancers: Prognostic Implication of TSR Compared to Hypoxia-Inducible Factor-1α Expression and Microvessel Density. Curr Oncol 2021;28:1314-24. [PMID: 33810015 DOI: 10.3390/curroncol28020125] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
435 Wagner BJ, Plum PS, Apel K, Scherer M, Buchner D, Brinkmann S, Buettner R, Stippel D, Quaas A, Drebber U. Protein-loss of SWI/SNF-complex core subunits influences prognosis dependent on histological subtypes of intra- and extrahepatic cholangiocarcinoma. Oncol Lett 2021;21:349. [PMID: 33747206 DOI: 10.3892/ol.2021.12610] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
436 Li Z, Li S, Zang S, Ma X, Chen F, Xia Y, Chen L, Shen F, Lu Y, Lu J. Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Mucinous Adenocarcinoma Using an MRI-Based Radiomics Nomogram. Front Oncol 2021;11:671636. [PMID: 34109121 DOI: 10.3389/fonc.2021.671636] [Reference Citation Analysis]
437 Kumar A, Kumar B, Muthu GS, Mitra S. 68Ga-DOTANOC PET/CT Detects a Rare Case of Metastatic Neuroendocrine Neoplasm of the Gallbladder. Clin Nucl Med 2022. [PMID: 35384899 DOI: 10.1097/RLU.0000000000004142] [Reference Citation Analysis]
438 Hatsis AJ, Henry RK, Curtis MT, Bilyk JR, Sivalingam MD, Eagle RC, Milman T. Ocular adnexal manifestations of neuroendocrine neoplasms: a case report and a major review. Orbit 2020;:1-11. [PMID: 33140682 DOI: 10.1080/01676830.2020.1839108] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
439 Reynolds IS, Thomas V, O'Connell E, Fichtner M, McNamara DA, Kay EW, Prehn JHM, Burke JP, Furney SJ. Mucinous Adenocarcinoma of the Rectum: A Whole Genome Sequencing Study. Front Oncol 2020;10:1682. [PMID: 32984045 DOI: 10.3389/fonc.2020.01682] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
440 Grewal JS, Berger E, Garner J, Mayer SL, Beaty JS. Surveillance Colonoscopy Revealing Asymptomatic Low-Grade Appendiceal Mucinous Neoplasm. Cureus 2021;13:e16222. [PMID: 34367822 DOI: 10.7759/cureus.16222] [Reference Citation Analysis]
441 Nannar J, Anciro A, Nanda AK. Collision tumor at the rectum consisting of a neuroendocrine carcinoma and adenocarcinoma: A case report. Annals of Medicine and Surgery 2022;78:103748. [DOI: 10.1016/j.amsu.2022.103748] [Reference Citation Analysis]
442 Nakao E, Namikawa K, Hirasawa T, Nakano K, Tokai Y, Yoshimizu S, Horiuchi Y, Ishiyama A, Yoshio T, Nunobe S, Fujisaki J. Risk factors for lymph node metastasis and indication of local resection in duodenal neuroendocrine tumors. JGH Open. [DOI: 10.1002/jgh3.12718] [Reference Citation Analysis]
443 Chen S, Zhang M, Wang J, Xu M, Hu W, Wee L, Dekker A, Sheng W, Zhang Z. Automatic Tumor Grading on Colorectal Cancer Whole-Slide Images: Semi-Quantitative Gland Formation Percentage and New Indicator Exploration. Front Oncol 2022;12:833978. [PMID: 35646672 DOI: 10.3389/fonc.2022.833978] [Reference Citation Analysis]
444 Liu M, Popa EC, Finnerty BM, Fahey TJ 3rd, Zarnegar R. Clinicopathological Features of Gastroesophageal Neuroendocrine Neoplasms. Curr Gastroenterol Rep 2020;22:50. [PMID: 32797314 DOI: 10.1007/s11894-020-00788-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
445 Li Y, Li J, Li J. Two updates on oesophagogastric junction adenocarcinoma from the fifth WHO classification: Alteration of definition and emphasis on HER2 test. Histol Histopathol 2021;36:339-46. [PMID: 33377175 DOI: 10.14670/HH-18-296] [Reference Citation Analysis]
446 Tashima T, Ryozawa S, Tanisaka Y, Fujita A, Miyaguchi K, Ogawa T, Mizuide M, Mashimo Y, Kawasaki T, Yasuda M. Endoscopic resection using an over-the-scope clip for duodenal neuroendocrine tumors. Endosc Int Open 2021;9:E659-66. [PMID: 33937505 DOI: 10.1055/a-1374-6141] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
447 Danilova NV, Mikhailov IA, Kalinin DV, Oleynikova NA, Chayka AV, Khomyakov VM, Kakotkin VV, Yudin MY, Vychuzhanin DV, Andreeva YY, Malkov PG. [Study of gastric adenocarcinomas association with the Epstein-Barr virus-encoded small RNAs]. Arkh Patol 2022;84:5-12. [PMID: 35417943 DOI: 10.17116/patol2022840215] [Reference Citation Analysis]
448 Wei W, Liu C, Yao R, Tan Q, Wang Q, Tian H. miR‑486‑5p suppresses gastric cancer cell growth and migration through downregulation of fibroblast growth factor 9. Mol Med Rep 2021;24:771. [PMID: 34490480 DOI: 10.3892/mmr.2021.12411] [Reference Citation Analysis]
449 Kim CW, Cha JM, Kwak MS. Identification of Potential Biomarkers and Biological Pathways for Poor Clinical Outcome in Mucinous Colorectal Adenocarcinoma. Cancers (Basel) 2021;13:3280. [PMID: 34208938 DOI: 10.3390/cancers13133280] [Reference Citation Analysis]
450 Guan X, Xu ZY, Chen R, Qin JJ, Cheng XD. Identification of an Immune Gene-Associated Prognostic Signature and Its Association With a Poor Prognosis in Gastric Cancer Patients. Front Oncol 2020;10:629909. [PMID: 33628738 DOI: 10.3389/fonc.2020.629909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
451 Chen K, Wang H, Collins G, Hollands E, Law IYJ, Toh JWT. Current Perspectives on the Importance of Pathological Features in Prognostication and Guidance of Adjuvant Chemotherapy in Colon Cancer. Current Oncology 2022;29:1370-89. [DOI: 10.3390/curroncol29030116] [Reference Citation Analysis]
452 Magi L, Rinzivillo M, Panzuto F. Tumor Heterogenity in Gastro-Entero-Pancreatic Neuroendocrine Neoplasia. Endocrines 2021;2:28-36. [DOI: 10.3390/endocrines2010003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
453 Marini I, Sansovini M, Bongiovanni A, Nicolini S, Grassi I, Ranallo N, Monti M, DI Iorio V, Germanò L, Caroli P, Sarnelli A, Paganelli G, Severi S. Theragnostic in neuroendocrine tumors. Q J Nucl Med Mol Imaging 2021;65:342-52. [PMID: 34881852 DOI: 10.23736/S1824-4785.21.03426-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
454 Deng M, Li S, Wang Q, Zhao R, Zou J, Lin W, Mei J, Wei W, Guo R. Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy. Ann Med 2022;54:803-11. [PMID: 35272564 DOI: 10.1080/07853890.2022.2048416] [Reference Citation Analysis]
455 Kan J, Tian Y, Shao Y, Xu H, Li X, Tang Q. Role of the ratio of NSE serum concentration in evaluating the therapeutic effect on metastatic neuroendocrine neoplasms of the liver. Tumori 2021;:3008916211002272. [PMID: 33759643 DOI: 10.1177/03008916211002272] [Reference Citation Analysis]
456 Feng Y, Chang X, Zhao Y, Wu D, Meng Z, Wu X, Guo T, Jiang Q, Zhang S, Wang Q, Yang A. A new needle-based confocal laser endomicroscopy pattern of malignant pancreatic mucinous cystic lesions (with video). Endosc Ultrasound 2021;10:200-6. [PMID: 32655084 DOI: 10.4103/eus.eus_35_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
457 Chatani PD, Agarwal SK, Sadowski SM. Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors. Front Endocrinol (Lausanne) 2020;11:575620. [PMID: 33537001 DOI: 10.3389/fendo.2020.575620] [Reference Citation Analysis]
458 Pedrazzani C, Conti C, Di Vittori A, Turri G, Bernardoni L, Mafficini A, Luchini C, Gabbrielli A, Scarpa A, Guglielmi A. Video technical notes for approaching a unique case of Juvenile Polyposis with massive gastric ingrowth. Asian Journal of Surgery 2022. [DOI: 10.1016/j.asjsur.2022.07.058] [Reference Citation Analysis]
459 Chang LC, Hsu YC, Chiu HM, Ueda K, Wu MS, Kao CH, Shen TL. Exploration of the Proteomic Landscape of Small Extracellular Vesicles in Serum as Biomarkers for Early Detection of Colorectal Neoplasia. Front Oncol 2021;11:732743. [PMID: 34589434 DOI: 10.3389/fonc.2021.732743] [Reference Citation Analysis]
460 Leão B, Wen X, Duarte HO, Gullo I, Gonçalves G, Pontes P, Castelli C, Diniz F, Mereiter S, Gomes J, Carneiro F, Reis CA. Expression of Thomsen-Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability. Int J Mol Sci 2021;22:1340. [PMID: 33572915 DOI: 10.3390/ijms22031340] [Reference Citation Analysis]
461 Zhu M, Jin Z, Hubbard JM. Management of Non-Colorectal Digestive Cancers with Microsatellite Instability. Cancers (Basel) 2021;13:651. [PMID: 33561950 DOI: 10.3390/cancers13040651] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
462 Peshevska-Sekulovska M, Velikova TV, Peruhova M. Artificial intelligence assisted endocytoscopy: A novel eye in endoscopy. Artif Intell Gastrointest Endosc 2020; 1(3): 44-52 [DOI: 10.37126/aige.v1.i3.44] [Reference Citation Analysis]
463 Litchinko A, Kobayashi K, Halkic N. A retrospective study of histological outcome for IPMN after surgery in Lausanne, Switzerland: A case series. Ann Med Surg (Lond) 2020;60:110-4. [PMID: 33145018 DOI: 10.1016/j.amsu.2020.10.028] [Reference Citation Analysis]
464 Yuan B, Shi Y, Li Y, Tan H, Jiao P, Su W, Liu M, Qi Z, Tan H, Luo J. Ki-67 index of 5% could better predict the clinical prognosis of well-differentiated pancreatic neuroendocrine tumours. Jpn J Clin Oncol 2021:hyab144. [PMID: 34580725 DOI: 10.1093/jjco/hyab144] [Reference Citation Analysis]
465 Stankiewicz R, Grąt M. Current status of surgical management of patients with gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Surg 2022; 14(4): 276-285 [DOI: 10.4240/wjgs.v14.i4.276] [Reference Citation Analysis]
466 Tziatzios G, Gkolfakis P, Lazaridis LD, Facciorusso A, Antonelli G, Hassan C, Repici A, Sharma P, Rex DK, Triantafyllou K. High-definition colonoscopy for improving adenoma detection: a systematic review and meta-analysis of randomized controlled studies. Gastrointest Endosc 2020;91:1027-1036.e9. [PMID: 31954133 DOI: 10.1016/j.gie.2019.12.052] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
467 Lu A, Cho J, Vazmitzel M, Layfield L, Staveley-O'Carroll K, Gaballah A, Rao D. High-grade appendiceal mucinous neoplasm presenting as a giant appendiceal mucocele. Radiol Case Rep 2021;16:1051-6. [PMID: 33680275 DOI: 10.1016/j.radcr.2021.02.014] [Reference Citation Analysis]
468 Chu H, Shi Y, Liu J, Huang D, Zhang J, Dou C. Update in clinical management for gallbladder neuroendocrine carcinoma. Medicine (Baltimore) 2021;100:e25449. [PMID: 33832150 DOI: 10.1097/MD.0000000000025449] [Reference Citation Analysis]
469 Zhou YJ, Wang QW, Zhang QW, Chen JN, Wang XY, Gao YJ, Li XB. Patterns of Lymph Node Metastasis in Patients With T1/T2 Gastroduodenal Neuroendocrine Neoplasms: Implications for Endoscopic Treatment. Front Endocrinol (Lausanne) 2021;12:658392. [PMID: 34122337 DOI: 10.3389/fendo.2021.658392] [Reference Citation Analysis]
470 Tomita H, Tanaka K, Hirata A, Okada H, Imai H, Shirakami Y, Ohnishi K, Sugie S, Aoki H, Hatano Y, Noguchi K, Kanayama T, Niwa A, Suzui N, Miyazaki T, Tanaka T, Akiyama H, Shimizu M, Yoshida K, Hara A. Inhibition of FGF10-ERK signal activation suppresses intraductal papillary neoplasm of the bile duct and its associated carcinomas. Cell Rep 2021;34:108772. [PMID: 33626352 DOI: 10.1016/j.celrep.2021.108772] [Reference Citation Analysis]
471 Basile D, Simionato F, Calvetti L, Cappetta A, Pesavento A, Mongillo M, Roviello G, Rosati G, Rossi G, Aprile G. Comparing immunotherapies to other frequently used treatments of gastric cancer. Expert Rev Clin Pharmacol 2021;:1-12. [PMID: 34114518 DOI: 10.1080/17512433.2021.1938546] [Reference Citation Analysis]
472 Oliveira RC, Terracciano L, Cipriano MA. Primary biliary adenosarcoma of the liver-a special and new entity. Virchows Arch 2020;477:461-6. [PMID: 32219513 DOI: 10.1007/s00428-020-02783-y] [Reference Citation Analysis]
473 Sahakyan MA, Verbeke CS, Tholfsen T, Ignjatovic D, Kleive D, Buanes T, Lassen K, Røsok BI, Labori KJ, Edwin B. Prognostic Impact of Resection Margin Status in Distal Pancreatectomy for Ductal Adenocarcinoma. Ann Surg Oncol 2021. [PMID: 34296358 DOI: 10.1245/s10434-021-10464-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
474 Zenovia S, Neculae E, Trifan AV, Dimache M, Fotea V, Sîngeap AM. Duodenal large-cell neuroendocrine carcinoma as unusual cause of acute pancreatitis. Arch Clin Cases 2020;7:15-21. [PMID: 34754922 DOI: 10.22551/2020.26.0701.10167] [Reference Citation Analysis]
475 Maharjan CK, Ear PH, Tran CG, Howe JR, Chandrasekharan C, Quelle DE. Pancreatic Neuroendocrine Tumors: Molecular Mechanisms and Therapeutic Targets. Cancers (Basel) 2021;13:5117. [PMID: 34680266 DOI: 10.3390/cancers13205117] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
476 Carvão J, Dinis-Ribeiro M, Pimentel-Nunes P, Libânio D. Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for Gastroenterologists. GE Port J Gastroenterol 2021;28:336-48. [PMID: 34604465 DOI: 10.1159/000512089] [Reference Citation Analysis]
477 Mas L, Lupinacci RM, Cros J, Bachet JB, Coulet F, Svrcek M. Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights. Int J Mol Sci 2021;22:6756. [PMID: 34201897 DOI: 10.3390/ijms22136756] [Reference Citation Analysis]
478 Melita G, Pallio S, Tortora A, Crinò SF, Macrì A, Dionigi G. Diagnostic and Interventional Role of Endoscopic Ultrasonography for the Management of Pancreatic Neuroendocrine Neoplasms. J Clin Med 2021;10:2638. [PMID: 34203922 DOI: 10.3390/jcm10122638] [Reference Citation Analysis]
479 Lan J, Guo D, Qin X, Chen B, Liu Q. Mixed Neuroendocrine Carcinoma and Hepatocellular Carcinoma: A Case Report and Literature Review. Front Surg 2021;8:678853. [PMID: 34336917 DOI: 10.3389/fsurg.2021.678853] [Reference Citation Analysis]
480 Katsukura N, Watanabe S, Shirasaki T, Hibiya S, Kano Y, Akahoshi K, Tanabe M, Kirimura S, Akashi T, Kitagawa M, Okamoto R, Watanabe M, Tsuchiya K. Intestinal phenotype is maintained by Atoh1 in the cancer region of intraductal papillary mucinous neoplasm. Cancer Sci 2021;112:932-44. [PMID: 33275808 DOI: 10.1111/cas.14755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
481 Wang T, Yang X, Tang H, Kong J, Shen S, Qiu H, Wang W. Integrated nomograms to predict overall survival and recurrence-free survival in patients with combined hepatocellular cholangiocarcinoma (cHCC) after liver resection. Aging (Albany NY) 2020;12:15334-58. [PMID: 32788423 DOI: 10.18632/aging.103577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
482 He L, Wang W, Shi H, Jiang C, Yao H, Zhang Y, Qian W, Lin R. THBS4/integrin α2 axis mediates BM-MSCs to promote angiogenesis in gastric cancer associated with chronic Helicobacter pylori infection. Aging (Albany NY) 2021;13:19375-96. [PMID: 34390328 DOI: 10.18632/aging.203334] [Reference Citation Analysis]
483 Sowińska-Przepiera E, Starzyński D, Syrenicz A, Dziuba I, Wiszniewska B, Rzeszotek S. Neuroendocrine Tumors: Clinical, Histological and Immunohistochemical Perspectives and Case Report-Mature Teratoma in a 16-Year-Old Girl. Pathophysiology 2021;28:373-86. [PMID: 35366281 DOI: 10.3390/pathophysiology28030025] [Reference Citation Analysis]
484 Weng CY, Sun SP, Cai C, Xu JL, Lv B. Endoscopic submucosal dissection for early signet ring cell gastric cancer: A systematic review and meta-analysis. World J Clin Cases 2022; 10(20): 6915-6926 [DOI: 10.12998/wjcc.v10.i20.6915] [Reference Citation Analysis]
485 Lombardi PM, Mazzola M, Nicastro V, Giacopuzzi S, Baiocchi GL, Castoro C, Rosati R, Fumagalli Romario U, Bonavina L, Staderini F, Gockel I, Gregori D, De Martini P, Gualtierotti M, Danieli M, Beretta S, Mutignani M, Forti E, Ferrari G. The iGreenGO Study: The Clinical Role of Indocyanine Green Imaging Fluorescence in Modifying the Surgeon’s Conduct During the Surgical Treatment of Advanced Gastric Cancer—Study Protocol for an International Multicenter Prospective Study. Front Oncol 2022;12:854754. [DOI: 10.3389/fonc.2022.854754] [Reference Citation Analysis]
486 Chen I, Zhang D, Velez M, Kovar S, Liao X. Poorly differentiated neuroendocrine carcinomas of the gastrointestinal tract: A single-institute study of 43 cases. Pathol Res Pract 2021;226:153614. [PMID: 34555651 DOI: 10.1016/j.prp.2021.153614] [Reference Citation Analysis]
487 Marchegiani G, Salvia R; Verona EBM 2020 on IPMN. Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice- Results From an International Survey. Gastroenterology 2021;160:2234-8. [PMID: 33609506 DOI: 10.1053/j.gastro.2021.02.026] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
488 Manneh Kopp R, Espinosa-Olarte P, Alonso-Gordoa T. Diagnosis in Neuroendocrine Neoplasms: From Molecular Biology to Molecular Imaging. Cancers (Basel) 2022;14:2514. [PMID: 35626118 DOI: 10.3390/cancers14102514] [Reference Citation Analysis]
489 Giannis D, Morsy S, Geropoulos G, Esagian SM, Sioutas GS, Moris D. The Epidemiology, Staging and Outcomes of Sarcomatoid Hepatocellular Carcinoma: A SEER Population Analysis. In Vivo 2021;35:393-9. [PMID: 33402488 DOI: 10.21873/invivo.12270] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
490 Goeppert B, Stichel D, Toth R, Fritzsche S, Loeffler MA, Schlitter AM, Neumann O, Assenov Y, Vogel MN, Mehrabi A, Hoffmann K, Köhler B, Springfeld C, Weichenhan D, Plass C, Esposito I, Schirmacher P, von Deimling A, Roessler S. Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesis. Gut 2022;71:391-401. [PMID: 33468537 DOI: 10.1136/gutjnl-2020-322983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
491 Kühl Svoboda Baldin R, Austrália Paredes Marcondes Ribas C, de Noronha L, Veloso da Silva-Camargo CC, Santos Sotomaior V, Martins Sebastião AP, Vasconcelos de Castilho AP, Rodrigues Montemor Netto M. Expression of Parkin, APC, APE1, and Bcl-xL in Colorectal Polyps. J Histochem Cytochem 2021;69:437-49. [PMID: 34126796 DOI: 10.1369/00221554211026296] [Reference Citation Analysis]
492 Kiczmer P, Mielcarska S, Chrabańska M, Dawidowicz M, Kula A, Rynkiewicz M, Seńkowska AP, Waniczek D, Piecuch J, Jopek J, Kajor M, Świętochowska E. The Concentration of CMKLR1 Expression on Clinicopathological Parameters of Colorectal Cancer: A Preliminary Study. Medicina (Kaunas) 2021;57:1299. [PMID: 34946244 DOI: 10.3390/medicina57121299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
493 Zhu F, Wang Y, Zhou J, Meng N, Wang Y, Jiang B, Wang S. The Histopathological Types and Distribution Characteristics of Gastric Mixed Tumors. Front Oncol 2022;12:873005. [DOI: 10.3389/fonc.2022.873005] [Reference Citation Analysis]
494 Aparicio-López D, Palomares-Cano A, Hörndler-Algarate C, Serrablo-Requejo A, Serradilla-Martín M. Mucinous cystic liver neoplasm with invasive component and sarcomatous differentiation. Acta Chir Belg 2022;:1-4. [PMID: 35647933 DOI: 10.1080/00015458.2022.2082061] [Reference Citation Analysis]
495 Roseland ME, Francis IR, Shampain KL, Stein EB, Wasnik AP, Millet JD. Gastric neuroendocrine neoplasms: a primer for radiologists. Abdom Radiol (NY) 2022. [PMID: 35411433 DOI: 10.1007/s00261-022-03509-1] [Reference Citation Analysis]
496 Islam F, Gopalan V, Lu CT, Pillai S, Lam AK. Identification of novel mutations and functional impacts of EPAS1 in colorectal cancer. Cancer Med 2021;10:5557-73. [PMID: 34250767 DOI: 10.1002/cam4.4116] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
497 Lang SA, Bednarsch J, Czigany Z, Joechle K, Kroh A, Amygdalos I, Strnad P, Bruns T, Heise D, Ulmer F, Neumann UP. Liver transplantation in malignant disease. World J Clin Oncol 2021; 12(8): 623-645 [PMID: 34513597 DOI: 10.5306/wjco.v12.i8.623] [Reference Citation Analysis]
498 Bolidong D, Domoto T, Uehara M, Sabit H, Okumura T, Endo Y, Nakada M, Ninomiya I, Miyashita T, Wong RW, Minamoto T. Potential therapeutic effect of targeting glycogen synthase kinase 3β in esophageal squamous cell carcinoma. Sci Rep 2020;10:11807. [PMID: 32678196 DOI: 10.1038/s41598-020-68713-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
499 Walter F, Fuchs F, Gerum S, Rottler MC, Erdelkamp R, Neumann J, Nierer L, Guba M, De Toni EN, Seidensticker M, Ricke J, Belka C, Corradini S. HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience. Front Oncol 2021;11:717792. [PMID: 34513694 DOI: 10.3389/fonc.2021.717792] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
500 Silva DJ, Dos Santos J, Vaz AP, Mesquita A. Rectal mixed adenoneuroendocrine carcinoma: Case report. Medicine (Baltimore) 2021;100:e27348. [PMID: 34622834 DOI: 10.1097/MD.0000000000027348] [Reference Citation Analysis]
501 Kriger AG, Karmazanovsky GG, Berelavichus SV, Gorin DS, Kaldarov AR, Panteleev VI, Dvukhzhilov MV, Kalinin DV, Glotov AV, Zektser VY. [Duodenopancreatectomy for pancreatic tumors - pros and cons]. Khirurgiia (Mosk) 2019;:28-36. [PMID: 31825340 DOI: 10.17116/hirurgia201912128] [Reference Citation Analysis]
502 Cree IA. The WHO Classification of Haematolymphoid Tumours. Leukemia 2022. [PMID: 35732830 DOI: 10.1038/s41375-022-01625-x] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
503 Truong LH, Pauklin S. Pancreatic Cancer Microenvironment and Cellular Composition: Current Understandings and Therapeutic Approaches. Cancers (Basel) 2021;13:5028. [PMID: 34638513 DOI: 10.3390/cancers13195028] [Reference Citation Analysis]
504 Csanyi-bastien M, Blanchard F, Lamy A, Sabourin J. A case of Pseudomyxoma Peritonei of an unexpected origin. Diagn Pathol 2021;16. [DOI: 10.1186/s13000-021-01179-z] [Reference Citation Analysis]
505 Mostafa AM, Saafan HA, Al-Tawashi AS, Kasem MH, Alaa AM, Eltobgy MM, Moubarak AS, Gharib MM, Awwad MA, Omar HM, El-Derany MO. Interleukin-17 haplotyping predicts hepatocellular carcinoma in sofosbuvir, pegylated interferon-alpha-2a & ribavirin treated chronic hepatitis C patients. Virus Res 2021;292:198226. [PMID: 33171166 DOI: 10.1016/j.virusres.2020.198226] [Reference Citation Analysis]
506 Trillo Aliaga P, Spada F, Peveri G, Bagnardi V, Fumagalli C, Laffi A, Rubino M, Gervaso L, Guerini Rocco E, Pisa E, Curigliano G, Fazio N. Should temozolomide be used on the basis of O6-methylguanine DNA methyltransferase status in patients with advanced neuroendocrine tumors? A systematic review and meta-analysis. Cancer Treat Rev 2021;99:102261. [PMID: 34332293 DOI: 10.1016/j.ctrv.2021.102261] [Reference Citation Analysis]
507 Wang K, Li E, Busuttil RA, Kong JC, Pattison S, Sung JJY, Yu J, El-Omar EM, Simpson JA, Boussioutas A. A cohort study and meta-analysis of the evidence for consideration of Lauren subtype when prescribing adjuvant or palliative chemotherapy for gastric cancer. Ther Adv Med Oncol 2020;12:1758835920930359. [PMID: 32754227 DOI: 10.1177/1758835920930359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
508 Mochizuki K, Kudo SE, Ichimasa K, Kouyama Y, Matsudaira S, Takashina Y, Maeda Y, Ishigaki T, Nakamura H, Toyoshima N, Mori Y, Misawa M, Ogata N, Kudo T, Hayashi T, Wakamura K, Sawada N, Ishida F, Miyachi H. Left-sided location is a risk factor for lymph node metastasis of T1 colorectal cancer: a single-center retrospective study. Int J Colorectal Dis 2020;35:1911-9. [PMID: 32548720 DOI: 10.1007/s00384-020-03668-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
509 Wang Y, Huang B, Fu Q, Wang J, Ye M, Hu M, Qu K, Liu K, Hu X, Wei S, Sun K, Xiao W, Zhang B, Li H, Li J, Zhang Q, Liang T. Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms: A Large-Volume Multicenter Study During One Decade. Ann Surg Oncol 2022. [PMID: 35849293 DOI: 10.1245/s10434-022-12107-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
510 Liu X, Wang W, Liu X, Zhang Z, Yu L, Li R, Guo D, Cai W, Quan X, Wu H, Dai M, Liang Z. Multi‐omics analysis of intra‐tumoural and inter‐tumoural heterogeneity in pancreatic ductal adenocarcinoma. Clinical & Translational Med 2022;12. [DOI: 10.1002/ctm2.670] [Reference Citation Analysis]
511 Ginghina O, Hudita A, Zamfir M, Spanu A, Mardare M, Bondoc I, Buburuzan L, Georgescu SE, Costache M, Negrei C, Nitipir C, Galateanu B. Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient's Stratification. Front Oncol 2022;12:856575. [PMID: 35356214 DOI: 10.3389/fonc.2022.856575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
512 de la Fouchardiere C, Decoster L, Samalin E, Terret C, Kenis C, Droz JP, Coutzac C, Smyth E. Advanced oesophago-gastric adenocarcinoma in older patients in the era of immunotherapy. A review of the literature. Cancer Treat Rev 2021;100:102289. [PMID: 34583303 DOI: 10.1016/j.ctrv.2021.102289] [Reference Citation Analysis]
513 Bazzichetto C, Luchini C, Conciatori F, Vaccaro V, Di Cello I, Mattiolo P, Falcone I, Ferretti G, Scarpa A, Cognetti F, Milella M. Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology. Int J Mol Sci 2020;21:E8841. [PMID: 33266496 DOI: 10.3390/ijms21228841] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
514 Cheng T, Gamage SMK, Lu C, Aktar S, Gopalan V, Lam AK. Polymorphisms in PAH metabolising enzyme CYP1A1 in colorectal cancer and their clinicopathological correlations. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153801] [Reference Citation Analysis]
515 Marji N, Dhillon J, Lauwers GY, Feuerlein S, Nikfar R, Chatwal M, Vosoughi A, Wu MLC. Colonic Adenocarcinoma with Plasmacytoid Feature: Histopathology and Molecular Characteristics of a Rare Neoplasm with an Unusual Presentation. Case Reports in Pathology 2022;2022:1-5. [DOI: 10.1155/2022/2640456] [Reference Citation Analysis]
516 Kim H, Yoon H, Thakur N, Hwang G, Lee EJ, Kim C, Chong Y. Deep learning-based histopathological segmentation for whole slide images of colorectal cancer in a compressed domain. Sci Rep 2021;11:22520. [PMID: 34795365 DOI: 10.1038/s41598-021-01905-z] [Reference Citation Analysis]
517 Kasuga K, Yamada M, Shida D, Tagawa T, Takamaru H, Sekiguchi M, Sakamoto T, Uraoka T, Sekine S, Kanemitsu Y, Saito Y. Treatment outcomes of endoscopic submucosal dissection and surgery for colorectal neoplasms in patients with ulcerative colitis. United European Gastroenterol J 2021. [PMID: 34232561 DOI: 10.1002/ueg2.12118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
518 Clairet CDMAV, De Aquino JLB, Clairet LM. Evaluation of the Serrated Lesions Detection Rate and Its Role as a Colonoscopy Quality Criteria. Journal of Coloproctology 2021;41:228-33. [DOI: 10.1055/s-0041-1730261] [Reference Citation Analysis]
519 Kim JH, Yoon JH, Joo I, Lee JM. Evaluation of Primary Liver Cancers Using Hepatocyte-Specific Contrast-Enhanced MRI: Pitfalls and Potential Tips. J Magn Reson Imaging 2021;53:655-75. [PMID: 32700807 DOI: 10.1002/jmri.27213] [Reference Citation Analysis]
520 Hidayat F, Labeda I, Sampetoding S, Pattelongi IJ, Lusikooy RE, Warsinggih, Dani MI, Mappincara, Kusuma MI, Uwuratuw JA, Syarifuddin E, Faruk M. Correlation of interleukin-6 and C-reactive protein levels in plasma with the stage and differentiation of colorectal cancer: A cross-sectional study in East Indonesia. Ann Med Surg (Lond) 2021;62:334-40. [PMID: 33552492 DOI: 10.1016/j.amsu.2021.01.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
521 Teran S, Camara Jurado M, Nuñez Sobrino JA. A Patient with an Ileocecal MiNEN and a Synchronous Squamous Non-Small-Cell Lung Cancer: Case Report and Review of the Literature. Case Rep Oncol Med 2021;2021:8896254. [PMID: 33859853 DOI: 10.1155/2021/8896254] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
522 Nikas IP, Proctor T, Seide S, Chatziioannou SS, Reynolds JP, Ntourakis D. Diagnostic Performance of Pancreatic Cytology with the Papanicolaou Society of Cytopathology System: A Systematic Review, before Shifting into the Upcoming WHO International System. Int J Mol Sci 2022;23:1650. [PMID: 35163571 DOI: 10.3390/ijms23031650] [Reference Citation Analysis]
523 Kuwano H, Yokobori T, Ide M, Saeki H, Sohda M, Sakai M, Yoshida T, Kuriyama K, Ogata K, Ogawa H, Okada T, Miyazaki T, Takahashi S, Shirabe K. Coexistence of superficial carcinogenesis of resident epithelium besides neuroendocrine neoplasm of the digestive tract. Cancer Med 2022. [PMID: 35048546 DOI: 10.1002/cam4.4485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
524 Luley K, Gebauer J, Gebauer N, Tharun L, Buchmann I, Barkhausen J, von Bubnoff N, Lindner K, Keck T, Lehnert H, Schmid SM. [Gastroenteropancreatic neuroendocrine neoplasms-Heterogeneity, management and perspectives of treatment and research]. Internist (Berl). 2020;61:875-890. [PMID: 32676723 DOI: 10.1007/s00108-020-00832-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
525 Ren S, Li Q, Liu S, Qi Q, Duan S, Mao B, Li X, Wu Y, Zhang L. Clinical Value of Machine Learning-Based Ultrasomics in Preoperative Differentiation Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Multicenter Study. Front Oncol 2021;11:749137. [PMID: 34804935 DOI: 10.3389/fonc.2021.749137] [Reference Citation Analysis]
526 Ferreira R, Abreu P, Jeismann VB, Segatelli V, Coelho FF, David AI. Mucinous cystic neoplasm of the liver with biliary communication: case report and surgical therapeutic option. BMC Surg 2020;20:328. [PMID: 33308210 DOI: 10.1186/s12893-020-01003-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
527 de Sousa MJ, Gervaso L, Meneses-Medina MI, Spada F, Abdel-Rahman O, Fazio N. Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside. Curr Oncol Rep 2022. [PMID: 35262877 DOI: 10.1007/s11912-022-01251-x] [Reference Citation Analysis]
528 Hinterleitner M, Sipos B, Wagner V, Grottenthaler JM, Lauer UM, Zender L, Hinterleitner C. Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine Malignancies. Cancers (Basel) 2021;13:2286. [PMID: 34064565 DOI: 10.3390/cancers13102286] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
529 Rodrigues M, Winkler KK, Svirydenka H, Nilica B, Uprimny C, Virgolini I. Long-Term Survival and Value of 18F-FDG PET/CT in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with Second Peptide Receptor Radionuclide Therapy Course with 177Lu-DOTATATE. Life (Basel) 2021;11:198. [PMID: 33806393 DOI: 10.3390/life11030198] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
530 Liu YJ, Rogers J, Liu YZ, Gui X, Jalikis F, Koch L, Swanson PE, Truong CD, Yeh MM. Interobserver agreement in pathologic evaluation of bile duct biopsies. Hum Pathol 2021;107:29-38. [PMID: 33129823 DOI: 10.1016/j.humpath.2020.10.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
531 Zou J, Wang S, Chai N, Yue H, Ye P, Guo P, Li F, Wei B, Ma G, Wei W, Linghu E. Construction of gastric cancer patient-derived organoids and their utilization in a comparative study of clinically used paclitaxel nanoformulations. J Nanobiotechnology 2022;20:233. [PMID: 35585597 DOI: 10.1186/s12951-022-01431-8] [Reference Citation Analysis]
532 Li K, Yuan J, Li Y, Zhang H, Liu X, Ke N. Successful Neoadjuvant Chemotherapy for Small-Cell Neuroendocrine Carcinoma of the Pancreas: A Case Report. Front Oncol 2021;11:719422. [PMID: 34568048 DOI: 10.3389/fonc.2021.719422] [Reference Citation Analysis]
533 Gui H, Husson MA, Mannan R. Correlations of morphology and molecular alterations in traditional serrated adenoma. World J Gastrointest Pathophysiol 2020; 11(4): 78-83 [PMID: 32587787 DOI: 10.4291/wjgp.v11.i4.78] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
534 Wang M, Jing J, Li H, Liu J, Yuan Y, Sun L. The expression characteristics and prognostic roles of autophagy-related genes in gastric cancer. PeerJ 2021;9:e10814. [PMID: 33604190 DOI: 10.7717/peerj.10814] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
535 Bancheno WM, Adidam SR, Melaku MA. Metastatic rectal neuroendocrine carcinoma presenting with treatment-refractory immune thrombocytopenia: A case report and literature review. Medicine (Baltimore) 2022;101:e29616. [PMID: 35866784 DOI: 10.1097/MD.0000000000029616] [Reference Citation Analysis]
536 Saleh M, Bhosale PR, Yano M, Itani M, Elsayes AK, Halperin D, Bergsland EK, Morani AC. New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms. Abdom Radiol (NY) 2020. [PMID: 33095312 DOI: 10.1007/s00261-020-02833-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
537 Ryan ÉJ, Creavin B, Sheahan K. Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm. Front Oncol 2020;10:1369. [PMID: 32923389 DOI: 10.3389/fonc.2020.01369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
538 Heidarian A, Das KK, Mino-Kenudson M, Fernandez-Del Castillo C, Pitman MB. Cytology adds value to monoclonal antibody Das-1 testing for detection of high-risk pancreatic cysts. J Am Soc Cytopathol 2021;10:249-54. [PMID: 33541830 DOI: 10.1016/j.jasc.2021.01.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
539 Luo Q, Wang C, Peng B, Pu X, Cai L, Liao H, Chen K, Zhang C, Cheng Y, Pan M. Circulating Tumor-Cell-Associated White Blood Cell Clusters in Peripheral Blood Indicate Poor Prognosis in Patients With Hepatocellular Carcinoma. Front Oncol. 2020;10:1758. [PMID: 33224869 DOI: 10.3389/fonc.2020.01758] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
540 Søreide JA, Kvaløy JT, Lea D, Sandvik OM, Al-Saiddi M, Haslerud TM, Garresori H, Karlsen LN, Gudlaugsson E, Søreide K. The overriding role of surgery and tumor grade for long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based cohort study. Cancer Rep (Hoboken) 2021;:e1462. [PMID: 34105314 DOI: 10.1002/cnr2.1462] [Reference Citation Analysis]
541 Tulessin M, Sarker RSJ, Griger J, Leibing T, Geraud C, Weichert W, Steiger K, Mogler C. Vascular Remodeling Is a Crucial Event in the Early Phase of Hepatocarcinogenesis in Rodent Models for Liver Tumorigenesis. Cells 2022;11:2129. [DOI: 10.3390/cells11142129] [Reference Citation Analysis]
542 Low RRJ, Lim WW, Nguyen PM, Lee B, Christie M, Burgess AW, Gibbs P, Grimmond SM, Hollande F, Putoczki TL. The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids. Cancers (Basel) 2021;13:4979. [PMID: 34638463 DOI: 10.3390/cancers13194979] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
543 Baekdal J, Krogh J, Klose M, Holmager P, Langer SW, Oturai P, Kjaer A, Federspiel B, Hilsted L, Rehfeld JF, Knigge U, Andreassen M. Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors. Diagnostics (Basel) 2020;10:E881. [PMID: 33138020 DOI: 10.3390/diagnostics10110881] [Reference Citation Analysis]
544 Liu YH, Fan ZH, Yin SS, Yan K, Sun LQ, Jiang BB. Diagnostic value of color parametric imaging and contrast-enhanced ultrasound in the differentiation of hepatocellular adenoma and well-differentiated hepatocellular carcinoma. J Clin Ultrasound 2022. [PMID: 35084048 DOI: 10.1002/jcu.23138] [Reference Citation Analysis]
545 Iguchi K, Mushiake H, Hasegawa S, Inagaki D, Fukushima T, Numata M, Tamagawa H, Yukawa N, Rino Y, Masuda M. Rectal Cancer Surgery in Patients Older Than 80 Years: Is Hartmann's Procedure Safe? In Vivo 2020;34:3661-7. [PMID: 33144482 DOI: 10.21873/invivo.12213] [Reference Citation Analysis]
546 Sun J, Shen D, Zheng Y, Ren H, Liu H, Chen X, Gao Y. USP8 Inhibitor Suppresses HER-2 Positive Gastric Cancer Cell Proliferation and Metastasis via the PI3K/AKT Signaling Pathway. Onco Targets Ther 2020;13:9941-52. [PMID: 33116578 DOI: 10.2147/OTT.S271496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
547 Wang M, Chen Z, Guo P, Wang Y, Chen G. Therapy for advanced cholangiocarcinoma: Current knowledge and future potential. J Cell Mol Med 2021;25:618-28. [PMID: 33277810 DOI: 10.1111/jcmm.16151] [Reference Citation Analysis]
548 Jeong BS, Hwang HW, Kim JW, Hwang IG, Park JY. Gastric Mixed Adenoneuroendocrine Carcinoma with Revised Diagnosis after Retrospective Pathologic Review. Korean J Helicobacter Up Gastrointest Res 2021;21:343-8. [DOI: 10.7704/kjhugr.2021.0047] [Reference Citation Analysis]
549 Ahadi M, Sokolova A, Brown I, Chou A, Gill AJ. The 2019 World Health Organization Classification of appendiceal, colorectal and anal canal tumours: an update and critical assessment. Pathology 2021;53:454-61. [PMID: 33461799 DOI: 10.1016/j.pathol.2020.10.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
550 Dai M, Mullins CS, Lu L, Alsfasser G, Linnebacher M. Recent advances in diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Surg 2022; 14(5): 383-396 [DOI: 10.4240/wjgs.v14.i5.383] [Reference Citation Analysis]
551 Kattner N, Dyson N, Bury Y, Tiniakos D, White K, Davey T, Eliasson L, Tindale L, Wagner BE, Honkanen-Scott M, Doyle J, Ploeg RJ, Shaw JA, Scott WE 3rd. Development and validation of a quantitative electron microscopy score to assess acute cellular stress in the human exocrine pancreas. J Pathol Clin Res 2021;7:173-87. [PMID: 33225596 DOI: 10.1002/cjp2.185] [Reference Citation Analysis]
552 Brito HP, Torres IT, Turke KC, Parada AA, Waisberg J, Botelho RV. Comparison of endoscopic resection techniques for duodenal neuroendocrine tumors: systematic review. Endosc Int Open 2021;9:E1214-21. [PMID: 34447867 DOI: 10.1055/a-1487-5594] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
553 O’connell E, Reynolds IS, Lindner AU, Salvucci M, O’grady T, Bacon O, Cho S, Mcdonough E, Longley D, Ginty F, Mcnamara DA, Burke JP, Prehn JHM. Apoptotic and Necroptotic Mediators are Differentially Expressed in Mucinous and Non-Mucinous Colorectal Cancer. Front Oncol 2022;12:815001. [DOI: 10.3389/fonc.2022.815001] [Reference Citation Analysis]
554 Timmer FEF, Geboers B, Ruarus AH, Schouten EAC, Nieuwenhuizen S, Puijk RS, de Vries JJJ, Meijerink MR, Scheffer HJ. Irreversible Electroporation for Locally Advanced Pancreatic Cancer. Tech Vasc Interv Radiol. 2020;23:100675. [PMID: 32591191 DOI: 10.1016/j.tvir.2020.100675] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
555 Lee K, Song YS, Shin Y, Wen X, Kim Y, Cho NY, Bae JM, Kang GH. Intrahepatic cholangiocarcinomas with IDH1/2 mutation-associated hypermethylation at selective genes and their clinicopathological features. Sci Rep 2020;10:15820. [PMID: 32978444 DOI: 10.1038/s41598-020-72810-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
556 Li MX, Lopez-Aguiar AG, Poultsides G, Rocha F, Weber S, Fields R, Idrees K, Cho C, Maithel SK, Zhang XF, Pawlik TM. Surgical outcomes of gastro-entero-pancreatic neuroendocrine tumors G3 versus neuroendocrine carcinoma. J Surg Oncol 2022. [PMID: 35616186 DOI: 10.1002/jso.26928] [Reference Citation Analysis]
557 Zheng K, Liu T, Zhao J, Meng P, Bian Y, Ni C, Wang H, Pan Y, Wu S, Jiang H, Jin G. Mutational landscape and potential therapeutic targets for sporadic pancreatic neuroendocrine tumors based on target next-generation sequencing. Exp Ther Med 2021;21:415. [PMID: 33747156 DOI: 10.3892/etm.2021.9859] [Reference Citation Analysis]
558 Gogna S, Samson D, Gachabayov M, Rojas A, Felsenreich DM, Koo D, Gu K, Quintero L, Miller KR, Azim A, Da Eric Dong X. Neuroendocrine neoplasms of the gallbladder: early detection and surgery is key to improved outcome. Langenbecks Arch Surg 2021. [PMID: 34236488 DOI: 10.1007/s00423-021-02256-z] [Reference Citation Analysis]
559 Lichtenberger JP 3rd, Zeman MN, Dulberger AR, Alqutub S, Carter BW, Manning MA. Esophageal Neoplasms: Radiologic-Pathologic Correlation. Radiol Clin North Am 2021;59:205-17. [PMID: 33551082 DOI: 10.1016/j.rcl.2020.11.002] [Reference Citation Analysis]
560 Kierans AS, Gavlin A, Wehrli N, Flisnik LM, Eliades S, Pittman ME. Utility of gadolinium for identifying the malignant potential of pancreatic cystic lesions. Abdom Radiol (NY) 2022;47:1351-9. [PMID: 35195765 DOI: 10.1007/s00261-022-03446-z] [Reference Citation Analysis]
561 Mapelli P, Partelli S, Salgarello M, Doraku J, Muffatti F, Schiavo Lena M, Pasetto S, Bezzi C, Bettinardi V, Andreasi V, Rancoita PMV, Gianolli L, Picchio M, Falconi M. Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms. Diagnostics (Basel) 2021;11:192. [PMID: 33525712 DOI: 10.3390/diagnostics11020192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
562 Massaras D, Masourou Z, Papazian M, Psarras G, Polydorou A. Solid Pseudopapillary Tumor of the Pancreas in a 25-Year-Old Female: A Rare Entity of Pancreatic Tumors. Cureus 2021;13:e14747. [PMID: 34084675 DOI: 10.7759/cureus.14747] [Reference Citation Analysis]
563 Mei SW, Liu Z, Wei FZ, Chen JN, Wang ZJ, Shen HY, Li J, Zhao FQ, Pei W, Wang Z, Wang XS, Liu Q. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients. World J Gastroenterol 2020; 26(31): 4624-4638 [PMID: 32884221 DOI: 10.3748/wjg.v26.i31.4624] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
564 Lu L, Shang Y, Zechner D, Mullins CS, Linnebacher M, Zhang X, Gong P. Development and Validation of a Score for Screening Suicide of Patients With Neuroendocrine Neoplasms. Front Psychiatry 2021;12:638152. [PMID: 34177643 DOI: 10.3389/fpsyt.2021.638152] [Reference Citation Analysis]
565 Goutas D, Goutas N, Theocharis S. Divulging the Critical Role of HuR in Pancreatic Cancer as a Therapeutic Target and a Means to Overcome Chemoresistance. Cancers (Basel) 2021;13:4634. [PMID: 34572861 DOI: 10.3390/cancers13184634] [Reference Citation Analysis]
566 Ahn B, Jung JK, Jung H, Ryu Y, Kim YW, Song TJ, Park DH, Hwang DW, Cho H, Kim S, Hong S. Double Ki-67 and synaptophysin labeling in pancreatic neuroendocrine tumor biopsies. Pancreatology 2022. [DOI: 10.1016/j.pan.2022.03.005] [Reference Citation Analysis]
567 Fernandez-Cuesta L, Foll M. Molecular studies of lung neuroendocrine neoplasms uncover new concepts and entities. Transl Lung Cancer Res 2019;8:S430-4. [PMID: 32038931 DOI: 10.21037/tlcr.2019.11.08] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
568 Michalski K, Laubner K, Stoykow C, Omrane MA, Maecke HR, Seufert J, Goetz C, Meyer PT, Ruf J. Detection of Insulinomas Using Dual-Time-Point 68Ga-DOTA-Exendin 4 PET/CT. Clin Nucl Med 2020;45:519-24. [PMID: 32453080 DOI: 10.1097/RLU.0000000000003093] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
569 Matsuda Y, Ohkubo S, Nakano-Narusawa Y, Fukumura Y, Hirabayashi K, Yamaguchi H, Sahara Y, Kawanishi A, Takahashi S, Arai T, Kojima M, Mino-Kenudson M. Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems. Sci Rep 2020;10:18278. [PMID: 33106543 DOI: 10.1038/s41598-020-74067-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
570 Krogh S, Grønbæk H, Knudsen AR, Kissmeyer-nielsen P, Hummelshøj NE, Dam G. Predicting Progression, Recurrence, and Survival in Pancreatic Neuroendocrine Tumors: A Single Center Analysis of 174 Patients. Front Endocrinol 2022;13:925632. [DOI: 10.3389/fendo.2022.925632] [Reference Citation Analysis]
571 Capretti G, Nebbia M, Gavazzi F, Nappo G, Ridolfi C, Sollai M, Spaggiari P, Bozzarelli S, Carrara S, Luberto A, Zerbi A. Invasive IPMN relapse later and more often in lungs in comparison to pancreatic ductal adenocarcinoma. Pancreatology 2022. [DOI: 10.1016/j.pan.2022.05.006] [Reference Citation Analysis]
572 Levy S, Arthur JD, Banks M, Kok NFM, Fenwick SW, Diaz-Nieto R, van Leerdam ME, Cuthbertson DJ, Valk GD, Kuhlmann KFD, Tesselaar MET. Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers. Ann Surg Oncol 2022. [PMID: 35842528 DOI: 10.1245/s10434-022-12030-0] [Reference Citation Analysis]
573 Kitasaki N, Abe T, Oshita A, Hanada K, Noriyuki T, Nakahara M. Pyloric adenomatous carcinoma of the gallbladder following laparoscopic cholecystectomy: A case report. Int J Surg Case Rep 2021;85:106278. [PMID: 34388892 DOI: 10.1016/j.ijscr.2021.106278] [Reference Citation Analysis]
574 Liverani C, Bongiovanni A, Mercatali L, Pieri F, Spadazzi C, Miserocchi G, Di Menna G, Foca F, Ravaioli S, De Vita A, Cocchi C, Rossi G, Recine F, Ibrahim T. Diagnostic and Predictive Role of DLL3 Expression in Gastroenteropancreatic Neuroendocrine Neoplasms. Endocr Pathol 2021;32:309-17. [PMID: 33409812 DOI: 10.1007/s12022-020-09657-8] [Reference Citation Analysis]
575 Kong XX, Li XL, Tian Y, Ye QC, Xu XM, Liu Y, Yang Q, Zhang LN, Mei YX, Wen JH, Xiao Q, Li JS, Ding KF, Li J. The Clinicopathological Characteristics of Alpha-Fetoprotein-Producing Adenocarcinoma of the Gastrointestinal Tract-A Single-Center Retrospective Study. Front Oncol 2021;11:635537. [PMID: 33996549 DOI: 10.3389/fonc.2021.635537] [Reference Citation Analysis]
576 Roviello F, Marano L, Ambrosio MR, Resca L, D'Ignazio A, Petrelli F, Petrioli R, Costantini M, Polom K, Macchiarelli R, Biviano I, Marrelli D. Signet ring cell percentage in poorly cohesive gastric cancer patients: A potential novel predictor of survival. Eur J Surg Oncol 2021:S0748-7983(21)00726-5. [PMID: 34511269 DOI: 10.1016/j.ejso.2021.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
577 Fujisawa M, Matsushima M, Carreras J, Hirabayashi K, Y Kikuti Y, Ueda T, Kaneko M, Fujimoto R, Sano M, Teramura E, Monma M, Nakae H, Suzuki T, Suzuki H, Nakamura N. Whole-genome copy number and immunohistochemical analyses on surgically resected intracholecystic papillary neoplasms. Pathol Int 2021. [PMID: 34643317 DOI: 10.1111/pin.13177] [Reference Citation Analysis]
578 Dobashi A, Ono S, Furuhashi H, Futakuchi T, Tamai N, Yamauchi T, Suka M, Sumiyama K. Texture and Color Enhancement Imaging Increases Color Changes and Improves Visibility for Squamous Cell Carcinoma Suspicious Lesions in the Pharynx and Esophagus. Diagnostics (Basel) 2021;11:1971. [PMID: 34829318 DOI: 10.3390/diagnostics11111971] [Reference Citation Analysis]
579 Choi SH, Jeon SK, Lee SS, Lee JM, Hur BY, Kang HJ, Kim H, Park Y. Radio-pathologic correlation of biphenotypic primary liver cancer (combined hepatocellular cholangiocarcinoma): changes in the 2019 WHO classification and impact on LI-RADS classification at liver MRI. Eur Radiol 2021. [PMID: 34037829 DOI: 10.1007/s00330-021-07984-w] [Reference Citation Analysis]
580 Wang L, Li C, Tian J, Liu J, Zhao Y, Yi Y, Zhang Y, Han J, Pan C, Liu S, Deng N, Xian Z, Li G, Zhang X, Liang A. Genome-wide transcriptional analysis of Aristolochia manshuriensis induced gastric carcinoma. Pharm Biol 2020;58:98-106. [PMID: 31957525 DOI: 10.1080/13880209.2019.1710219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
581 Gigante E, Paradis V, Ronot M, Cauchy F, Soubrane O, Ganne-Carrié N, Nault JC. New insights into the pathophysiology and clinical care of rare primary liver cancers. JHEP Rep 2021;3:100174. [PMID: 33205035 DOI: 10.1016/j.jhepr.2020.100174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
582 Fei Z, Wang Y, Gu Y, Xie R, Hao Q, Jiang Y. CircKIF5B Promotes Hepatocellular Carcinoma Progression by Regulating the miR-192 Family/XIAP Axis. Front Oncol 2022;12:916246. [DOI: 10.3389/fonc.2022.916246] [Reference Citation Analysis]
583 Albertelli M, Grillo F, Lo Calzo F, Puliani G, Rainone C, Colao AAL, Faggiano A; NIKE group. Pathology Reporting in Neuroendocrine Neoplasms of the Digestive System: Everything You Always Wanted to Know but Were Too Afraid to Ask. Front Endocrinol (Lausanne) 2021;12:680305. [PMID: 33967966 DOI: 10.3389/fendo.2021.680305] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
584 Dong XF, Wang Y, Tang CH, Huang BF, Du Z, Wang Q, Shao JK, Lu HJ, Wang CQ. Upregulated WTAP expression in colorectal cancer correlates with tumor site and differentiation. PLoS One 2022;17:e0263749. [PMID: 35143566 DOI: 10.1371/journal.pone.0263749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
585 Mehdorn AS, Richter F, Hess K, Beckmann JH, Egberts JH, Linecker M, Becker T, Braun F. The Role of ICG in Robot-Assisted Liver Resections. J Clin Med 2022;11:3527. [PMID: 35743595 DOI: 10.3390/jcm11123527] [Reference Citation Analysis]
586 Takada R, Minaga K, Hara A, Otsuka Y, Omoto S, Kamata K, Yamao K, Takenaka M, Hagiwara S, Honjo H, Matsui S, Chikugo T, Watanabe T, Kudo M. Diagnostic Value of EUS-Guided Fine-Needle Aspiration Biopsy for Gastric Linitis Plastica with Negative Endoscopic Biopsy. J Clin Med 2021;10:3716. [PMID: 34442011 DOI: 10.3390/jcm10163716] [Reference Citation Analysis]
587 Zhuo S, Zhou J, Ruan G, Zeng S, Ma H, Xie C, An C. Percutaneous microwave ablation vs surgical resection for ovarian cancer liver metastasis.Int J Hyperthermia. 2020;37:28-36. [PMID: 31918591 DOI: 10.1080/02656736.2019.1706767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
588 Li J, Wang J, Su D, Nie X, Liu Y, Teng L, Pang J, Wu H, Liang Z, Sakai E. p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms. Gastroenterology Research and Practice 2021;2021:1-9. [DOI: 10.1155/2021/2510195] [Reference Citation Analysis]
589 Wan L, Peng W, Zou S, Shi Q, Wu P, Zhao Q, Ye F, Zhao X, Zhang H. Predicting perineural invasion using histogram analysis of zoomed EPI diffusion-weighted imaging in rectal cancer. Abdom Radiol (NY) 2022. [PMID: 35779094 DOI: 10.1007/s00261-022-03579-1] [Reference Citation Analysis]
590 Ooki A, Yamaguchi K. The beginning of the era of precision medicine for gastric cancer with fibroblast growth factor receptor 2 aberration. Gastric Cancer 2021. [PMID: 34398359 DOI: 10.1007/s10120-021-01235-z] [Reference Citation Analysis]
591 Takeda Y, Kobayashi N, Kessoku T, Okubo N, Suzuki A, Tokuhisa M, Miwa H, Udaka N, Ichikawa Y. Case reports: chemoradiotherapy for locally advanced neuroendocrine carcinoma of the gallbladder. Clin J Gastroenterol 2022. [PMID: 35653037 DOI: 10.1007/s12328-022-01645-1] [Reference Citation Analysis]
592 Peltrini R, Cantoni V, Green R, Lionetti R, D'Ambra M, Bartolini C, De Luca M, Bracale U, Cuocolo A, Corcione F. Risk of appendiceal neoplasm after interval appendectomy for complicated appendicitis: A systematic review and meta-analysis. Surgeon 2021:S1479-666X(21)00031-7. [PMID: 33640282 DOI: 10.1016/j.surge.2021.01.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
593 Liu S, Jin J. Radiotherapy guidelines for rectal cancer in China (2020 Edition). Precision Radiation Oncology. [DOI: 10.1002/pro6.1141] [Reference Citation Analysis]
594 Watanabe H, Fujishima F, Komoto I, Imamura M, Hijioka S, Hara K, Yatabe Y, Kudo A, Masui T, Tsuchikawa T, Sakamoto K, Shiga H, Nakamura T, Nakaya N, Motoi F, Unno M, Sasano H. Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors. Cancers (Basel) 2022;14:775. [PMID: 35159042 DOI: 10.3390/cancers14030775] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
595 Wang R, Liu H, Liang P, Zhao H, Li L, Gao J. Radiomics analysis of CT imaging for differentiating gastric neuroendocrine carcinomas from gastric adenocarcinomas. Eur J Radiol 2021;138:109662. [PMID: 33774440 DOI: 10.1016/j.ejrad.2021.109662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
596 Souza da Silva RM, Queiroga EM, Paz AR, Neves FFP, Cunha KS, Dias EP. Standardized Assessment of the Tumor-Stroma Ratio in Colorectal Cancer: Interobserver Validation and Reproducibility of a Potential Prognostic Factor. Clin Pathol 2021;14:2632010X21989686. [PMID: 33634262 DOI: 10.1177/2632010X21989686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
597 Christensen AW, Goldberg AF. Mitotic count of fine needle aspiration material of gastrointestinal stromal tumours of the stomach underestimates actual mitotic count. Cytopathology 2021. [PMID: 34390589 DOI: 10.1111/cyt.13050] [Reference Citation Analysis]
598 Trovato A, Turshudzhyan A, Tadros M. Serrated lesions: A challenging enemy. World J Gastroenterol 2021; 27(34): 5625-5629 [PMID: 34629791 DOI: 10.3748/wjg.v27.i34.5625] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
599 Gambella A, Falco EC, Benazzo G, Osella-abate S, Senetta R, Castellano I, Bertero L, Cassoni P. The Importance of Being “That” Colorectal pT1: A Combined Clinico-Pathological Predictive Score to Improve Nodal Risk Stratification. Front Med 2022;9:837876. [DOI: 10.3389/fmed.2022.837876] [Reference Citation Analysis]
600 Yang YP, Yu LY, Shi J, Li JN, Wang XY, Liu TJ. Primary signet ring cell carcinoma with tubular adenoma of the rectum: A case report and a review of the literature. Medicine (Baltimore) 2020;99:e20985. [PMID: 32590811 DOI: 10.1097/MD.0000000000020985] [Reference Citation Analysis]
601 Kim YM, Kim JH, Park JS. Reply to the letter by Junjie Jiang et al. regarding our manuscript "Association between triglyceride-glucose index and gastric carcinogenesis: a health checkup cohort study". Gastric Cancer 2021;24:1372-3. [PMID: 34480658 DOI: 10.1007/s10120-021-01245-x] [Reference Citation Analysis]
602 Corbett V, Arnold S, Anthony L, Chauhan A. Management of Large Cell Neuroendocrine Carcinoma. Front Oncol 2021;11:653162. [PMID: 34513663 DOI: 10.3389/fonc.2021.653162] [Reference Citation Analysis]
603 Ma J, Meng Y, Zhou X, Guo L, Fu W. The Prognostic Significance and Gene Expression Characteristics of Gastric Signet-Ring Cell Carcinoma: A Study Based on the SEER and TCGA Databases. Front Surg 2022;9:819018. [DOI: 10.3389/fsurg.2022.819018] [Reference Citation Analysis]
604 Deng J, Zhou S, Wang Z, Huang G, Zeng J, Li X. Comparison of Prognosis and Lymph Node Metastasis in T1-Stage Colonic and Rectal Carcinoma: A Retrospective Study. IJGM 2022;Volume 15:3651-62. [DOI: 10.2147/ijgm.s354120] [Reference Citation Analysis]
605 Elpek GO. Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update. World J Gastroenterol 2022; 28(8): 794-810 [DOI: 10.3748/wjg.v28.i8.794] [Reference Citation Analysis]
606 Gkountakos A, Simbolo M, Bariani E, Scarpa A, Luchini C. Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology. Int J Mol Sci 2022;23:1283. [PMID: 35163206 DOI: 10.3390/ijms23031283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
607 Masui T, Ito T, Komoto I, Kojima S, Kasai Y, Tanabe M, Hara K, Hirano S, Okusaka T, Ichikawa Y, Kinugasa Y, Kokudo N, Kudo A, Sakurai A, Sugihara K, Date H, Haruma K, Hijioka S, Hirata K, Yamano H, Sakamine M, Kikuchi T, Fukushima M, Imamura M, Uemoto S. Nationwide registry for patients with neuroendocrine neoplasm of pancreas, gastrointestinal tract, lungs, bronchi, or thymus in Japan. Int J Clin Oncol 2022. [PMID: 35178624 DOI: 10.1007/s10147-022-02130-y] [Reference Citation Analysis]
608 Kriegsmann M, Kriegsmann K, Steinbuss G, Zgorzelski C, Kraft A, Gaida MM. Deep Learning in Pancreatic Tissue: Identification of Anatomical Structures, Pancreatic Intraepithelial Neoplasia, and Ductal Adenocarcinoma. Int J Mol Sci 2021;22:5385. [PMID: 34065423 DOI: 10.3390/ijms22105385] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
609 Feng Z, Li X, Ren Z, Feng J, He X, You C. Prognostic and Predictive Value of Cadherin 11 for Patients with Gastric Cancer and Its Correlation with Tumor Microenvironment: Results from Microarray Analysis. Biomed Res Int 2020;2020:8107478. [PMID: 32685527 DOI: 10.1155/2020/8107478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
610 Fornaro L, Spallanzani A, de Vita F, D'Ugo D, Falcone A, Lorenzon L, Tirino G, Cascinu S; GAIN (GAstric Cancer Italian Network). Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN). Cancers (Basel) 2021;13:1304. [PMID: 33804024 DOI: 10.3390/cancers13061304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
611 Katsura H, Hori T, Harada H, Matsumura K, Yamamoto M, Yamada M, Yazawa T, Sasaki B, Kuriyama K, Tani M, Sato A, Sasaki Y, Yamamoto H. Mucinous Cystic Adenoma of the Liver: A Thought-Provoking Case of an Uncommon Hepatic Neoplasm. Am J Case Rep 2021;22:e931368. [PMID: 33811210 DOI: 10.12659/AJCR.931368] [Reference Citation Analysis]
612 Holmager P, Willemoe GL, Nielsen K, Grøndahl V, Klose M, Andreassen M, Langer SW, Hansen CP, Kjær A, Federspiel BH, Knigge U. Neuroendocrine neoplasms of the appendix: Characterization of 335 patients referred to the Copenhagen NET Center of Excellence. Eur J Surg Oncol 2021;47:1357-63. [PMID: 33589240 DOI: 10.1016/j.ejso.2021.02.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
613 Exarchou K, Kamieniarz L, Tsoli M, Victor A, Oleinikov K, Khan MS, Srirajaskanthan R, Mandair D, Grozinsky-Glasberg S, Kaltsas G, Howes N, Pritchard DM, Toumpanakis C. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms? Endocrine 2021. [PMID: 34120313 DOI: 10.1007/s12020-021-02775-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
614 Chan DKH, Buczacki SJA. Tumour heterogeneity and evolutionary dynamics in colorectal cancer. Oncogenesis 2021;10:53. [PMID: 34272358 DOI: 10.1038/s41389-021-00342-x] [Reference Citation Analysis]
615 Feng JY, Li XP, Wu ZY, Ying LP, Xin C, Dai ZZ, Shen Y, Wu YF. Sarcomatoid intrahepatic cholangiocarcinoma with good patient prognosis after treatment with Huaier granules following hepatectomy: A case report. World J Clin Cases 2022; 10(9): 2827-2833 [DOI: 10.12998/wjcc.v10.i9.2827] [Reference Citation Analysis]
616 Festa S, Zerboni G, Derikx LAAP, Ribaldone DG, Dragoni G, Buskens C, van Dijkum EN, Pugliese D, Panzuto F, Krela-Kaźmierczak I, Reiss Mintz H, Shitrit AB, Chaparro M, Gisbert JP, Kopylov U, Teich N, Vainer E, Nagtegaal I, Hoentjen F, Garcia MJ, Filip R, Foteinogiannopoulou K, Koutroubakis IE, Argollo M, van Wanrooij RLJ, Laja H, Lobaton T, Truyens M, Molnar T, Savarino E, Aratari A, Papi C, Goren I. Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series. J Crohns Colitis 2021:jjab217. [PMID: 34864927 DOI: 10.1093/ecco-jcc/jjab217] [Reference Citation Analysis]
617 Centonze G, Lagano V, Sabella G, Mangogna A, Garzone G, Filugelli M, Belmonte B, Cattaneo L, Crisafulli V, Pellegrinelli A, Simbolo M, Scarpa A, Spaggiari P, Brambilla T, Pusceddu S, Prinzi N, Anichini A, Tripodo C, Milione M. Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms. J Clin Med 2021;10:1741. [PMID: 33920514 DOI: 10.3390/jcm10081741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
618 Minczeles NS, van Eijck CHJ, van Gils MJ, van Velthuysen MF, Nieveen van Dijkum EJM, Feelders RA, de Herder WW, Brabander T, Hofland J. Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients. Eur J Nucl Med Mol Imaging 2022. [PMID: 35230492 DOI: 10.1007/s00259-022-05734-8] [Reference Citation Analysis]
619 Tian C, Zhang B, Ge C. Effect of CEACAM6 silencing on the biological behavior of human gallbladder cancer cells. Oncol Lett 2020;20:2677-88. [PMID: 32782584 DOI: 10.3892/ol.2020.11806] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
620 Liu C, Hua X, Yang Z, Guo Y, Wu L, Cai J, Li L, Zhang Y, Fan N. Case Report: Response With Immunotherapy in a Patient With Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gallbladder. Front Oncol 2021;11:770156. [PMID: 34869003 DOI: 10.3389/fonc.2021.770156] [Reference Citation Analysis]
621 Im J, Nam SK, Lee HS. MicroRNA-552 expression in colorectal cancer and its clinicopathological significance. J Pathol Transl Med 2021;55:125-31. [PMID: 33596633 DOI: 10.4132/jptm.2021.01.17] [Reference Citation Analysis]
622 Yoshizawa T, Uehara T, Iwaya M, Asaka S, Kobayashi S, Nakajima T, Kinugawa Y, Nagaya T, Kamakura M, Shimizu A, Kubota K, Notake T, Masuo H, Hosoda K, Sakai H, Hayashi H, Umemura K, Kamachi A, Goto T, Tomida H, Yamazaki S, Ota H, Soejima Y. Correlation of LGR5 expression and clinicopathological features in intrahepatic cholangiocarcinoma. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153832] [Reference Citation Analysis]
623 Ieni A, Pizzimenti C, Arena S, Romeo C, Tuccari G. Unusual case of pleural effusion in a young woman. Cytopathology 2020;31:613-5. [PMID: 32579714 DOI: 10.1111/cyt.12881] [Reference Citation Analysis]
624 Murtha-Lemekhova A, Fuchs J, Schulz E, Sterkenburg AS, Mayer P, Pfeiffenberger J, Hoffmann K. Scirrhous Hepatocellular Carcinoma: Systematic Review and Pooled Data Analysis of Clinical, Radiological, and Histopathological Features. J Hepatocell Carcinoma 2021;8:1269-79. [PMID: 34712626 DOI: 10.2147/JHC.S328198] [Reference Citation Analysis]
625 Das S, Du L, Lee CL, Arhin ND, Chan JA, Kohn EC, Halperin DM, Berlin J, LaFerriere H, Singh S, Kunz PL, Dasari A. Comparison of Design, Eligibility, and Outcomes of Neuroendocrine Neoplasm Trials Initiated From 2000 to 2009 vs 2010 to 2020. JAMA Netw Open 2021;4:e2131744. [PMID: 34705010 DOI: 10.1001/jamanetworkopen.2021.31744] [Reference Citation Analysis]
626 Kang X, Zhang R, Kwong TN, Lui RN, Wu WK, Sung JJ, Yu J, Wong SH. Serrated neoplasia in the colorectum: gut microbiota and molecular pathways. Gut Microbes 2021;13:1-12. [PMID: 33382354 DOI: 10.1080/19490976.2020.1863135] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
627 Wang B, Jiao N, Shi L. A case report of advanced gastric small cell carcinoma with neoadjuvant chemotherapy followed by radical total gastrectomy. Asian J Surg 2020;43:1205-6. [PMID: 33069575 DOI: 10.1016/j.asjsur.2020.09.021] [Reference Citation Analysis]
628 Bongiovanni A, Maiorano BA, Azzali I, Liverani C, Bocchini M, Fausti V, Di Menna G, Grassi I, Sansovini M, Riva N, Ibrahim T. Activity and Safety of Immune Checkpoint Inhibitors in Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis. Pharmaceuticals (Basel) 2021;14:476. [PMID: 34067837 DOI: 10.3390/ph14050476] [Reference Citation Analysis]
629 Pan Q, Yang W, Zhang Z, Shao Z. Rare Bone Metastasis of Neuroendocrine Tumors of Unknown Origin: A Case Report and Literature Review. Orthop Surg 2022. [PMID: 35856167 DOI: 10.1111/os.13384] [Reference Citation Analysis]
630 Liu X, Ni X, Li Y, Yang C, Wang Y, Ma C, Zhou C, Lu X. Diagnostic Performance of LI-RADS Version 2018 for Primary Liver Cancer in Patients With Liver Cirrhosis on Enhanced MRI. Front Oncol 2022;12:934045. [DOI: 10.3389/fonc.2022.934045] [Reference Citation Analysis]
631 Shi J, Yang X, Wang X, Luo Y, Zhou W, Luo H, Bianba Z, Nima Z, Wang Q, Wang H, Liao R, Ciren Q, Li M, Pang J. Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer. Biomed Res Int 2022;2022:2684065. [PMID: 35734348 DOI: 10.1155/2022/2684065] [Reference Citation Analysis]
632 Sato H, Saito T, Horii H, Kajiura M, Kikuchi N, Takada N, Taguchi K, Yoshida M, Hasegawa M, Taguchi H, Yoshida Y, Ando K, Fujiya M, Omori Y, Hank T, Liss AS, Gala MK, Makita Y, Ono Y, Mizukami Y, Okumura T. Case Report: A Rare Case of Esophagogastric Junctional Squamous Cell Carcinoma After the Successful Treatment of Neuroendocrine Carcinoma: Clonal Tumor Evolution Revealed by Genetic Analysis. Front Genet 2021;12:608324. [PMID: 34616420 DOI: 10.3389/fgene.2021.608324] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
633 Xie Y, Zhang S, Liu X, Huang X, Zhou Q, Luo Y, Niu Q, Zhou J. Minimal apparent diffusion coefficient in predicting the Ki-67 proliferation index of pancreatic neuroendocrine tumors. Jpn J Radiol. [DOI: 10.1007/s11604-022-01262-5] [Reference Citation Analysis]
634 Kalinathan L, Kathavarayan RS, Kanmani M, Dinakaran N. Nuclei detection in hepatocellular carcinoma and dysplastic liver nodules in histopathology images using bootstrap regression. Histol Histopathol 2020;35:1115-23. [PMID: 32691405 DOI: 10.14670/HH-18-240] [Reference Citation Analysis]
635 Chevalier B, Dupuis H, Jannin A, Lemaitre M, Do Cao C, Cardot-Bauters C, Espiard S, Vantyghem MC. Phakomatoses and Endocrine Gland Tumors: Noteworthy and (Not so) Rare Associations. Front Endocrinol (Lausanne) 2021;12:678869. [PMID: 34025587 DOI: 10.3389/fendo.2021.678869] [Reference Citation Analysis]
636 Celayir OM, Selcukbiricik F, Tanik C, Altuntas Y. Evaluation of Human Epidermal Growth Factor Receptor 2 Overexpression, Clinicopathological Characteristics, and Factors Affecting Survival in Gastric Cancer. Sisli Etfal Hastan Tip Bul 2021;55:224-31. [PMID: 34349600 DOI: 10.14744/SEMB.2021.23356] [Reference Citation Analysis]
637 Renzulli M, Ramai D, Singh J, Sinha S, Brandi N, Ierardi AM, Albertini E, Sacco R, Facciorusso A, Golfieri R. Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma. Cancers (Basel) 2021;13:3336. [PMID: 34283065 DOI: 10.3390/cancers13133336] [Reference Citation Analysis]
638 Tang Y, Zhang T, Zhao Y, Chen Z, Ma X. Development and validation of a comprehensive radiomics nomogram for prognostic prediction of primary hepatic sarcomatoid carcinoma after surgical resection. Int J Med Sci 2021;18:1711-20. [PMID: 33746587 DOI: 10.7150/ijms.53602] [Reference Citation Analysis]
639 Zang C, Li S, Chi B, Chen S, Ye Z. An intraductal papillary mucinous neoplasm associated tubular adenocarcinoma with sarcomatoid component: A case report. Radiol Case Rep 2021;16:3494-8. [PMID: 34539943 DOI: 10.1016/j.radcr.2021.08.040] [Reference Citation Analysis]
640 Lou L, Lv F, Wu X, Li Y, Zhang X. Clinical implications of mismatch repair deficiency screening in patients with mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN). Eur J Surg Oncol 2021;47:323-30. [PMID: 32907775 DOI: 10.1016/j.ejso.2020.08.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
641 Cruz M, Moutinho-ribeiro P, Costa-moreira P, Macedo G. Solid Pseudopapillary Neoplasm of the Pancreas: Unfolding an Intriguing Condition. GE Port J Gastroenterol. [DOI: 10.1159/000519933] [Reference Citation Analysis]
642 Theiler D, Cattaneo M, Dierickx LO, Igaz P, Grozinsky-Glasberg S, Bournaud C, O'Dorisio T, O'Dorisio MS, Wild D, Christ E, Nicolas GP. Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients. Cancers (Basel) 2021;13:6290. [PMID: 34944910 DOI: 10.3390/cancers13246290] [Reference Citation Analysis]
643 Bober B, Saracyn M, Zaręba K, Lubas A, Mazurkiewicz P, Wilińska E, Kamiński G. Early Complications of Radioisotope Therapy with Lutetium-177 and Yttrium-90 in Patients with Neuroendocrine Neoplasms-A Preliminary Study. J Clin Med 2022;11:919. [PMID: 35207193 DOI: 10.3390/jcm11040919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
644 Wang H, Jiang H, Zhao J, Liu X, Li T, Chai J, Meng M, Pan T, Xu K, Wang F. Acupuncture therapy for gastric ulcer: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e27656. [PMID: 34713858 DOI: 10.1097/MD.0000000000027656] [Reference Citation Analysis]
645 Lin DL, Wang LL, Zhao P, Ran WW, Wang W, Zhang LX, Han M, Bao H, Liu K, Wu X, Shao Y, Xing XM. Gastrointestinal Goblet Cell Adenocarcinomas Harbor Distinctive Clinicopathological, Immune, and Genomic Landscape. Front Oncol 2021;11:758643. [PMID: 34804955 DOI: 10.3389/fonc.2021.758643] [Reference Citation Analysis]
646 Li SP, Wang P, Deng KX. Imaging presentation of biliary adenofibroma: A case report. World J Clin Cases 2022; 10(4): 1366-1372 [DOI: 10.12998/wjcc.v10.i4.1366] [Reference Citation Analysis]
647 Safi SA, Haeberle L, Goering W, Keitel V, Fluegen G, Stoecklein N, Rehders A, Knoefel WT, Esposito I. Genetic Alterations Predict Long-Term Survival in Ductal Adenocarcinoma of the Pancreatic Head. Cancers (Basel) 2022;14:850. [PMID: 35159117 DOI: 10.3390/cancers14030850] [Reference Citation Analysis]
648 Zhu Y, Weng S, Li Y, Yan C, Ye R, Wen L, Zhou L, Gao L. A radiomics nomogram based on contrast-enhanced MRI for preoperative prediction of macrotrabecular-massive hepatocellular carcinoma. Abdom Radiol (NY) 2021;46:3139-48. [PMID: 33641018 DOI: 10.1007/s00261-021-02989-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
649 Meng F, Sun N, Liu D, Jia J, Xiao J, Dai H. BCL2L13: physiological and pathological meanings. Cell Mol Life Sci 2021;78:2419-28. [PMID: 33201252 DOI: 10.1007/s00018-020-03702-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
650 Ding Y, Chen Y, Wu M, Li L, Huang Y, Wang H, Wang H, Yu X, Xu N, Teng L. Identification of genes associated with gastric cancer survival and construction of a nomogram to improve risk stratification for patients with gastric cancer. Oncol Lett 2020;20:215-25. [PMID: 32537023 DOI: 10.3892/ol.2020.11543] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
651 Duchateau NM, Canovai E, Vianna RM, Vanuytsel T, Verslype C, Mazariegos GV, Monbaliu D, Pirenne J, Ceulemans LJ. Combined liver-intestinal and multivisceral transplantation for neuroendocrine tumors extending beyond the liver: A systematic literature review. Transplantation Reviews 2022. [DOI: 10.1016/j.trre.2022.100678] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
652 Busse A, Mochmann LH, Spenke C, Arsenic R, Briest F, Jöhrens K, Lammert H, Sipos B, Kühl AA, Wirtz R, Pavel M, Hummel M, Kaemmerer D, Baum RP, Grabowski P. Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment. Cancers (Basel) 2020;12:E3448. [PMID: 33228231 DOI: 10.3390/cancers12113448] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
653 Andrisani G, Fukuchi T, Hassan C, Hamanaka J, Antonelli G, Costamagna G, Di Matteo FM, Hirasawa K. Rectal neoplasia extending to the dentate line: clinical outcomes of endoscopic submucosal dissection. Scand J Gastroenterol 2020;55:1363-8. [PMID: 33016792 DOI: 10.1080/00365521.2020.1825791] [Reference Citation Analysis]
654 Wen Y, Chen Y, Ren F. Gastric mixed neuroendocrine-nonneuroendocrine neoplasm misdiagnosed by preoperative pathology: A case report. Asian Journal of Surgery 2022. [DOI: 10.1016/j.asjsur.2022.03.124] [Reference Citation Analysis]
655 Li X, Ai S, Lu X, Liu S, Guan W. Nanotechnology-based strategies for gastric cancer imaging and treatment. RSC Adv 2021;11:35392-407. [PMID: 35493171 DOI: 10.1039/d1ra01947c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
656 Li M, Kong J, Wang L, Yan H, Liang W, Wang N, Zhao J. Defective expression of C20orf54 in esophageal dysplasia: a possible biomarker of esophageal carcinoma for early detection. World J Surg Oncol 2022;20:155. [PMID: 35549728 DOI: 10.1186/s12957-022-02612-3] [Reference Citation Analysis]
657 Jin Y, Xu Y, Li Y, Chen R, Cai W. Integrative Radiogenomics Approach for Risk Assessment of Postoperative and Adjuvant Chemotherapy Benefits for Gastric Cancer Patients. Front Oncol 2021;11:755271. [PMID: 34804945 DOI: 10.3389/fonc.2021.755271] [Reference Citation Analysis]
658 Ismail A, Lall V, Ayonrinde OT. Should the high prevalence of sessile serrated lesions in patients aged below 50 years influence screening colonoscopy recommendations? J Gastroenterol Hepatol 2021;36:2022-3. [PMID: 33783871 DOI: 10.1111/jgh.15511] [Reference Citation Analysis]
659 Murugesan K, Sharaf R, Montesion M, Moore JA, Pao J, Pavlick DC, Frampton GM, Upadhyay VA, Alexander BM, Miller VA, Javle MM, Bekaii Saab TS, Albacker LA, Ross JS, Ali SM. Genomic Profiling of Combined Hepatocellular Cholangiocarcinoma Reveals Genomics Similar to Either Hepatocellular Carcinoma or Cholangiocarcinoma. JCO Precis Oncol 2021;5:PO. [PMID: 34476330 DOI: 10.1200/PO.20.00397] [Reference Citation Analysis]
660 Sundlöv A, Sjögreen-Gleisner K. Peptide Receptor Radionuclide Therapy - Prospects for Personalised Treatment. Clin Oncol (R Coll Radiol) 2021;33:92-7. [PMID: 33189510 DOI: 10.1016/j.clon.2020.10.020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
661 Cigrovski Berkovic M, Ulamec M, Marinovic S, Balen I, Mrzljak A. Malignant insulinoma: Can we predict the long-term outcomes? World J Clin Cases 2022; 10(16): 5124-5132 [DOI: 10.12998/wjcc.v10.i16.5124] [Reference Citation Analysis]
662 Li Z, Chen F, Zhang S, Ma X, Xia Y, Shen F, Lu Y, Shao C. The feasibility of MRI-based radiomics model in presurgical evaluation of tumor budding in locally advanced rectal cancer. Abdom Radiol (NY) 2022;47:56-65. [PMID: 34673995 DOI: 10.1007/s00261-021-03311-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
663 Lu J, Ding Y, Chen Y, Jiang J, Chen Y, Huang Y, Wu M, Li C, Kong M, Zhao W, Wang H, Zhang J, Li Z, Lu Y, Yu X, Jin K, Zhou D, Zhou T, Teng F, Zhang H, Zhou Z, Wang H, Teng L. Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets. Nat Commun 2021;12:3946. [PMID: 34168152 DOI: 10.1038/s41467-021-24170-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
664 Fazio N, Spada F, Bertani E. Looking for the right TNM staging system for pancreatic neuroendocrine tumors. Hepatobiliary Surg Nutr 2021;10:382-4. [PMID: 34159169 DOI: 10.21037/hbsn-2021-1] [Reference Citation Analysis]
665 Talaat IM, Yakout NM, Soliman AS, Venkatachalam T, Vinod A, Eldohaji L, Nair V, Hareedy A, Kandil A, Abdel-rahman WM, Hamoudi R, Saber-ayad M. Evaluation of Galanin Expression in Colorectal Cancer: An Immunohistochemical and Transcriptomic Study. Front Oncol 2022;12:877147. [DOI: 10.3389/fonc.2022.877147] [Reference Citation Analysis]
666 Fortunati E, Argalia G, Zanoni L, Fanti S, Ambrosini V. New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms. Curr Treat Options Oncol 2022. [PMID: 35325412 DOI: 10.1007/s11864-022-00967-z] [Reference Citation Analysis]
667 Uccelli L, Boschi A, Cittanti C, Martini P, Panareo S, Tonini E, Nieri A, Urso L, Caracciolo M, Lodi L, Carnevale A, Giganti M, Bartolomei M. 90Y/177Lu-DOTATOC: From Preclinical Studies to Application in Humans. Pharmaceutics 2021;13:1463. [PMID: 34575538 DOI: 10.3390/pharmaceutics13091463] [Reference Citation Analysis]
668 Babu BI, Shapiro AMJ. Current Evidence in the Management of Premalignant Cystic Lesions of the Pancreas in Patients Undergoing Liver Transplantation. Pancreas 2022;51:117-20. [DOI: 10.1097/mpa.0000000000001974] [Reference Citation Analysis]
669 Schizas D, Mastoraki A, Routsi E, Papapanou M, Tsapralis D, Vassiliu P, Toutouzas K, Felekouras E. Combined hepatocellular-cholangiocarcinoma: An update on epidemiology, classification, diagnosis and management. Hepatobiliary Pancreat Dis Int 2020;19:515-23. [PMID: 32753331 DOI: 10.1016/j.hbpd.2020.07.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
670 Park JH, Yoon JY, Hwang SW, Park SH, Yang DH, Ye BD, Myung SJ, Yang SK, Byeon JS. A Surveillance Endoscopy Strategy Based on Local Recurrence Rates after Colorectal Endoscopic Submucosal Dissection. J Clin Med 2021;10:4591. [PMID: 34640609 DOI: 10.3390/jcm10194591] [Reference Citation Analysis]
671 Du Z, Yan D, Li Z, Gu J, Tian Y, Cao J, Tang Z. Genes Involved in the PD-L1 Pathway Might Associate with Radiosensitivity of Patients with Gastric Cancer. J Oncol 2020;2020:7314195. [PMID: 32963532 DOI: 10.1155/2020/7314195] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
672 Cree IA, Indave BI. Commentary: Cancer research quality and tumour classification. Tumour Biol 2020;42:1010428320907544. [PMID: 32098581 DOI: 10.1177/1010428320907544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
673 Tong C, Wang W, Xia Y, He C. A potential novel biomarker in predicting lymph node metastasis of gastric signet ring cell carcinoma: A derived monocyte to lymphocyte ratio. Am J Surg 2021:S0002-9610(21)00618-8. [PMID: 34702491 DOI: 10.1016/j.amjsurg.2021.10.026] [Reference Citation Analysis]
674 Takashina Y, Kudo SE, Ichimasa K, Kouyama Y, Mochizuki K, Akimoto Y, Maeda Y, Mori Y, Misawa M, Ogata N, Kudo T, Hisayuki T, Hayashi T, Wakamura K, Sawada N, Baba T, Ishida F, Yokoyama K, Daita M, Nemoto T, Miyachi H. Clinicopathological features of small T1 colorectal cancers. World J Clin Cases 2021; 9(33): 10088-10097 [PMID: 34904078 DOI: 10.12998/wjcc.v9.i33.10088] [Reference Citation Analysis]
675 Ma G, Li G, Xiao Z, Gou A, Xu Y, Song S, Guo K, Liu Z. Narrative review of intraductal papillary mucinous neoplasms: pathogenesis, diagnosis, and treatment of a true precancerous lesion. Gland Surg 2021;10:2313-24. [PMID: 34422602 DOI: 10.21037/gs-21-450] [Reference Citation Analysis]
676 Xu J. Current treatments and future potential of surufatinib in neuroendocrine tumors (NETs). Ther Adv Med Oncol 2021;13:17588359211042689. [PMID: 34484432 DOI: 10.1177/17588359211042689] [Reference Citation Analysis]
677 Mathai AM, Alexander J, Huang HY, Li CF, Jeng YM, Fung KM, Harris WP, Swanson PE, Truong C, Yeh MM. S100P as a marker for poor survival and advanced stage in gallbladder carcinoma. Ann Diagn Pathol 2021;52:151736. [PMID: 33798925 DOI: 10.1016/j.anndiagpath.2021.151736] [Reference Citation Analysis]
678 Chen Y, Lu Q, Zhang W, Cao J, Dong Y, Wang W. Preoperative Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Nomogram Based on Ultrasonographic Features and Clinical Indicators. Front Oncol 2022;12:757774. [PMID: 35242699 DOI: 10.3389/fonc.2022.757774] [Reference Citation Analysis]
679 Wang Y, Wang X, Huang X, Zhang J, Hu J, Qi Y, Xiang B, Wang Q. Integrated Genomic and Transcriptomic Analysis reveals key genes for predicting dual-phenotype Hepatocellular Carcinoma Prognosis. J Cancer 2021;12:2993-3010. [PMID: 33854600 DOI: 10.7150/jca.56005] [Reference Citation Analysis]
680 Jiang H, Shao D, Zhao P, Wu Y. The Predictive and Guidance Value of Signet Ring Cell Histology for Stage II/III Colon Cancer Response to Chemotherapy. Front Oncol 2021;11:631995. [PMID: 33708632 DOI: 10.3389/fonc.2021.631995] [Reference Citation Analysis]
681 Pellat A, Cottereau AS, Terris B, Coriat R. Neuroendocrine Carcinomas of the Digestive Tract: What Is New? Cancers (Basel) 2021;13:3766. [PMID: 34359666 DOI: 10.3390/cancers13153766] [Reference Citation Analysis]
682 Goh BKP, Park RHS, Koh YX, Teo JY, Tan EK, Cheow PC, Thng CH, Low AS, Tan DM, Chow PKH, Chan CY, Chung AYF, Ooi LLPJ. Changing trends in the clinicopathological features, practices and outcomes in the surgical management for cystic lesions of the pancreas and impact of the international guidelines: Single institution experience with 462 cases between 1995-2018. Pancreatology 2020;20:1786-90. [PMID: 33008749 DOI: 10.1016/j.pan.2020.09.019] [Reference Citation Analysis]
683 Chen G, Xu R, Yue B, Jia M, Li P, Ji M, Zhang S. A Parallel Comparison Method of Early Gastric Cancer: The Light Transmission-Assisted Pathological Examination of Specimens of Endoscopic Submucosal Dissection. Front Oncol 2021;11:705418. [PMID: 34414114 DOI: 10.3389/fonc.2021.705418] [Reference Citation Analysis]
684 Yozgat A, Kekilli M, Altay M. Time to give up traditional methods for the management of gastrointestinal neuroendocrine tumours. World J Clin Cases 2021; 9(29): 8627-8646 [PMID: 34734042 DOI: 10.12998/wjcc.v9.i29.8627] [Reference Citation Analysis]
685 Gu J, Xie S, Wang S, Xue L, Zhou J, Li M, Fan Z, Chen R, Middleton DRS, Hao C, Wang J, Li B, Li X, Wei W. Surveillance of premalignant gastric cardia lesions: A population-based prospective cohort study in China. Int J Cancer 2021;149:1639-48. [PMID: 34181269 DOI: 10.1002/ijc.33720] [Reference Citation Analysis]
686 Virarkar M, Saleh M, Diab R, Taggart M, Bhargava P, Bhosale P. Hepatic Hemangioendothelioma: An update. World J Gastrointest Oncol 2020; 12(3): 248-266 [PMID: 32206176 DOI: 10.4251/wjgo.v12.i3.248] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
687 Fang X, Liu F, Li J, Cao K, Wang T, Zhang H, Li Q, Meng Y, Yu J, Feng X, Jiang H, Wang L, Lu J, Shao C, Bian Y. Computed tomography nomogram to predict a high-risk intraductal papillary mucinous neoplasm of the pancreas. Abdom Radiol (NY) 2021;46:5218-28. [PMID: 34409514 DOI: 10.1007/s00261-021-03247-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
688 Ren SJ, Wang X, Ke NW, Tan QQ, Yang F, Yao WQ, Tan CL, Liu XB. Clinicopathological features and long-term prognosis of purely cystic pancreatic neuroendocrine tumors: A single center experience. Asian J Surg 2022:S1015-9584(22)00975-7. [PMID: 35850904 DOI: 10.1016/j.asjsur.2022.07.029] [Reference Citation Analysis]
689 Sanvito F, Gallotti A, Cobianchi L, Vanoli A, Cho NS, Preda L. Magnetic Resonance Diffusion-Weighted Imaging for Detecting Fundal Intracholecystic Papillary Neoplasm inside Rokitansky-Aschoff Sinuses: A Comparison of Two Cases and a Literature Review. Radiation 2022;2:52-61. [DOI: 10.3390/radiation2010004] [Reference Citation Analysis]
690 Sa-ngiamwibool P, Aphivatanasiri C, Sangkhamanon S, Intarawichian P, Kunprom W, Thanee M, Prajumwongs P, Loilome W, Khuntikeo N, Titapun A, Jareanrat A, Thanasukarn V, Srisuk T, Luvira V, Eurboonyanun K, Promsorn J, Wee A, Koonmee S. Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand. HPB 2022. [DOI: 10.1016/j.hpb.2022.06.004] [Reference Citation Analysis]
691 Da Fonseca LG, Hashizume PH, de Oliveira IS, Izquierdo-sanchez L, Saud LRDC, Xerfan MP, Alves VAF, de Mello ES, Herman P, Banales JM, Oliveira CP, Carrilho FJ. Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence. Cancers 2022;14:3483. [DOI: 10.3390/cancers14143483] [Reference Citation Analysis]
692 Manivannan S, Sharouf F, Lammie G, Leach P. Unusual cause of a painless soft tissue mass of the scalp: a rare presentation of primary intracranial neuroendocrine neoplasm. BMJ Case Rep 2021;14:e236856. [PMID: 33619129 DOI: 10.1136/bcr-2020-236856] [Reference Citation Analysis]
693 Zhang G, Li B, Yin X, Gao S, Shen S, Wang H, Shi X, Liu W, Zheng K, Jing W, Zhang Y, He T, Li G, Hu X, Guo S, Jin G. Systemic therapy and perioperative management improve the prognosis of pancreatic ductal adenocarcinoma: A retrospective cohort study of 2000 consecutive cases. Int J Surg 2022;104:106786. [PMID: 35868619 DOI: 10.1016/j.ijsu.2022.106786] [Reference Citation Analysis]
694 Karls S, Gold R, Kravets S, Wang Y, Cheng S, Perez K, Chan J, Jacene H. Correlation of 68Ga-DOTATATE uptake on PET/CT with pathologic features of cellular proliferation in neuroendocrine neoplasms. Ann Nucl Med 2021;35:1066-77. [PMID: 34146243 DOI: 10.1007/s12149-021-01642-3] [Reference Citation Analysis]
695 Ren T, Zhang W, Li S, Deng L, Xue C, Li Z, Liu S, Sun J, Zhou J. Combination of clinical and spectral-CT parameters for predicting lymphovascular and perineural invasion in gastric cancer. Diagnostic and Interventional Imaging 2022. [DOI: 10.1016/j.diii.2022.07.004] [Reference Citation Analysis]
696 Cho SH, Park BS, Son GM, Kim HS, Kim SJ, Park SB, Choi CW, Kim HW, Shin DH, Yun MS. Differences in Factors Predicting Lymph Node Metastasis Between pT1 Rectal Cancer and pT1 Colon Cancer: A Retrospective Study. Am Surg 2022;:31348221111517. [PMID: 35766839 DOI: 10.1177/00031348221111517] [Reference Citation Analysis]
697 Refardt J, Hofland J, Wild D, Christ E. New Directions in Imaging Neuroendocrine Neoplasms. Curr Oncol Rep 2021;23:143. [PMID: 34735669 DOI: 10.1007/s11912-021-01139-2] [Reference Citation Analysis]
698 Heo JH, Choi EJ, Yu SJ, Park YH, Choi JS. Neuroendocrine Tumor with Metachronous Gastrointestinal Stromal Tumor in a Patient: A Case Report. Korean J Gastroenterol 2022;79:72-6. [PMID: 35232922 DOI: 10.4166/kjg.2022.020] [Reference Citation Analysis]
699 Vitali E, Piccini S, Trivellin G, Smiroldo V, Lavezzi E, Zerbi A, Pepe G, Lania AG. The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors. Mol Cell Endocrinol 2021;527:111226. [PMID: 33675866 DOI: 10.1016/j.mce.2021.111226] [Reference Citation Analysis]
700 Wang M, Ding D, Qin T, Wang H, Liu Y, Liu J, Liu J, Zhang H, Zhao J, Wu CH, Javed A, Wolfgang C, Guo S, Chen Q, Zhao W, Shi W, Zhu F, Guo X, Li X, He R, Xu S, Edil B, Tien YW, Jin G, Zheng L, He J, Qin R; Minimally Invasive Pancreas Treatment Group in the Pancreatic Disease Branch of China's International Exchange and Promotion Association for Medicine and Healthcare. New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification []. Cancer Lett 2021;518:207-13. [PMID: 34271105 DOI: 10.1016/j.canlet.2021.07.018] [Reference Citation Analysis]
701 Zhang Q, Han Y, Zhang Y, Liu D, Ming J, Huang B, Qiu X. Treatment-Emergent Neuroendocrine Prostate Cancer: A Clinicopathological and Immunohistochemical Analysis of 94 Cases. Front Oncol 2020;10:571308. [PMID: 33598420 DOI: 10.3389/fonc.2020.571308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
702 Vinagre J, Pinheiro J, Martinho O, Reis RM, Preto J, Soares P, Lopes JM. A 30-Year Long-Term Experience in Appendix Neuroendocrine Neoplasms-Granting a Positive Outcome. Cancers (Basel) 2020;12:E1357. [PMID: 32466539 DOI: 10.3390/cancers12061357] [Reference Citation Analysis]
703 Koffas A, Toumpanakis C. Comparative safety review of the current therapies for gastroenteropancreatic neuroendocrine tumors. Expert Opin Drug Saf 2021;20:321-34. [PMID: 33338383 DOI: 10.1080/14740338.2021.1867097] [Reference Citation Analysis]
704 Chu YX, Gong HY, Hu QY, Song QB. Adenosquamous carcinoma may have an inferior prognosis to signet ring cell carcinoma in patients with stages I and II gastric cancer. World J Gastrointest Oncol 2020; 12(1): 101-112 [PMID: 31966918 DOI: 10.4251/wjgo.v12.i1.101] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
705 Jacob S, Bösch F, Schoenberg MB, Pretzsch E, Lampert C, Haoyu R, Renz BW, Michl M, Kumbrink J, Kirchner T, Werner J, Angele MK, Neumann J. Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosis. BMC Cancer 2021;21:1243. [PMID: 34794407 DOI: 10.1186/s12885-021-08927-w] [Reference Citation Analysis]